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HIV/AIDS poses a threat to the productivity and growth of organisations. The construction sector 
not only stands to be threatened by the disease, but also poses as a contributor to the spread of the 
HIV virus. A combined survey and case study approach was employed to determine the responses 
to HIV/AIDS of construction companies in the Western Cape area. An exploratory survey was 
conducted through an online questionnaire to ascertain the perceptions of HIV/AIDS as a threat 
and to reveal the nature of interventions employed. Findings from the survey of 42 construction 
participants revealed moderately strong perceptions of HIV/AIDS as a long-term threat. This is 
however not coupled with a comprehensive response as the focus of the majority of HIV/AIDS 
interventions take the form of HIV/AIDS awareness and prevention campaigns. The provision of 
HIV/AIDS treatment programmes is not common due to a lack of perceived need, non-disclosure, 
perceived cost implications, size of companies, fears of stigmatisation of HIV positive people, 
and a lack of knowledge on how to provide these services. 
 
Follow-up face-to-face case study interviews were conducted with 12 construction participants, 
making use of a case study protocol. Six of the construction companies were considered for 
analysis as they provided an in-depth account of construction professionals’ experiences in 
dealing with HIV/AIDS. Common among construction companies is the use of an external 
service provider in the provision of awareness and prevention campaigns and to a certain extent 
treatment programmes. Treatment programmes are not popular as a result of perceptions of high 
costs of provision and the invisibility of the HIV/AIDS disease. Perceptions of high costs were 
not confirmed by companies providing treatment as they reported on benefits outweighing costs 
of paying for treatment and high levels of disclosure by HIV positive employees. Despite efforts 
by construction companies in managing HIV/AIDS in the workplace, their responses lacks 
comprehensiveness in preventing new infections and managing existing infections. It is 
recommended that professional associations for construction companies play a proactive role to 
embark on an HIV/AIDS treatment campaign by providing guidelines based on examples of 

















Table of Contents 
 
Declarations ………………………………………………………………………………………...i	  
Acknowledgements .......................................................................................................................... ii	  
Abstract……………………………………………………………………………………………iii	  
List of Figures .................................................................................................................................. ix	  
List of Tables .................................................................................................................................... x	  
List of Abbreviations ....................................................................................................................... xi	  
CHAPTER 1: Research Overview ................................................................................................... 1	  
1.1	   Introduction ..................................................................................................................... 1	  
1.2	   Background to the Study ................................................................................................. 1	  
1.3	   Definition of HIV/AIDS ................................................................................................. 3	  
1.4	   HIV/AIDS in Africa and Southern Africa ...................................................................... 4	  
1.5	   HIV/AIDS in South Africa ............................................................................................. 6	  
1.6	   HIV/AIDS and the Workplace ........................................................................................ 7	  
1.7	   HIV/AIDS in the South African Construction Industry .................................................. 8	  
1.8	   Problem Statement ........................................................................................................ 10	  
1.9	   Research Questions ....................................................................................................... 10	  
1.10	   Research Proposition ..................................................................................................... 10	  
1.11	   Aim of the Research ...................................................................................................... 10	  
1.12	   Objectives of the Study ................................................................................................. 11	  
1.13	   Research Method ........................................................................................................... 11	  
1.14	   Limitations of the Study ................................................................................................ 11	  
1.15	   Structure of the Report .................................................................................................. 12	  
CHAPTER 2: HIV/AIDS in the South African Construction Industry .......................................... 13	  
2.1	   Introduction ................................................................................................................... 13	  
2.2	   Profile of the Construction Industry .............................................................................. 13	  
2.3	   Vulnerability of the Construction Industry to HIV/AIDS ............................................ 17	  
2.3.1	   Migratory labour ....................................................................................................... 17	  
2.3.2	   Workforce skills ........................................................................................................ 18	  
2.3.3	   Informal labour ......................................................................................................... 20	  
2.3.4	   Aging of the workforce ............................................................................................. 21	  
2.4	   HIV/AIDS Impact on the Business Sector .................................................................... 21	  












2.5.1	   HIV/AIDS workplace policy .................................................................................... 25	  
2.5.2	   HIV/AIDS workplace interventions ......................................................................... 26	  
2.5.3	   Government responses to the HIV/AIDS pandemic ................................................. 27	  
2.5.4	   Private sector response to the HIV/AIDS pandemic ................................................ 29	  
2.6	   Implementation of HIV/AIDS Treatment Programmes ................................................ 31	  
2.6.1	   Models of workplace treatment programmes ........................................................... 32	  
2.6.2	   Benefits of treatment provision to workers .............................................................. 34	  
2.6.3	   Motivations for implementing HIV/AIDS workplace programmes ......................... 34	  
2.6.4	   Barriers to the implementation of HIV/AIDS workplace programmes .................... 37	  
2.7	   Challenges faced by the Construction Industry ............................................................ 38	  
2.8	   Conclusion .................................................................................................................... 40	  
CHAPTER 3: An Opinion-Based Survey Research Design .......................................................... 41	  
3.1	   Introduction ................................................................................................................... 41	  
3.2	   Distinction between Surveys and Case Studies ............................................................ 42	  
3.3	   Survey-based Approaches ............................................................................................. 43	  
3.3.1	   A critical review of survey-based approaches .......................................................... 43	  
3.3.2	   Limitations of survey-based research approaches .................................................... 45	  
3.3.3	   Summary of issues .................................................................................................... 46	  
3.4	   Justification of a Combined Survey and Case Study Approach ................................... 47	  
3.5	   Survey Instrument Design ............................................................................................. 48	  
3.5.1	   Questionnaire design ................................................................................................ 48	  
3.6	   Conclusion .................................................................................................................... 49	  
CHAPTER 4: Survey Administration, Data Presentation, ............................................................. 50	  
Analysis and Interpretation ............................................................................................................. 50	  
4.1	   Introduction ................................................................................................................... 50	  
4.2	   Method of Data Collection ............................................................................................ 50	  
4.3	   Limitations of Survey .................................................................................................... 52	  
4.4	   Analysis of the Data and Discussion of the Results ...................................................... 53	  
4.4.1	   Demographic profile of survey respondents ............................................................. 53	  
4.4.2	   Perceptions of HIV/AIDS as a long term problem ................................................... 54	  
4.4.3	   Implementation of HIV/AIDS policies ..................................................................... 55	  
4.4.4	   Implementation of awareness, prevention and treatment programmes .................... 57	  
4.4.5	   HIV/AIDS and employees ........................................................................................ 61	  












4.4.7	   Participation of HIV positive staff on company treatment programmes .................. 63	  
4.4.8	   HIV-positive staff remaining on treatment programmes .......................................... 64	  
4.4.9	   Company involvement and HIV/AIDS .................................................................... 65	  
4.4.10	   Medical aid provision ........................................................................................... 66	  
4.4.11	   Responsibility of HIV/AIDS programmes ........................................................... 66	  
4.4.12	   Commitment of company to HIV/AIDS treatment programme ........................... 67	  
4.4.13	   Measure of success of treatment programmes ..................................................... 67	  
4.4.14	   Financial viability of treatment programmes ....................................................... 67	  
4.5	   Conclusions ................................................................................................................... 69	  
CHAPTER 5: Case-Study Approach .............................................................................................. 70	  
5.1	   Introduction ................................................................................................................... 70	  
5.2	   The Survey Issues to be Explored ................................................................................. 70	  
5.3	   Justification of a Case Study Approach ........................................................................ 71	  
5.4	   Case Study Research Design ......................................................................................... 73	  
5.4.1	   Units of analysis ....................................................................................................... 73	  
5.4.2	   Concerns of case selection ........................................................................................ 74	  
5.4.3	   Case selection ........................................................................................................... 75	  
5.4.4	   Case interview data requirements ............................................................................. 77	  
5.5	   Analytical Strategies ..................................................................................................... 78	  
CHAPTER 6: Case Study Analysis ................................................................................................ 79	  
6.1	   Introduction ................................................................................................................... 79	  
6.2	   CareWorks HIV Management Consultants ................................................................... 80	  
6.2.1	   Company Description ............................................................................................... 80	  
6.2.2	   Interview Summary .................................................................................................. 81	  
6.2.3	   Conclusion of Supplementary Case Study: CareWorks ........................................... 86	  
6.3	   Case Study 1 .................................................................................................................. 88	  
6.3.1	   Case details ............................................................................................................... 88	  
6.3.2	   Company description ................................................................................................ 88	  
6.3.3	   Interview summary ................................................................................................... 88	  
6.3.4	   Conclusion of case study on company A .................................................................. 94	  
6.4	   Case Study 2 .................................................................................................................. 95	  
6.4.1	   Case details ............................................................................................................... 95	  
6.4.2	   Company description ................................................................................................ 95	  












6.4.4	   Conclusion of case study on company B .................................................................. 99	  
6.5	   Case Study 3 ................................................................................................................ 100	  
6.5.1	   Case details ............................................................................................................. 100	  
6.5.2	   Company description .............................................................................................. 100	  
6.5.3	   Interview summary ................................................................................................. 100	  
6.5.5	   Conclusion of case study on company C ................................................................ 107	  
6.6	   Case Study 4 ................................................................................................................ 108	  
6.6.1	   Case details ............................................................................................................. 108	  
6.6.2	   Company description .............................................................................................. 108	  
6.6.3	   Interview summary ................................................................................................. 108	  
6.6.4	   Conclusion of case study on company D ................................................................ 111	  
6.7	   Case Study 5 ................................................................................................................ 112	  
6.7.1	   Case details ............................................................................................................. 112	  
6.7.2	   Company description .............................................................................................. 112	  
6.7.3	   Interview summary ................................................................................................. 112	  
6.7.4	   Conclusion of case study on company E ................................................................ 118	  
6.8	   Case Study 6 ................................................................................................................ 119	  
6.8.1	   Case details ............................................................................................................. 119	  
6.8.2	   Company description .............................................................................................. 119	  
6.8.3	   Interview summary ................................................................................................. 120	  
6.8.4	   Conclusion of case study on company F ................................................................ 124	  
6.9	   Conclusions Based on an Inter-Case Study Analysis of the Findings ........................ 125	  
6.9.1	   HIV/AIDS policy .................................................................................................... 127	  
6.9.2	   HIV/AIDS awareness campaigns ........................................................................... 127	  
6.9.3	   HIV/AIDS treatment programmes .......................................................................... 128	  
6.9.4	   Disclosure of HIV status ......................................................................................... 129	  
6.9.5	   Financial viability of HIV/AIDS treatment programmes ....................................... 130	  
6.9.6	   Challenges in the provision of HIV/AIDS programmes ......................................... 131	  
6.9.7	   Innovative approaches to HIV/AIDS programmes ................................................. 131	  
6.9.8	   HIV/AIDS “stories” ................................................................................................ 131	  
6.10	   Conclusion .................................................................................................................. 132	  
CHAPTER 7: Conclusions and Recommendations ..................................................................... 133	  
7.1	   Introduction ................................................................................................................. 133	  












7.3	   Validation of the Research Proposition ...................................................................... 136	  
8.0	   References ................................................................................................................... 140	  
Appendix A: Survey Questionnaire ......................................................................................... 149	  









































List of Figures 
 
Figure 1.1 HIV prevalence (%) in adults (aged 15-49 years) in Africa, 2007 ................................. 5 
Figure 2.1 Employment by industry and sex at the end of September 2009 .................................. 16	  
Figure 2.2 Age-specific HIV prevalence (%) for migrant and non-migrant men .......................... 18	  
Figure 2.3 HIV prevalence among construction employees by nature of employment ................. 19	  
Figure 2.4 Implementation of HIV/AIDS programmes among different industrial sectors ........... 30 






































List of Tables 
 
Table 2.1 Distribution of employment by company size (of annual turnover) in the formal sector – 
2009 ................................................................................................................................................ 14	  
Table 2.2 Employment by economic sector (September 2009) ..................................................... 15	  
Table 2.3 Implementation process of the HIV/AIDS awareness programme ................................ 28 
Table 4.1 Size of company by annual turnover .............................................................................. 54	  
Table 4.2 Existence of an HIV/AIDS policy within companies .................................................... 55	  
Table 4.3 Existence of awareness and prevention campaigns and treatment programmes ............ 57	  
Table 4.4 Relationship between presence of a treatment programme and policy implementation 
and other HIV/AIDS programmes .................................................................................................. 60	  
Table 4.5 Respondents’ assumption of HIV positive employees ................................................... 62	  
Table 4.6 Relationship between disclosure and other related factors ............................................. 64	  
Table 4.7 Support for HIV positive employees .............................................................................. 65	  
Table 4.8 Responsibility of HIV/AIDS programmes ..................................................................... 66 
Table 5.1 Case study interview design protocol.............................................................................77 



























List of Abbreviations 
 
AIDS   Acquired Immune Deficiency Syndrome 
ART   Anti-retroviral treatment 
ARVs   Anti-retrovirals 
ASSA   Actuarial Society of South Africa 
BER   Bureau for Economic Research 
CD4   Cluster of Differentiation 4 
GDP   Gross Domestic Product 
HAART  Highly Active Anti-retroviral Treatment 
HEARD  Health Economics and HIV/AIDS Research Division 
HIV   Human Immunodeficiency Disease 
HSRC   Human Sciences Research Council 
ILO   International Labour Organisation 
KAP   Knowledge, Attitude and Practices survey 
KZN   KwaZulu-Natal 
MRC   Medical Research Council 
MTCT   Mother to Child Transmission 
NGOs   Non-governmental Organisations 
OIs   Opportunistic Infections 
PLWHA  Person/People living with HIV/AIDS 
SA   South Africa 
SABCOHA  South African Business Council on HIV/AIDS 
SME   Small, Medium and Micro-enterprises 
STD(s)   Sexually Transmitted Disease(s) 
UNAIDS  United Nations Program on HIV/AIDS 
VCT   Voluntary Counselling and Testing 
WC   Western Cape 



















This chapter introduces the research topic. The purpose of the study is to establish the responses 
by Western Cape construction companies to the HIV/AIDS pandemic in South Africa. This 
chapter is divided into four sections. The first section is a brief background to the problem, which 
provides the context of the research problem on a global, regional and construction industry scale. 
In the second section, the research problem is concisely stated, followed by a formulation of the 
research questions and research proposition. Section three is an outline of the objectives of the 
research and a clearly defined research method. Limitations of the research are identified in this 
section, and lastly, an outline of the structure of the research report is given. 
 
1.2 Background to the Study 
 
Since the beginning of the global awareness and recognition of an HIV/AIDS epidemic in about 
1981, an estimated 60 million people have been infected with the HIV virus and 25 million have 
died of AIDS-related illnesses worldwide (UNAIDS, 2009). In the business sector alone, an 
estimated 28 million workers have been lost since 2005 due to HIV/AIDS (ILO, 2008). The 
effects of the disease extend beyond just the individual, resulting in extreme social and economic 
consequences (Fourie and Schonteich, 2002). HIV/AIDS deprives developing economies of 
already limited resources, deprives children of their parents, destroys a generation in the prime of 
their working lives, reduces life expectancy, and slows down economic growth (Drimie, 2002). 
 
In Africa, the vast majority of people infected with HIV are the most productive population aged 
between 15 and 49 years (USAID, 2008). As companies rely on this population for productivity, 
they can no longer assume that HIV/AIDS is a government’s responsibility alone because the 
disease poses a substantial threat to company productivity, profits and stability (Rau et al., 2002). 
In South Africa, the first established business coalition on HIV/AIDS was launched in the year 
2000, with the birth of the South African Business Coalition on HIV/AIDS (SABCOHA) 













Over the years, companies have been implementing different workplace HIV/AIDS strategies and 
interventions which include, inter alia: awareness and education; voluntary counselling and 
testing; prevention campaigns; and treatment and care programmes (Rosen et al., 2004a; 
Dickinson and Stevens, 2005). These responses have however been reported mostly among large 
companies (Rosen et al., 2007). Small to medium enterprises face various constraints to offering 
HIV/AIDS services (Connelly and Rosen 2005). 
 
While there has been an increase in responses among the various industrial sectors, the 
construction industry’s response has been slow compared to the manufacturing and financial 
services industries that are less vulnerable to HIV/AIDS (SABCOHA, 2006). Many of the 
construction industry’s responses have been described as following a slow and passive approach, 
characterised by once-off education and awareness campaigns (Meintjes et al., 2007). This has 
been attributed to a lack of effective leadership and legislation in the industry, which if present 
can govern the universal adoption of HIV/AIDS programmes (ILO, 2008). 
 
Construction is particularly prone to the effects of the HIV/AIDS pandemic, due to the large 
informal workforce, high usage of migrant labour (DPW, 2004), and risk factors associated with 
the industry’s workforce which include: the age of the workforce, nature of employment and the 
nature of occupation (Bowen et al., 2008). The construction industry’s response is of particular 
importance because of its contribution to the South African economic growth. In 2008, the 
industry contributed an estimated 3.4% of the country’s Gross Domestic Product (GDP) (StatsSA, 
2008). Furthermore it plays a significant role that extends from strengthening economic 
performance to creating one of the largest employment opportunities (CIDB, 2004). 
 
Before establishing the nature of the study, a brief review of the definition of HIV/AIDS and the 
nature of the disease is necessary to provide an insight into the illness. This is followed by a 


















1.3 Definition of HIV/AIDS 
 
AIDS is a disease caused by the Human Immunodeficiency Virus (HIV) which leads to the 
suppression of the body’s immune system, and therefore allows opportunistic pathogens to cause 
diseases in HIV-infected persons (Walensky et al., 2006). Opportunistic diseases can be classified 
as respiratory infections, oral and gastrointestinal infections, skin conditions, neurological 
infections and genital tract infections (ILO, 2007). 
 
The time-period between HIV infection and the onset of AIDS-identifying opportunistic 
infections can range from eight to ten years (Patterson, 2008), meaning that one can live for years 
with the HIV virus. The progression of HIV/AIDS from infection to full-blown AIDS constitutes 
the following clinical stages and symptoms identified by WHO (2005, p.5): 
 
Primary HIV infection – asymptomatic, acute retroviral syndrome. 
 
Clinical Stage 1 – asymptomatic and persistent swollen lymph nodes. 
 
Clinical Stage 2 – moderate unexplained weight loss which is <10% of presumed or measured 
body weight, respiratory tract infections, herpes and oral ulcerations. 
 
Clinical Stage 3 – chronic diarrhoea lasting longer than one month, persistent fever, severe 
weight loss which is >10% of presumed or measured body weight, severe bacterial infection and 
unexplained anaemia. 
 





The preferred method that is currently available for treatment of HIV/AIDS is antiretroviral 
therapy. A standard antiretroviral therapy (ART) consists of the use of at least three antiretroviral 
(ARV) drugs to maximally suppress the HIV virus and stop the progression of the HIV disease 
(WHO, 2009). This form of treatment has been reported to reduce mortality and opportunistic 












The criteria for HIV patients to be started on treatment are based on WHO (2009) 
recommendations. These state that for patients with HIV and WHO clinical stage 1 or 2 to start 
antiretroviral treatment, CD4 count testing is required. A CD4 count test determines the number 
of fighting cells in the blood. The normal CD4 count in adolescents and adults ranges from 500 to 
1500 cells per cubic millimetre of blood (WHO, 2007). According to WHO recommendations, 
ART should start in all patients with a CD4 count < 350 cells per cubic millimetre irrespective of 
clinical symptoms and in all patients with HIV and assessed as WHO clinical stage 3 or 4 
irrespective of CD4 count (WHO, 2009). 
 
With effective ART treatment HIV-positive individuals can live longer and healthier lives, 
meaning that workers can continue being productive whilst on HIV/AIDS treatment (Auerbach, 
2004). However, compliance with treatment regimens is essential to continued good health (Hope 
and Israel, 2007). 
 
1.4 HIV/AIDS in Africa and Southern Africa 
 
In 2004, WHO (2004) reported HIV/AIDS as the leading cause of death in Africa and the sixth 
cause of death globally. The pandemic remains an enormous economic, social and human 
challenge in Africa (World Bank, 2008). National HIV prevalence rates amongst adults vary from 
country to country across Africa. 
 
With reference to Figure 1.1, North Africa recorded the lowest prevalence rates at below 1% 
West and Central Africa recorded HIV prevalence rates below 2% in the range 1 to 5%. In seven 
Southern African countries including South Africa, HIV prevalence rates exceeded 15% and fell 
in the range 10 to 28% (UNAIDS 2008a). High HIV prevalence rates in Africa are attributed to 
the presence of poverty, natural disasters, violence and social turmoil (Bingham, 1999). These 




















Figure 1.1 HIV prevalence (%) in adults (aged 15-49 years) in Africa, 2007 
(Source: UNAIDS, 2008a: p. 39) 
 
Although HIV/AIDS is most prevalent in African countries (UNAIDS, 2008a), Sub-Saharan 
Africa remains the epicentre of the epidemic (UNAIDS and WHO, 2009). As illustrated by 
Figure 1.1, the Sub-Saharan region presented the highest HIV prevalence rates, exceeding 10%. 
In 2008, an estimated 22.4 million people were living with HIV in this region, representing two-
thirds of the total number of people living with HIV globally (UNAIDS, 2008a). Development 
goals in the Sub-Saharan region have been threatened by the burden of HIV/AIDS, unlike 


















1.5 HIV/AIDS in South Africa 
 
In 2007, HIV data from population based surveys and ASSA modelling recorded South Africa as 
the country with the largest HIV epidemic in the world, with an estimated 5.7 million people 
living with HIV (UNAIDS, 2008a). Having borne one of the largest epidemics, the responses in 
South Africa have been marginalised due to apartheid politics and democratic transition (Meintjes 
et al., 2007).  
 
During the apartheid era, initiatives by the regime were questioned and not well received 
(Ashforth, 2001). Following that, the subsequent government of national unity denied HIV/AIDS 
as a social problem, further impeding the government’s response (Nattrass, 2004). 
 
In 1999, the government acted as a major barrier to the provision of medication to AIDS patients 
when President Thabo Mbeki questioned the usefulness of ARV drugs and whether HIV was the 
cause of AIDS (Chigwedere et al., 2008). A lack of leadership involvement and commitment 
delayed disclosure of accurate HIV/AIDS data and the development of adequate interventions 
(Meintjes et al., 2007). As a result, the South African government’s response has been mixed, 
with slow policy and programme implementation (Gauri and Lieberman, 2004). 
 
According to UNAIDS (2004), treatment and care policy changes were driven by pressure from 
the country’s HIV-positive community, prominent legal and health professionals, and many 
national and international NGOs. In October 2003, after pressure from civil society organisations 
such as the Treatment Action Campaign (TAC), the government began the national rollout of 
antiretroviral drugs to HIV-infected people (Nattrass, 2004). Since the rollout, an indication of 
progress has been reported through stabilising prevalence levels even though prevalence rates 
remain high as fewer people die from AIDS-related illnesses (UNAIDS, 2008a). 
 
Even though South Africa is claimed to have the largest ART programme in the world (HSRC, 
2008), challenges are still rife as demand exceeds supply (Nattrass, 2006). Of the one million 
chronically AIDS-ill individuals that were targeted to be enrolled on the ART national 
programme by 2008, fewer than 50% of these individuals were actually enrolled (Gow, 2009). 
This failure has been met with lack of political commitment and an inadequate public health 












Continued poor management of the disease at a national level has resulted in the shift of 




1.6 HIV/AIDS and the Workplace 
 
Employers have come to the realisation that HIV/AIDS not only results in the loss of workers but 
dramatically affects the labour market, stalling economic activity and social progress (UNAIDS 
2002). The impact on economies is severe, with a study of 33 countries worldwide estimating an 
18% loss of the Gross Domestic Product by 2020, which is a representative cumulative shortfall 
of USD 144 billion in lost growth due to HIV/AIDS (ILO, 2008). 
 
Even though businesses have recognised the impact that the HIV virus has on human, financial 
and social costs to business operations and host communities (UNAIDS et al., 2000), the 
responses by most businesses have been isolated (UNAIDS, 2008b). Some companies merely 
focus on their core business and do not have time to address the epidemic, whilst other companies 
are aware of the risks but lack the knowledge about how or where to start mitigating the risks 
(UNAIDS, 2008b). 
 
Among the first in the private sector to respond to HIV/AIDS was the mining industry, which was 
the first to be confronted with HIV/AIDS in South Africa in the mid-1980s, with comparatively 
high rates of infection (IFC, 2002; Mapolisa et al., 2004). The mining sector continues to 
outperform other industries such as retailers, wholesalers, vehicle dealers and the building and 
construction sector in terms of implementing voluntary counselling and testing (VCT) 
programmes and care, support and treatment programmes (SABCOHA, 2005). Across different 
company sizes, large companies have been leading in the provision of HIV/AIDS services to 


















1.7 HIV/AIDS in the South African Construction Industry 
 
Since the beginning of the decade, in the early 2000s, the South African construction industry has 
undergone dramatic growth (IOM, 2010). In 2001, the formal and informal sectors of the industry 
employed 520,000 workers (CIDB, 2004). By mid-2009, these two sectors had more than 
doubled, employing about 1.1 million workers, which represented 8.3% of the country’s 
workforce (IOM, 2010). 
Being a significant employer in the country, construction enterprises are at risk because of the 
impact of HIV/AIDS on their workforce (ILO, 2008). Lost days of work among construction 
workers is a major concern for the industry (Haupt et al., 2005). In 2005, a study indicated a loss 
of up to a month’s work per employee per year due to HIV-related absenteeism in South African 
businesses (Meintjes et al., 2007). In terms of costs, direct and indirect costs of HIV/AIDS for 
construction companies were estimated to be in the range of 4.5 to 7.9% of labour costs (ILO, 
2008). 
The construction industry not only stands to be affected by the disease, but also emerges as a high 
contributor to the spread of the HIV virus (Meintjes et al., 2007). The nature of the work requires 
the continuous migration of the labour force from their homes to the construction sites (Dickinson 
and Versteeg, 2004). Consequently, construction workers often live a nomadic, on-site lifestyle, 
in temporary accommodation, away from their families and support systems for long periods of 
time, with few recreational facilities (IOM, 2010). 
On these sites, workers are prone to visit sex workers or have multiple sexual partners, increasing 
their risk of contracting HIV (Fourie and Schonteich, 2002), while far-removed from the 
proximity of health care facilities (Bowen et al., 2008). In cases where health care facilities are 
available, undocumented (illegal) workers may be reluctant to seek medical services for fear of 
harassment or deportation (IOM, 2010). Such conditions create a fertile environment for the 
transmission of the HIV virus, as other sexually transmitted diseases or infections may go 
untreated for long periods of time. 
The research documented in this thesis has been informed by earlier studies done on HIV/AIDS 
in the South African construction industry. One of the first studies of HIV/AIDS interventions in 
the construction industry in South Africa was done by Haupt and Smallwood (2002), who 












The HIV/AIDS intervention activities reported were the presence of HIV/AIDS policies and the 
distribution of educational material. There were no reports of interventions extending beyond 
awareness. Similar findings from Meintjes et al. (2007) reported HIV/AIDS interventions 
implemented by independent companies being limited to awareness initiatives at project level. 
Meintjes et al. (2007) called for a sector-specific response with an increased focus on HIV/AIDS 
that extends beyond awareness and education only. 
 
A study by Bowen et al. (2008) highlighted the threat of HIV/AIDS to the construction industry 
by showing the extent of HIV/AIDS prevalence among construction workers in South Africa. The 
study covered 55 construction companies countrywide. Out of 10,243 workers who were tested, 
1,430 (13.96%) were HIV positive. Although the study did not cover the full extent of HIV 
prevalence countrywide, the results show to some degree the extent of HIV/AIDS prevalence in 
the construction industry. In comparison to the national HIV prevalence rate of the total 
population in 2008 (10.9%), the construction industry recorded a higher HIV prevalence (Shisana 
et al., 2008). 
 
Evidence from various studies has indicated the prevalent adoption of awareness and prevention 
interventions in the construction industry. The SABCOHA (2005) study reported on the 
implementation of awareness, prevention and treatment programmes. Evidence showed that 31% 
of construction companies had implemented an HIV/AIDS workplace awareness programme; 
15% provided VCT; 10% had instituted an HIV/AIDS care, support and treatment programme; 
and only 3% provided ART. Another review of the interventions undertaken by general building 
contractors reported the use of posters, awareness education (speaker), pamphlets / flyers, 
provision of condoms and induction as the most prevalent (Smallwood et al., 2001). 
 
In view of the high HIV prevalence among the construction workforce, the response by 
construction companies does not constitute a comprehensive response to curb the disease. 
Surprisingly, given the increased drive for corporate reporting on HIV/AIDS among listed 
companies (Fakier, 2004) and a drive towards good corporate governance in large South African 
companies (Dickinson and Stevens, 2005), the construction industry’s response is still lacking. 
Much of the awareness and prevention initiatives are targeted towards preventing new infections, 












The focus of this study then, is to explore in detail the type of responses that companies operating 
in the Cape Town area have implemented, their reasons for such responses and the potential 
barriers to the implementation of treatment programmes. 
 
1.8 Problem Statement  
 
The problem to be examined in this study is stated as follows: 
The construction industry’s response to HIV/AIDS lacks comprehensive intervention 
programmes, with the majority of the programmes focusing largely on awareness and 
prevention with little emphasis on treatment programmes. 
 
1.9 Research Questions 
 
The research questions to be addressed are as follows: 
a. What are the perceptions of HIV/AIDS as a threat to the construction industry? 
b. What are the responses of construction companies to HIV/AIDS in the Western Cape 
construction industry? 
c. What are the barriers to the implementation of treatment programmes within construction 
companies? 
d. What are the benefits of implementing treatment programmes within construction 
companies? 
 
1.10 Research Proposition 
 
The study is based on the following proposition: 
The benefits of implementing treatment programmes outweigh those of non-
implementation, rendering the implementation of treatment programmes an effective 
response. 
 
1.11 Aim of the Research 
 
The aim of this research study is to: 













1.12 Objectives of the Study 
 
The objectives of this study are to: 
 
a. Establish the perceptions of construction firms regarding the extent of the HIV/AIDS threat to 
the industry. 
b. Establish the nature of existing programmes that address HIV/AIDS in construction 
companies. 
c. Examine how construction companies have implemented treatment programmes. 
d. Establish the benefits of, and barriers to, implementing treatment programmes. 
 
1.13 Research Method 
 
To achieve the research objectives, the following research method is employed: 
 
1. A review of pertinent literature on the impacts of, and responses to HIV/AIDS in the 
construction industry. 
2. A questionnaire survey of construction participants on their perceptions of HIV/AIDS as a 
threat to the industry, and their workplace responses to the pandemic. 
3. Case studies of selected construction companies to examine the nature and extent of their 
responses to the HIV/AIDS pandemic. 
4. Analysis of the findings, conclusions and recommendations. 
 
1.14 Limitations of the Study 
 
The study is subject to the following limitations: 
 
a. The area of study is limited to construction companies in the Western Cape region of South 
Africa. Practical logistical reasons preclude expansion of the research to the whole of South 
Africa, particularly for the case studies. 
b. Considering the sensitivity of HIV/AIDS, obtaining statistical data relating to the HIV status 













1.15 Structure of the Report  
 
This research report is structured in seven chapters: 
 
Chapter One introduces the background to the study, highlighting the definition of HIV/AIDS, 
its impact on Africa and South Africa, and its impact on the workplace; specifically in the 
construction industry. This is followed by an outline of the research problem and research 
question. The research proposition is defined, followed by an outline of the aims and objectives 
of the study.  Finally, a description of the research method is provided, together with the 
limitations of the study. 
 
 
Chapter Two presents a critical review of the literature pertaining to HIV/AIDS in the South 
African construction industry. This chapter explores the impact of HIV/AIDS on the construction 
industry, the vulnerability of the construction industry to HIV/AIDS, the motivations for, and 
barriers to, responses by construction companies and the nature of responses. This chapter 
provides a conceptual framework that facilitates the empirical research in the chapters to follow. 
 
Chapter Three proposes an opinion-based survey research design to determine the nature and 
availability of workplace HIV/AIDS programmes. This chapter introduces the research methods 
to be adopted in this study and the justification thereof. 
 
Chapter Four comprises the analysis and interpretation of the questionnaire survey results, 
together with a discussion of the findings. 
 
Chapter Five describes a case study design to explore the underlying issues identified by the 
survey results. It aims to further explore the implementation or non-implementation of HIV/AIDS 
intervention programmes of selected construction companies in the Western Cape. 
 
Chapter Six comprises the analysis and interpretation of the case study results. 
 
Chapter Seven: presents a discussion of the findings, draws conclusions and makes 












CHAPTER 2: HIV/AIDS in the South African Construction Industry 
 
2.1 Introduction  
 
This literature review discusses the impact of HIV/AIDS on the South African construction 
industry, the industry’s vulnerability to the disease, and the nature of responses employed to fight 
HIV/AIDS in the construction workplace. While there is considerable information generally on 
workplace responses to HIV/AIDS, literature directly assessing the impact of HIV/AIDS on the 
construction industry and the type of responses employed is relatively limited. Much of the 
literature available is generalised and derived from studies across different industrial sectors. 
 
This chapter is divided into four sections. The first section provides an overview of the South 
African construction industry’s profile and its vulnerability to HIV/AIDS. The next section is a 
presentation of evidence-based findings on the impact of HIV/AIDS on the general business 
sector. Section three is the focus of this study as it analyses responses of the construction industry 
to HIV/AIDS by looking at the policies and the nature of government’s and the private sector’s 
responses. Of particular interest is the implementation of treatment programmes which looks at 
the motivations for providing treatment services to employees and the different models available. 
 
The fourth section will shed light on companies’ motivations for responding to HIV/AIDS and 
possible barriers for failure to respond, presenting challenges common to the construction 
industry in implementing comprehensive responses. Concluding the review is a summary of the 
important issues determined in the literature. 
 
2.2 Profile of the Construction Industry 
 
A collective description of the construction industry given by the CIDB (2004) describes it as an 
industry that delivers products in a uniquely project-specific environment involving different 
combinations of: investors, clients, contractual arrangements and consulting professions; site 
conditions, design, materials and technologies; contractors, specialist subcontractors, skills and 
the workforce. The general structure of the construction industry comprises innumerable 













Company sizes range from large to micro enterprises as categorised by Stats SA (2009a) 
according to their annual turnover. Statistics presented by Stats SA (2009) shows the distribution 
of employment among the different company sizes as illustrated in Table 2.1.  
 
Table 2.1 Distribution of employment by company size (of annual turnover) in the formal 
sector – 2009 
 
Size Annual Turnover  Employment Figures Percentage of 
total (%) 
Large Turnover ≥ R26m 190 681 35.3 
Medium R13m ≤ Turnover < R26m 126 804 23.5 
Small R6m ≤ Turnover < R13m 55 476 10.3 
Micro Turnover < R6m 167 620 31.0 
Total   540 581 100.0 
 
(Source: Stats SA, 2009a) 
 
As depicted in Table 2.1 large and micro-sized companies contribute the largest share of 
employment, 35% and 31% respectively. Statistics from 2008 showed a similar pattern, with 
large companies contributing 35.8% and micro contributing 30.8% to the total employment in the 
industry (Stats SA, 2008).  
 
In terms of the distribution of companies by sizes in the construction industry, the Construction 
Education and Training Authority (CETA) estimate 95% of construction enterprises to be small 
or micro organisations, both in the formal and informal sectors (Bowen et al., 2008). This could 
be attributed to the dominance of small to medium enterprises (SMEs) in the informal sector 
(Davies and Thurlow, 2009). 
 
The industry offers different types of services which include: site preparation; construction of 
buildings; construction of civil engineering structures; construction of other structures; construction 
by specialist trade contractors; plumbing; electrical contractors; shop fittings; other building 
installations; painting and decorating; and other building completion (Stats SA, 2008). Among these 
services, the largest employers and contributors of income are in the construction of buildings, 












In South Africa, the construction industry’s role is important to the country’s economic growth. 
In 2009, the industry contributed 3.9% towards the gross domestic product (GDP) (SABCOHA, 
2010). Investment in the construction sector has grown over the years, with an estimated 9.2% 
annual increase since 2000 (Quantec database). In 2008, the gross domestic fixed investment was 
reported at ZAR 5 billion (Quantec database). Although there was a significant contribution from 
private building activity, this expansion was mainly attributed to the public investment in 
stadiums and infrastructure.  
 
To the wider South African community, the industry forms the basis for all modern human 
endeavour, economic growth and social development (CIDB, 2004). This is achieved through 
facilitating the objectives of providing potable water, sewerage disposal, electrification, health, 
education, housing and productive employment (CIDB, 2004). The industry provides 
employment to a significant portion of the economy, as illustrated in Table 2.2.  
 
Table 2.2 Employment by economic sector (September 2009) 
 








Agriculture - - 653 000 5.07 
Mining 297 000 2 000 299 000 2.32 
Manufacturing 1 547 000 176 000 1 723 000 13.37 
Utilities 80 000 2 000 82 000 0.64 
Construction 804 000 253 000 1 057 000 8.20 
Trade 1 882 000 970 000 2 852 000 22.13 
Transport 179 000 558 000 737 000 5.72 
Finance 1 557 000 126 000 1 683 000 13.06 
Social services 2 341 000 286 000 2 627 000 20.39 
Private households - - 1 166 000 9.05 
Other 6 000 - 6 000 0.05 
Total 8 693 000 2 373 000 12 885 000 100.00 
 













Being an employer in both the formal and informal sectors, construction offers a wide range of 
jobs for different skills levels. The industry employs highly skilled workers such as consulting 
engineers, project managers, architects and quantity surveyors whose involvement is essential to 
the delivery of construction projects. Besides being an employer of skilled professionals, the 
industry also employs a significant number of semi-skilled and low-skilled workers such as 
labourers, machine operators and artisans. A breakdown of employment skills of different 
economic sectors presented in the HSRC (2008) report, reported the construction sector as the 
largest employer of semi-skilled workers. A reported 11% of all semi-skilled workers relative to 
all economic sectors belonged to the construction sector in 2004. 
 
Due to the nature of the job and the physical demands, the workforce is predominantly male. As 
shown in Figure 2.1, the construction industry employed the highest percentage of male workers 
in 2009 at 87% (Stats SA, 2009b). Moreover, compared to other industries, the industry has the 



















































































Figure 2.1 Employment by industry and sex at the end of September 2009 













The background information on the industry’s profile has provided an insight into understanding 
possible areas of concern in the context of HIV/AIDS. This leads to a discussion on the factors 
that make the construction industry vulnerable to HIV/AIDS. Reference is made to some of the 
relevant statistics presented above. 
 
2.3 Vulnerability of the Construction Industry to HIV/AIDS 
 
There are risk factors associated with working in the construction industry, which are likely to 
increase the HIV prevalence rate among the workforce. In construction, the workforce not only 
emerges as the most susceptible to the impact of HIV/AIDS but is also the largest contributor to 
the industry’s vulnerability (ILO, 2008). Meintjes et al. (2007) point out factors that increase the 
vulnerability of the construction workforce. These include the migratory nature of the workforce, 
the employment of informal labour, the tendency to employ semi-skilled and unskilled workforce, 
and the aging of the workforce. These factors are explained more fully below. 
 
2.3.1 Migratory labour 
Migration plays a major role in the spread of the HIV virus. For migrant workers, the spread of 
HIV/AIDS is generally as a result of men becoming infected while away from home and on 
returning, infecting their wives and/or regular partners (Isaksen et al., 2002). By being separated 
from their regular sexual partners, migrant workers are prone to engage in risky sexual behaviour 
with multiple sexual partners including sex workers (Fourie and Schonteich, 2002). Migrant 
workers are therefore susceptible to contracting and spreading HIV/AIDS (ILO, 2003). In a study 
on the impact of migration on HIV transmission in South Africa, migration was reported to be an 
















Statistical evidence presented in Figure 2.2 shows that migrant men have higher HIV prevalence 




























Figure 2.2 Age-specific HIV prevalence (%) for migrant and non-migrant men 
(Source: Lurie et al., 2003) 
The predilection of the construction industry to employ migrant labour is paramount to the 
industry’s vulnerability to HIV/AIDS (Haupt et al., 2005). There is an inherent migratory nature 
to construction, where the movement of labour is relatively high compared to other industries 
(IOM, 2010). A process of circular migration is created whereby migrant workers return home 
once their job is completed and return to work only when further work is available (IOM, 2010). 
The nature of migrant employment places workers in conditions that promote poor lifestyle 
choices that increase the risk of contracting HIV with little or no immediate health care facilities 
(Bowen et al., 2008). The risk of infection not only lies on the workers themselves, but also on 
their families and the communities sited near construction sites (Isaksen et al., 2002). 
 
2.3.2 Workforce skills 
SABCOHA (2006) identified two components of HIV/AIDS risk from the supply side. These 
include the HIV prevalence rate of the industry’s workforce and the level of skills of the 
workforce. Evidence from Bowen et al. (2008) and SABCOHA (2006) shows a comparatively 












These figures are comparable to that of the hardest hit region in South Africa, the province of 
KwaZulu-Natal, which recorded a prevalence of 15.8% among the general population in 2008 
(Shisana et al., 2009). High HIV prevalence among construction workers is attributed to the 
labour-intensive nature of the industry and its tendency to employ semi-skilled and unskilled 
workers who generally have a higher HIV prevalence rate than the general population (Evian et 
al., 2004). 
 
Results of a national study by Bowen et al. (2008) of risk attributes of construction workers to 
contracting HIV/AIDS are shown in Figure 2.3. The highest prevalence rate (18%) was found to 
exist among hourly-paid workers, whether employed on contract or permanent staff. These results 
agree with the findings reported by SABCOHA (2005), which found HIV prevalence to be higher 





















HIV Prevalence (%) 
 
Figure 2.3 HIV prevalence among construction employees by nature of employment 













Highly skilled job categories, represented by permanent and monthly-paid permanent workers 
(see Figure 2.3), presented lower HIV prevalence (less than 10%) than contract and hourly-paid 
permanent workers (18%). Socio-economic status or occupation was observed to play a role in 
determining HIV prevalence, as salaried workers (monthly paid) such as site managers, engineers 
and foreman are likely to be more highly skilled (Bowen et al., 2008). 
 
Hourly paid workers or ‘wage earners’ are normally semi-skilled or unskilled workers with low 
levels of education and income (Bowen et al., 2008). Low levels of education and low income 
levels are factors which are associated with low levels of HIV awareness, and, in turn, associated 
with high HIV prevalence (Colvin et al., 2007). When infected, this pool of labour is adversely 
affected because they do not receive sufficient remuneration to afford HIV treatment in order to 
prolong their lives (Dickinson, 2004b). 
 
In the same study, HIV prevalence was examined in terms of the occupation of the workers. 
Reporting the lowest HIV prevalence rates were managers and administration staff with HIV 
prevalence not exceeding 1% (Bowen et al., 2008). The highest HIV prevalence (21%) was 
reported among operators or truck drivers, followed by the skilled construction workers (19%) 
and labourers (17%). 
 
2.3.3 Informal labour 
 
Employment of the industry’s workforce has changed over the years from formal employment to 
informal employment (CIDB, 2004). The change is as a result of the casualisation of 
employment, reliance on labour-only contracting, and the growing informal sector (CIDB, 2004). 
English and Mbuthia (2002:2) define informal labour in construction as “workers employed by 
contractors or subcontractors on a casual or temporary basis without any proper form of 
contract.” SADC member states, of which South Africa is a member, do not make provision for 
foreign semi-skilled and unskilled construction workers to obtain valid work permits and 
therefore construction companies often employ illegal and irregular migrant workers (IOM, 
2010). These workers are often not included in StatsSA employment statistics, meaning that the 
actual informal sector employment could be higher than estimated. An estimated 60% of the 












According to Barnett and Whiteside (2002), the unregulated and informal nature of the 
construction industry increases its vulnerability to the impact of HIV/AIDS. This informal pool of 
labour is normally the productive, sexually active and less educated individuals who are likely to 
be struggling with socio-economic anxieties and are more vulnerable to acquiring and 
transmitting HIV/AIDS (Barnett and Whiteside, 2002; Meintjes et al., 2007). 
 
2.3.4 Aging of the workforce 
 
In South Africa, the construction industry predominantly employs older workers over the age of 
40 years. Data reported by Haupt et al. (2005) suggest that 60% of skilled workers in the industry 
are over the age of 40 years and that 69% of plant and machinery operators are over the age of 40 
years. With construction as one of the most dangerous lines of work (IOM, 2010), older workers 
are more vulnerable to health threats and infectious diseases such as TB and Hepatitis B (Haupt et 
al., 2005). Because of an increased risk of infection among older people, they are more 
susceptible to HIV infection when exposed to the virus (Meintjes et al., 2007). The greatest threat 
to the industry when losing workers in this group is the impact on the skills shortage (Dickinson 
and Versteeg, 2004). Older workers are a valuable asset to the industry because they possess a 
great amount of skill and knowledge acquired over a number of years (Meintjes et al., 2007). 
Losing such skills could pose a serious threat to the industry’s skills base. 
 
2.4 HIV/AIDS Impact on the Business Sector 
 
AIDS continues to be a growing concern for businesses worldwide. Its impact on the construction 
industry is felt on both the demand and supply sides of construction. On the demand side, 
HIV/AIDS diminishes individual and household disposable income as treatment and burial costs 
consume savings (Barnett and Whiteside, 2002). Individual and state consumption patterns are 
expected to change as resources are reallocated towards health and welfare. This will have an 
















On the supply side, if the profitability of the workers’ role in delivering construction products is 
threatened, the likelihood of their continued involvement in construction is questionable 
(Development Works, 2001). This is so because when a worker becomes infected with the HIV 
virus and not treated, they can suffer from an HIV/AIDS-related illness resulting in an increase in 
absenteeism, coupled with reduced productivity (SABCOHA, 2005). The impact further escalates 
to increasing medical expenses and upon death, companies incur expenditure in increased payout 
of employee benefits and labour turnover (Isaksen et al., 2002). 
 
According to the report by Development Works (2001), the nature of HIV/AIDS impacts on 
companies is likely to be felt differently, according to the degree of reliance of a company or 
industry on its workforce (i.e. ease of replacement of labour), the size and composition of its 
labour pool, and the institutional arrangements between labour and the company (i.e. contractual, 
part-time, casual, benefits). A presentation of evidence-based findings on the impact of 
HIV/AIDS on the business sector provides first-hand experiences of companies. 
 
Evidence-based Findings on the Impact of HIV/AIDS on the Business Sector  
 
Understanding the degree to which HIV/AIDS has impacted South Africa’s construction industry 
has been limited due to a lack of monitoring and evaluation measures (Dickinson and Stevens, 
2005). However, studies conducted by various researchers on the impacts of HIV/AIDS at 
company level in the general business sector in South Africa present the following findings. 
 
Results of the SABCOHA (2005) survey on the impact of HIV/AIDS on business sectors 
suggested that lower productivity and increased absenteeism, followed by higher employee 
benefit costs, were the largest impacts on the production level of companies surveyed. Between 
45 and 65% of respondents in the mining, manufacturing and transport sectors reported having 
experienced these impacts. In the construction sector, a significantly smaller percentage of the 

















In a case study of three Ekurhuleni manufacturing companies, absenteeism provided the most 
visible impact of the pandemic (Dickinson, 2004b). Even though there were other causes of 
absenteeism (family responsibilities, monotonous nature of work, long travel distances, long 
shifts and overtime), the main reason for associating absenteeism with HIV/AIDS was an 
observed increase in sickness patterns among most of the absentees, which led to an increase in 
the amount of leave taken, poor performance at work, and death from AIDS-related illnesses. The 
visible loss of employees due to HIV/AIDS amongst the companies studied ranged between 0.5% 
and 2%. 
 
A study in Kenya (Fox et al., 2004) presented some of the first empirical estimates of the impact 
of HIV/AIDS-related morbidity on labour productivity. The study aimed to examine the 
individual labour productivity and attendance of tea estate workers who died or were medically 
retired because of AIDS-related causes. The evidence indicated that 60% of the deaths and 
medical retirements that occurred between 1997 and 2002 were attributable to AIDS (Fox et al., 
2004). As early as 3 years before an AIDS-related termination occurred, the following impacts 
were observed: notably a higher occurrence of absenteeism of HIV-infected workers, a reduction 
in output, and a shift to less strenuous and in this case less productive duties, although this is not 
always the case (Fox et al., 2004). 
 
In a survey of 80 small to medium size enterprises (SMEs) in the KwaZulu-Natal and Gauteng 
provinces, AIDS accounted for 10% of the 13% overall annual employee turnover (Connelly and 
Rosen, 2005). In relation to direct costs being felt, few companies reported incurring direct costs 
in recruiting or training (Connelly and Rosen, 2005). This could be explained by literature which 
suggests that replacement costs of unskilled workers are not significant to a company, since most 
unskilled workers are replaceable within a week or so, at little or no cost, and the requisite 
training is capable of being done over a period of a few days (USAID, 2001). While low-skilled 
workers, such as labourers on limited duration contracts (LDCs), require limited training and are 
easy to replace, construction companies cannot afford to lose semi-skilled workers such as 

















The above studies have presented evidence-based findings on the impacts of HIV/AIDS in the 
workplace. The impacts mostly occurring are: increased absenteeism, lower productivity and high 
employee turnover. Even though loss of skills was not indicated as a major impact, this is an 
underlying threat especially in a skills-constrained economy such as South Africa. The loss of 
skilled workers can narrow the skills base of an industry because it can take between one to four 
years to train them up to full competency (Dickinson, 2004b). 
 
The discussion on the vulnerability of the construction industry to HIV/AIDS and impact on the 
business sector highlights possible threats of HIV/AIDS to the construction industry. The 
available evidence suggests that there is a high HIV prevalence in the construction industry 
although moderate impacts have been reported in studies across different sectors. The following 
section will look at the construction industry’s response to the pandemic. 
 
2.5 Responses to HIV/AIDS in the South African Construction Industry 
 
Various frameworks and guidelines on HIV/AIDS programme implementation exist for the South 
African construction industry. At an international level, ILO (2008) developed the ‘Code of 
Practice on HIV/AIDS and the World of Work: Guidelines for the Construction Sector’. The 
document provides useful guidelines specifically for the construction industry on workplace 
policy development and on how the industry can intervene in the fight against HIV/AIDS. The 
Code of Practice is accompanied by a manual that outlines how it can be used in practice (ILO, 
2008). The International Federation of Consulting Engineers (FIDIC) recognises construction 
sites as potential primary centres of HIV/AIDS in developing countries. A policy statement for 
FIDIC and FIDIC member firms was developed and approved in 2004. The policy outlines the 
HIV/AIDS clauses that can be included in contract documents for the provision of HIV/AIDS 
awareness programmes (FIDIC, 2004). 
 
In South Africa, the Construction Industry Development Board (CIDB) developed an HIV/AIDS 
intervention specification for the industry, which serves as a guideline for the contractual 
requirements for HIV/AIDS awareness programmes (CIDB, 2003). In 2004, the Department of 
Public Works developed an HIV/AIDS Awareness Programme which enforces the 
implementation of HIV/AIDS programmes in the construction work that it commissions (DPW, 













2.5.1 HIV/AIDS workplace policy 
 
When implementing an HIV/AIDS workplace programme, a holistic approach needs to be 
considered (Fraser et al., 2002). A key step in implementing a comprehensive and effective 
workplace programme is the development of a workplace policy (USAID, 2001). According to 
SABCOHA (2005), an HIV/AIDS policy sets out an organisation’s position and practices as they 
relate to combating HIV/AIDS. A comprehensive HIV/AIDS policy defines a company’s 
position, guides and sustains its awareness, prevention, treatment and care programmes 
(SABCOHA, 2005), as well as safeguarding and enforcing the protection of employees’ rights 
(ILO, 2008). An important factor to consider when formulating a comprehensive workplace HIV 
policy is to communicate with employees about the policy prior to its implementation (Dickinson, 
2003). This ensures effective involvement of all parties that will be affected by the policy. 
 
Studies reveal differences in HIV/AIDS policy implementation among South African companies. 
In 2004, a study by the South African Business Coalition on HIV/AIDS (SABCOHA) revealed 
that 262 companies out of 1 006 companies surveyed had established a formal HIV/AIDS policy 
in the workplace (SABCOHA, 2004). A possible explanation for the low implementation of 
policies could be the differences in company sizes in the study sample. The majority (75%) of the 
companies were small (less than 100 employees), with large companies that employed more than 
500 employees being represented by less than 10% of the study population. In the same year, 
Dickinson and Innes (2004) reported a high degree of HIV/AIDS policy implementation by large 
private sector companies. Of the 38 companies that responded, 92% (n=35) reported the presence 
of an HIV/AIDS policy. 
 
An important aspect of a workplace policy that is often overlooked in its formulation is turning it 
into a reality. Dickinson (2003) highlights this gap of turning policy into practice through a case 
study of a large South African corporation. The study revealed that even though policies 
encouraged voluntary counselling and testing (VCT), openness and disclosure, in reality there 
was confusion over testing, lack of access to available treatment, and lack of disclosure 
(Dickinson, 2003). This finding suggests that policies are at times being implemented 
prematurely with little consideration of their practical applicability. Careful consideration 
therefore needs to be given when designing a policy because they form the basis for company 













2.5.2 HIV/AIDS workplace interventions 
 
Fraser et al. (2002) describe a comprehensive HIV/AIDS workplace programme as one that 
addresses prevention through education, and mitigation through counselling and testing, as well 
as treatment and care. These attributes of a comprehensive HIV/AIDS programme are in line with 
ILO (2003) best practice workplace interventions that were generated from practical experience 
in the workplace across different sectors. The best practices are: policy and legal frameworks; 
workplace policies and programmes on prevention; workplace policies and programmes on care, 
support and treatment; links beyond the formal workplace; knowledge and evidence through data 
analysis, monitoring and feedback (ILO, 2003). 
 
Specific to the construction industry, McGreevey et al. (2003) identified eight interventions for 
HIV/AIDS prevention, care and treatment that can be implemented in the construction industry.  
 
Prevention interventions include: 
• condom distribution to all workers; 
• treatment of sexually transmitted infections; 
• peer counselling for safe behaviour; and  
• voluntary counselling and testing (VCT) 
 
For HIV positive individuals, the treatment and care interventions include: 
• palliative care for HIV positive persons showing symptoms of AIDS; 
• treatment of opportunistic infections associated with HIV/AIDS; 
• opportunistic illness prophylaxis (especially TB); and 
• Highly Active Anti-Retroviral Therapy (HAART) and related laboratory services to reduce 



















2.5.3 Government responses to the HIV/AIDS pandemic 
 
In South Africa, the recognition of HIV/AIDS as a threat to the construction industry dates back 
to 2002 when the National Department of Public Works (DPW) launched an HIV/AIDS 
awareness strategy. The HIV/AIDS strategy was driven by the Department of Public Works’ 
social responsibility towards the construction industry and perceptions of high HIV prevalence 
among the construction workforce (DPW, 2004). The strategy was initiated with three pilot 
projects, which resulted in the development of an HIV/AIDS awareness programme training 
manual in 2004 (DPW, 2004).  
 
The training manual provides guidelines on the scope of the HIV/AIDS requirements and 
implementation process for contractors appointed by the Department on contracts exceeding six 
months in duration and exceeding a value of ZAR2 million (DPW, 2004). It is a requirement of 
such contracts that a well-developed awareness programme be included in all Bills of Quantities 
(BoQ) as part of the formal contract documentation (DPW, 2004). In an effort to encourage 
compliance, it was proposed that partial or total non-compliance with such requirements should 
result in withholding the issuing of a progress payment certificate until satisfactory proof of 
compliance has been provided (DPW, 2004). 
 
The proposed intervention strategies include HIV/AIDS awareness training workshops through a 
service provider, and preventative measures such as condom distribution, posters, and distribution 
of booklets. These were designed to raise awareness on HIV/AIDS, and equip the construction 
workforce with the knowledge to change attitudes and behaviour (DPW, 2004). The parties 
involved in the implementation of the programme are outlined in Table 2.3, as well as their role 





















Table 2.3 Implementation process of the HIV/AIDS awareness programme 
 
Stages Contractor Service Provider Department’s 
Representative 
DPW 
Procurement Draft BoQ, select 
service provider, 
submit workshop 
plan and detailed 
BoQ 
 Evaluate and approve 
service provider, 










   




materials on site; 
condoms, posters 
and booklets 
   
Monitoring and 
Evaluation 




and evaluation against 
HIV/AIDS specifications 











(Source: DPW, 2004) 
 
As shown in Table 2.3, the programme implementation process requires the interaction of four 
different parties. Each party has a responsibility to carry, with the contractor’s main responsibility 
being to ensure that all the necessary requirements are met in accordance with the workshop plan 
and BoQ. The HIV/AIDS programme forms part of the contract and their costs of providing the 












providing an HIV/AIDS awareness programme was estimated to be between 0.12% and 0.8% of 
total project tender value. These costs differ, however, depending on a number of factors such as 
the number of workers, frequency of workshops, proximity of service provider (travelling costs), 
and proximity or availability of awareness materials (condoms, posters and booklets). 
 
The initiative by the DPW was a major step towards an action response in the construction 
industry, but it cannot be construed to constitute a unified response. The goal of the HIV/AIDS 
strategy was to reduce HIV/AIDS infection rates in the industry and successfully manage the 
impact of the disease, but the proposed HIV/AIDS awareness intervention falls short on 
effectively managing the disease. It focuses more on reducing HIV infections among the 
workforce than managing already existing HIV infections. The DPW requirement is only 
enforceable under government projects, with the exclusion of contractors engaged in private 
sector projects. The extent to which the initiative has been enforced is also not known because 
there have not been any follow-up reports on the implementation and success of the initiative. 
 
2.5.4 Private sector response to the HIV/AIDS pandemic 
 
In the private sector, the South African Business Coalition on HIV and AIDS (SABCOHA) has 
been playing a key role in addressing the epidemic in the business environment. The organisation 
has been a leader in coordinating HIV/AIDS prevention and treatment strategies through research 
they have conducted. Evidence from the SABCOHA (2005) study reported poor responses from 
the building and construction industry, while at the same time the industry reported experiencing 
moderate to severe impacts.  
 
Results presented in Figure 2.4 show the construction sector as the least responsive in 
implementing HIV/AIDS programmes in comparison to the mining, manufacturing and transport 
sectors (SABCOHA, 2005). In all provinces of South Africa, the Western Cape is the least 














Figure 2.4 Implementation of HIV/AIDS programmes among different industrial sectors 
(Source: SABCOHA, 2005) 
 
As shown in Figure 2.4, the most reported form of intervention in construction is the provision of 
HIV/AIDS awareness programmes. A review by Smallwood et al. (2001) of awareness 
interventions undertaken by general building contractors relative to HIV/AIDS, STDs and TB, 
reported the use of posters, awareness education through speakers, distribution of pamphlets and 
flyers, and the provision of condoms as the most prevalent interventions. 
 
IOM (2010) reported an increase in responses which extend beyond awareness, among large 
construction companies. These responses were reported to be influenced by the government’s 
HIV/AIDS awareness programme initiative. Companies reportedly make use of the services of 
CareWorks which is an independent HIV service provider that offers a comprehensive 
Presidential Plan for AIDS Relief (PEPFAR) funded intervention programme (IOM, 2010). Their 
programme includes training of peer educators; condom provision; information, education and 
communication materials on HIV/AIDS; stigma reduction; VCT and managing ART for HIV 
positive employees (IOM, 2010). A high rate of success was reported with the use of CareWorks, 







































However, the programme has limitations for temporary and casual employees in anti-retroviral 
therapy (ART) provision. This is because CareWorks offer treatment to employees on medical aid 
schemes, with the exclusion of temporary and casual workers who often cannot afford to be 
enrolled on a medical aid scheme (Dickinson, 2004b). If these workers test HIV positive, 
CareWorks will help to get them enrolled on governmental or NGO (non-governmental) services 
(IOM, 2010). Similarly, sub-contractor companies are unlikely to be covered by CareWorks for 
HIV treatment and care services because they largely employ casual workers (IOM, 2010). 
 
2.6 Implementation of HIV/AIDS Treatment Programmes 
 
The implementation of awareness, education and prevention programmes has been a significant 
initiative in reducing HIV incidence but these programmes are less effective in controlling the 
impact of existing infections in the absence of treatment programmes (Versteeg, 2004). Treatment 
programmes aim to manage existing infections and ensure the welfare of HIV-positive people, by 
improving medical care and support (George et al., 2009). The following motivations for the 
observed increase in the provision of treatment services to employees have been identified by 
McDonald (2004), cited in George (2006: 182): 
 
• A maturing epidemic – where employers are experiencing the financial effects of the 
epidemic, through rising absenteeism and staff turnover. 
• Falling costs of treatment – falling costs of treating an HIV-infected person encouraging 
companies to consider providing treatment. As reported by McDonald (2004), the annual cost 
of treating an HIV-infected individual decreased from R48 000 in 1998 to under R10 000 in 
2004. 
• Activist pressure – civil society, trade unions, and NGOs lobbied governments to provide 
treatment to HIV-infected individuals. The corporate culture within southern Africa that 
supports provision of treatment has resulted in more companies developing health or wellness 
management programmes to treat their HIV-infected employees. 
• Government (ART) programmes – the public ART programme by the South African 
Department of Health, announced in 2003 and first implemented in April 2004, prompted 
more companies to investigate the idea of providing such treatment to infected employees. 
• Corporate social responsibility – the corporate sector, especially larger companies, encounter 
greater social expectations about their role in society. Companies are increasingly being held 












Across different industrial sectors such as the financial, mining and manufacturing sectors, the 
construction industry lags behind in ART provision (Connelly and Rosen, 2006; Mahajan et al., 
2007). Among these, the mining sector took the significant step of large-scale ART provision for 
employees without medical insurance in 2002 (Dickinson, 2004a). On 6 August 2002, Anglo 
American announced drug provision to all employees based on the premise that it was cost 
effective and De Beers followed suit on 12th August 2002 (Dickinson, 2004a). 
 
The mining industry has been a leader in developing innovative strategies, with HIV/AIDS 
responses extending to mining-houses and partnerships with trade unions, government 
departments, and other stakeholders (Bowler, 2004). Other HIV/AIDS programmes aim to 
provide support to employees’ sex partners and commercial sex workers (Kelly, 2002). The De 
Beers programme extended the provision of ARVs to a limited number of the HIV-positive’s 
family members (Dickinson, 2004a). 
 
2.6.1 Models of workplace treatment programmes 
 
The approach by which South African companies make HIV/AIDS care and treatment available 
to employees has been categorised into four models (Connelly and Rosen, 2006): 
 
• Employer provider – where the employer finances and delivers treatment for HIV-positive 
employees using a ‘closed’ health insurance service (i.e. one designed only for employees 
and their dependents) and company clinic facilities. 
• Medical aid scheme – where employers subsidise health insurance premiums for HIV 
treatment through ‘medical aid schemes’. 
• Independent disease management programme – where a specialised HIV/AIDS management 
company is contracted by an employer to manage the costs and treatment of HIV-positive 
employees: for example, Careworks.  
• Clinic provider – where an employer contracts a medical NGO or general medical 















In instances where the employer contracts an independent service provider or clinic provider, the 
employer pays the provider to deliver a set of health services (Zellner and Ilana, 2008). Another 
system that is increasingly becoming popular is where employers make treatment services 
available to employees through a referral system. In a study by Zellner and Ilana (2008), the 
referral system was made available to employees who could not afford medical insurance offered 
by their companies. Employees were referred to outside providers that can be public facilities or 
private providers. This method was most common among small companies, who relied on 
referrals for free or highly-subsidised antiretroviral treatment (Zellner and Ilana, 2008). 
 
Utilisation of treatment models by companies differ. In a study of 52 of the largest South African 
employers, 10 companies reported the use of an independent disease management programme, 9 
made use of the employer provider, and 6 made use of medical aid schemes (Connelly and Rosen, 
2006). The remaining 27 companies offered treatment without a programme, but provided 
services with partial coverage through a medical aid scheme. Reed (2004) reported on mining 
companies heavily relying on medical aid schemes because of their comprehensive and 
exhaustive services. 
 
Stein et al. (2002) support Reed’s (2004) findings on the extensive coverage of HIV/AIDS 
services by medical aid schemes. These can range from HIV counselling; testing and education 
and information; treatment, screening and preventive therapy for HIV-related conditions, to 
beneficiaries having access to triple-therapy treatment which is the optimal anti-retroviral 
treatment; mother-to-child prevention therapy and post-exposure prophylaxis. 
 
Even though medical aid schemes offer comprehensive services, there is a wide variation in 
relation to access of medical aid scheme benefits by workers (Bowler, 2004; Reed, 2004; Stevens 
et al., 2004). In a study of HIV services provided by small to medium enterprises (SMEs), 58% of 
the companies surveyed offered medical aid benefits and 30% of the employees were enrolled. Of 
the 30% that were enrolled, 58% were managers, 33% skilled workers and 13% were unskilled 
workers (Connelly and Rosen, 2005).  
 
While employees may have access to such schemes, it is expensive and unaffordable for lower 
levels of employees (Dickinson, 2004b; Reed, 2004). Medical aid costs can range between 17% 
and 18% of the salary for a family of four (Bowler, 2004). On the other hand, senior employees’ 












A study of HIV/AIDS services in the workplace conducted in four Sub-Saharan African countries 
reported on-site services as the most popular form of HIV/AIDS service delivery (Zellner and 
Ilana, 2008). The described on-site services were similar to the clinic provider model that offered 
services for opportunistic infections (OIs) management, TB treatment, VCT, and ART treatment. 
Such services provide workers with immediate and convenient access to HIV/AIDS services but 
uptake of such services can be low due to fears of being singled out by other employees as HIV–
positive when seen seeking these services (Zellner and Ilana, 2008). 
 
2.6.2 Benefits of treatment provision to workers 
 
When considering the provision of treatment to employees, companies need to think about the 
financial implications on the company. Evidence suggests that benefits of investing in treatment 
and care exceed the costs of paying for the services (Rosen et al., 2000). Company risk 
assessments conducted show that the provision of ART has significant benefits (Setswe, 2009).  
Immediate benefits are measured in terms of deaths avoided, infections prevented, additional 
years of working life gained and retention of skills (Rosen, et al., 2004b; Charalambous et al., 
2007). 
 
Evidence from a Cote d’Ivoire study recorded the following benefits over a period of two years, 
after the implementation of a comprehensive HIV care and ART programme: a five-fold increase 
in company-based voluntary testing among HIV-infected persons; a 94% decrease in HIV-related 
absenteeism; an 81% decrease in HIV-related hospitalisations; an 8% decrease in new clinical 
cases of AIDS; and a 58% decrease in HIV-related mortality (George, 2006). In terms of costs, 
the savings to an employer associated with each death averted was estimated to pay for six to 
eight years of ART for an employee (Feeley et al., 2004). 
 
2.6.3 Motivations for implementing HIV/AIDS workplace programmes 
 
Literature on motivating factors for implementing workplace programmes to combat HIV/AIDS 
is drawn from a study by Dickinson and Stevens’ (2005) which reports on three case studies of 












The companies included chemical companies, information technology (IT) firms, and companies 
related to the health care sectors; each with over 20,000 South African-based employees. By 
reviewing the data and looking for common patterns and themes, they identified six factors that 
influence the response of companies to HIV/AIDS. These are, namely: 
• Legal requirements – the presence of company legislation can govern and enforce responses 
to HIV/AIDS. Currently there are no legal requirements that force businesses to implement 
programmes focused on minimising the impact of HIV/AIDS on its workforce (DPW, 2004). 
 
• Voluntary regulation – is when companies abide by one of the range of codes of good 
practice on offer or subscribe to one of the corporate reporting frameworks available, for 
example, the ILO Code of Practice on HIV/AIDS and the World of Work. Conformity is 
usually in line with expected requirements.  
 
• Business case – involves weighing up relative costs of responding or not responding with 
sufficient managerial capacity and information. 
 
• Social pressures – the relationships between business and almost all major social actors and 
the pressures exerted on business by the response or non-response of other businesses. For 
example, pressure from external stakeholders such as the Treatment Action Campaign (TAC) 
forced the government to embark on the national rollout of treatment to HIV-positive people. 
At a company level, Fakier, (2004) identifies these pressures as company pressure, investor 
pressure, and moral and social pressure. 
 
• Visibility of the disease – the visibility of the disease or lack thereof, is a product of the 
biological nature of HIV/AIDS (long incubation period) and social and economic divisions 
within companies. Social (e.g. stigma and discrimination) and economic divisions are 
impediments to the visibility of the disease. 
 
• Internal individuals – perceptions of personnel responsible for a company’s response to 














Voluntary regulation, visibility of the disease and perceptions of internal individuals were 
classified under internal pressures while legal requirements, economic performance and social 
pressure were classified as external pressures. The evidence presented in the Dickinson and 
Stevens (2005) study suggested social pressure as the most significant motivator. 
 
Zellner and Ilana (2008) support these findings by reporting on multinational companies’ 
responses being largely driven by social pressure to undertake corporate social responsibility. For 
example, a large-sized corporation selling consumer goods will be more vulnerable to damage to 
its public image than a small-sized company and will therefore be more likely to respond to the 
HIV/AIDS threat (Versteeg, 2004). 
 
In contrast, Rosen et al. (2004a) reported managers’ knowledge of the epidemic as a major 
motivation for action on a study of manufacturing firms in Nigeria. This entailed the managers’ 
exposure to external information about HIV and knowledge of workers who were HIV-positive or 
had left the workforce because of AIDS (Rosen et al., 2004a). Supporting evidence provided by 
Dickinson (2004a) revealed managers’ lack of knowledge of a company’s vulnerability as one of 
the major reasons for the slow responses to HIV/AIDS in South Africa. This means that if 
managers were aware of their company’s vulnerability to HIV/AIDS, they will be more likely to 
respond to the disease. 
 
Overall, Dickinson and Stevens (2005) concluded that external pressures have had an influence 
on workplace responses to some degree, but have generally been weak. An example of such 
pressure is the Global Reporting Initiative’s HIV/AIDS reporting, which was developed to assist 
organisations in the reporting of their HIV/AIDS policies and programmes for the workplace and 
beyond the workplace (Fakier, 2004). These initiatives have generally been weak because they 
are limited to publicly-listed companies and their responses are largely driven by good corporate 
governance (Fakier, 2004). A more effective approach would be facilitated by the interaction of 
















2.6.4 Barriers to the implementation of HIV/AIDS workplace programmes 
 
Several factors hinder efforts to provide HIV/AIDS programmes within organisations. The 
availability of free services through the government was reported as the major reason for not 
providing HIV/AIDS services in the workplace (Zellner and Ilana, 2008). This was reported by 
Zellner and Ilana (2008) in a study of multinational companies’ responses in four Sub-Saharan 
countries. For SMEs, the following factors were identified for their failure to provide HIV/AIDS 
services to employees: lack of information and access to services, low willingness to pay for 
HIV/AIDS services, stigma, and lack of pressure to act (Connelly and Rosen, 2005). 
 
A factor of considerable importance is the cost of providing HIV/AIDS services, which is often 
assumed to be too expensive for companies to realise (Zellner and Ilana, 2008). In construction, 
the cost of responding was estimated to be low enough to be included among the indirect costs for 
worker injury protection, insurance and emergency care without substantially increasing the total 
project costs (McGreevey et al., 2003). The cost of providing a comprehensive HIV/AIDS 
intervention programme was estimated to range between 0.14–1.00% of the cost of a major 
construction project for a workforce with an HIV prevalence ranging between 1–10% 
(McGreevey et al., 2003). 
 
In terms of treatment provision, research has shown that treatment provision is mainly being 
offered by large companies, with smaller companies lagging behind (SABCOHA, 2006; Connelly 
and Rosen, 2006). As determined earlier in the chapter, construction has a significant portion of 
small companies, meaning that the problems being faced by SMEs in responding to HIV/AIDS 
could also be rife in the construction. Weston et al., (2007) reports on the option for small 
companies to provide treatment to HIV-positive workers as not being economically viable, even 
in industries with high HIV prevalence. This is so because smaller companies are faced with 
competitive demands and therefore have limited time and resources to divert to health 

















However, evidence suggests that the cost of providing ART per patient decreases with time. At 
Anglo American, the cost to the company of providing ART per patient during the first year was 
R29 294, but after the first year of the programme and the first year of an employee’s treatment, 
the cost of providing ART decreased by more than half to R10 620 (George, 2006). This is 
because in the first year the patient had to go through initial treatment of opportunistic infections, 
pathology tests and frequent monitoring. 
 
In the South African workplace, a high level of access to HIV/AIDS services has been observed 
but low uptake by employees is prevalent (Connelly and Rosen, 2006). The low uptake of 
services undermines attempts by companies to provide HIV/AIDS treatment to HIV–positive 
employees. A small multi-national company in Zambia which was offering on-site ART services 
highlighted the reluctance of employees to access ART (Zellner and Ilana, 2008). Low uptake of 
treatment services could be attributed to fears of stigma and discrimination, lack of trust among 
employees that the employer will not learn their HIV status, lack of trust of the service provider, 
and the newness of the programme (Day et al., 2003; Connelly and  Rosen, 2006; George, 2006; 
Mahajan et al., 2007). Company managers’ lack of sufficient knowledge to effectively ensure 
confidentiality of employees’ status also hinders the implementation of HIV/AIDS workplace 
programmes (Chillag et al., 2002). 
 
2.7 Challenges faced by the Construction Industry 
 
The challenges associated with implementing comprehensive HIV/AIDS programmes in the 
construction industry are more extensive than for other industries such as the mining and 
manufacturing industries. Unlike other industries, the construction industry deals with a 
constantly changing workforce of limited durations contract (LDC) workers on short-term 
contracts and permanent employees who move between projects (Dickinson and Versteeg, 2004).  
 
Drawing on studies by the IOM (2010), the following reasons are cited for the industry’s failure 
in implementing effective HIV/AIDS programmes for employees: 
 
• Nature of Work – as one of the most dangerous lines of work with a high number of job-
related accidents and diseases, difficult and dangerous working conditions, occupational 
hazards and the risk of physical injury renders HIV/AIDS a distant risk compared to these 












• Discontinuous Employment - the very nature of construction projects leads to more 
complications because most construction projects are once-off projects. This means that 
workers can either be laid off or be moved to a new project site, encouraging discontinuous 
employment, resulting in difficulties in managing and monitoring workers on an HIV/AIDS 
programme (Haupt et al., 2005). 
 
• Subcontracting - the presence of subcontractors on construction sites increases the 
complexity of developing effective HIV/AIDS strategies and interventions. It becomes 
difficult to target everyone employed on a construction project because workers have 
different types of contracts, employment arrangements, contract durations, remuneration, 
entitlements and benefits (IOM, 2010). Another problem arising from subcontracting is that it 
indemnifies the general contractor from the health and safety responsibilities, resulting in a 
lack of health benefits provision to workers. Subcontractors are unlikely to provide access to 
HIV prevention and care programmes because they have to compete with other companies to 
tender for a job. The inclusion of HIV/AIDS services is likely to increase costs and render 
them less competitive (IOM, 2010). 
 
• Migratory Labour - the mobile nature of construction workers makes it difficult to 
implement HIV/AIDS programmes because existing HIV/AIDS programmes are mainly 
designed for a more settled population (IOM, 2010). 
 
It is widely acknowledged that company responses to HIV/AIDS are shaped by differing 
motivations that, to some extent, determine the success or failure of an intervention (Dickinson 
and Stevens, 2005). An understanding of a company’s motivations is imperative in making 






















In order to understand the context of HIV/AIDS in the South African construction industry, an 
overview of the structure of the industry was first undertaken. It was established that the 
industry’s contribution to the GDP is significant to the country’s economic growth and therefore 
any impact on industry capacity will have an adverse impact on the country’s growth. The 
industry’s threat from HIV/AIDS is evident in the nature of its workforce. Construction is a 
significant employer of semi-skilled workers, migratory and informal labour, who present 
relatively high HIV prevalence. 
 
Although the industry has presented a relatively high HIV prevalence rate, the reported impacts 
have been classified as small and moderate. There is a general awareness of the potential threat of 
HIV/AIDS on the construction industry, with attempts by both the government and private sector 
being driven by corporate social responsibility. What are most prevalent are awareness and 
prevention campaigns, with little attention on treatment programmes. One of the perceived 
impediments to providing treatment programmes is the cost factor, which is assumed to be high. 
However evidence suggests that the long-term benefits of providing treatment outweigh the costs. 
Going on further, this research will provide company-specific research to ascertain the 






























This chapter identifies and details the development of the research method to be used in the 
collection of data for this research study. A combination of an opinion-based survey and case 
study approach has been adopted for this research. 
 
The chapter is divided into four sections. Commencing the chapter is a distinction between 
surveys and case study methods in order to provide a clear definition of what the two methods 
entail. As a preliminary to establishing and designing the research instruments for this study on 
HIV/AIDS in the construction industry, a critical analysis of survey-based research on HIV/AIDS 
in the business sector, for the period 2000-2010 is conducted. The analysis aims to highlight 
weaknesses that arise from this single-technique approach to research. The critical review leads to 
a summary of the major issues to be explored. The next section provides a justification for a 
combined survey and case-based research approach. In the final section is the development of the 
opinion-based survey research design. 
 
The research design established will address the following research questions posed in Chapter 1: 
 
a) What are the perceptions of HIV/AIDS as a threat to the construction industry? 
b) What are the responses of construction companies to HIV/AIDS in the Western Cape 
construction industry? 
 
The case study research design will follow in Chapter 5, after a presentation and discussion of the 



















3.2 Distinction between Surveys and Case Studies 
 
According to Gable (1994:2) “the survey approach refers to a group of methods which emphasise 
quantitative analysis, where data for a large number of organisations is collected through 
methods such as mail questionnaires, telephone interviews, or from published statistics, and this 
data is analysed using statistical techniques.”  
A case study approach, on the other hand, refers to a group of methods that emphasise qualitative 
analysis (Yin, 2003b). Gable (1994) asserts that data for case studies can be collected from a 
small number of organisations in the form of structured in-depth interviews or through participant 
observation.  
 
An important point to understand is that the main purpose for carrying out surveys is to produce 
quantitative or numerical descriptions about an aspect of a study population, with the intention of 
generalising statements about the object of study (Fowler, 2002). Surveys ought to describe 
attitudes, opinions, behaviours as well as the relationships among variables, whereas case studies 
tend to be more descriptive and are likely to advance knowledge and understanding of a given 
topic (Yin, 2003a). Conclusions drawn from case studies are specific to the particular 
organisations studied and cannot be generalised to the study population. 
 
The main distinction between surveys and case studies is in the method of analysis. Surveys rely 
on comparing cases and describing the characteristics of a set of cases while case studies rely on 
understanding the ‘wholeness’ of a particular case and understanding particular attributes of the 
case (De Vaus, 2002: 5). An example provided by De Vaus (2002) states that in a study of the 
causes of industrial disputes, a survey approach would focus on the attitudes of management and 
workers and a case study would concentrate on a particular factory or a particular strike.  
 
In this research, the survey focuses on managers’ perceptions regarding the threat of HIV/AIDS 
to the company, and workplace responses to the pandemic. Case studies on the other hand focus 
on the implementation or non-implementation of HIV/AIDS treatment programmes within 
selected construction companies. In essence, the case studies are intended to provide richer, more 
comprehensive information about the measures being undertaken by construction companies in 














3.3 Survey-based Approaches 
 
In the following section a critical review of survey-based studies dealing with HIV/AIDS in the 
workplace published in peer-reviewed journals and reports for the period 2000-2010 is presented.  
 
3.3.1 A critical review of survey-based approaches 
 
Stevens et al. (2004) reported on results of a baseline and follow-up comparative cross-sectional 
study in 2002 and 2003, made up of 428 companies with over 50 employees. Telephonic 
interviews were conducted with managers who were responsible for HIV/AIDS in their respective 
companies. The study’s areas of focus were: company responsibility for HIV policy development, 
prevention activities, absenteeism, access to medical aid schemes, and knowledge of the impact 
of HIV/AIDS on the firm. The study relied heavily on self-reports with lack of evidence to assess 
the accuracy of data, especially with responses regarding workplace policy development, 
reporting of absenteeism and access to medical aid schemes; all of which requires statistical 
evidence that was not readily available. 
 
Connelly and Rosen’s (2005) study focused on the demand side of the provision of HIV/AIDS 
services. They identified and evaluated constraints that small to medium enterprises (SMEs) 
encounter, in order to determine the extent to which these enterprises could be expected to 
implement HIV/AIDS programmes. Structured interviews were carried out with owners, 
managers or human resources staff of 80 SMEs located in the KwaZulu Natal and Gauteng 
provinces. The participants were selected on the basis that their perceptions influenced company 
decisions on the development of HIV/AIDS policies and programmes. The results obtained were 
subjective because they largely relied on recall and self-reporting with very few company records. 
The constraints identified could not be generalised to all the companies surveyed because the 
companies were not homogeneous. They had differences in terms of HIV risk, cost exposure and 
capacity. The study recommended a company-specific case study as a more informative approach 















In a study by Connelly and Rosen (2006), telephonic interviews were carried out with 52 private-
sector and parastatal companies out of the 64 companies that were contacted, yielding a response 
rate of 81.3%. The aim of the study was to determine employees’ access to HIV/AIDS care and 
treatment, enrolment in disease management programmes, and the companies’ approach to 
financing and delivery of care. Even though a high response rate was achieved, it was reported 
that at least five of the non-participating companies had active treatment and care programmes in 
place. The non-respondents could have provided more comprehensive data that could possibly 
have altered the results of the study. Another limitation of the research was the reliance on 
anecdotal evidence that was largely based on estimates and guesswork. HIV prevalence figures, 
uptake figures and service utilisations reported by company representatives were based on 
estimates and could not be verified. 
 
Cross-sectional surveys were conducted by Colvin et al. (2007) in 22 public and private sector 
organisations to determine the prevalence and distribution of HIV in South African workplaces. A 
weakness highlighted in the research was the likeliness of non-participation of HIV-positive 
employees or those who suspected they were HIV-positive. Employees on sick leave could not be 
included in the study. This meant that the estimates of HIV in the workforce could have been 
biased downwards. The Colvin et al. (2007) study went on to determine the factors affecting HIV 
prevalence at an individual and company level using multilevel modelling. It was concluded that 
HIV prevalence within an organisation was not entirely explained by the race, age and gender 
structure of the workforce but by some other factor associated with an organisation. This factor 
could not be determined by the study, but was recommended to be determined by a more 
comprehensive company-level study. 
 
A study of four Sub-Saharan countries, namely, Ethiopia, Kenya, Namibia, and Zambia on 
HIV/AIDS services provision by 121 companies was administered through an online 
questionnaire by Zellner and Ilana (2008). The study explored the types of services being offered 
and how the services were financed. The method of administration of the survey using online 
questionnaires presents problems (Zellner and Ilana, 2008). There is no guarantee that the e-mails 
sent will reach the desired destination, or that they are read by the intended participant and 
therefore results were likely to be more indicative than absolute (Zellner and Ilana, 2008). In this 
study, a follow-up of in-depth interviews of company representatives was conducted to expand on 













In the same study, the study population targeted included human resources personnel and health 
care providers, with no information captured from employees (Zellner and Ilana, 2008). A 
significant limitation of underreporting could have occurred on questions that would have been 
more appropriate for other types of respondents. For example, data on the insight into the quality 
of HIV/AIDS services could have been more appropriately collected from the companies’ 
employees because they are recipients of the services. The use of a single source of data limited 
further verification of the accuracy of data. No matching or comparing the data for accuracy 
could be done. The study focused more on companies’ perceptions of their own HIV/AIDS 
services with no actual evidence presented to substantiate these opinions. 
 
Bowen et al. (2008) analysed data from a testing programme carried out by CareWorks as part of 
their HIV/AIDS education programmes for construction companies. The sample of employees 
consisted of 10243 construction employees from 55 companies operating throughout South 
Africa. The analysis aimed to establish the degree of association between one or more of the risk 
factors and the occurrence of HIV/AIDS among construction firms. The sample consisted of large 
construction firms with the exclusion of small or micro organisations. The South African industry 
was grossly underrepresented in this study because small and micro organisations comprise 95% 
of enterprises in the construction sector (Bowen et al., 2008). The findings therefore are not a true 
representation of the construction industry as a whole. 
 
3.3.2 Limitations of survey-based research approaches 
 
The research methods reviewed above made use of basic social science survey techniques. It is 
evident that not all researchers did so to a consistently rigorous standard, thereby raising several 
issues of concern. Some of the studies had the following limitations: inadequate sampling frame, 
sampling errors, and poor measurement and response rates, leading to generalised findings and 
conclusions which were not sustainable.  
 
Being opinion based, surveys rely on self-reports and recall which are not backed-up by evidence 
and prone to bias. There is also a possibility of misinterpretation and misunderstanding of 
questions or of respondents giving socially desirable responses or being intentionally deceptive. 












When conducting organisational surveys, careful selection of the most appropriate respondents 
knowledgeable about the subject matter of the research needs to be considered. Some respondents 
that are part of the population can be excluded and some that are not part of the population can be 
included in the sampling frame, presenting problems for the generalisation of findings. 
Underreporting occurred in studies where managers were asked questions that were most suited 
for employees. 
 
Generally, the work reviewed for HIV/AIDS workplace programmes takes the form of general 
opinion surveys and lacks reference to specific programmes. Few, if any of the surveys, explored 
the nature of HIV/AIDS programmes available and participants involved. HIV/AIDS workplace 
programmes take place in the concrete environment of actual events and participant involvement. 
To attempt to explore this from an abstract stance, without reference to specific events, is unlikely 
to progress knowledge in the field of HIV/AIDS in the construction industry. 
 
3.3.3 Summary of issues 
 
The critical review of survey-based research into HIV/AIDS in the workplace has contributed to 
the body of knowledge but the lack of rigor in the research method tends to undermine the value 
of the findings. Specifically, the surveys have been found wanting in terms of issues such as: 
• failure to provide hard evidence on the impacts of and responses to HIV/AIDS in the 
workplace; 
• lack of seeing the workplace as an entity and reliance on a single source of data, usually 
managers’ perceptions; and 
• lack of company specificity and consequent lack of data richness. 
 
Based on the recommendations by the researchers of the above studies, it can be concluded that 
opinion survey research alone cannot serve as an adequate technique for exploring HIV/AIDS in 
the workplace. Surveys are best suited for problem identification purposes and offering 
recommendations for solutions that can only be explored by the use of other research methods. 
This analysis leads to consideration of a combination of opinion survey and case-based study as 














3.4 Justification of a Combined Survey and Case Study Approach 
 
Research designs that extensively integrate both fieldwork and survey research were uncommon 
in earlier years (Gable, 1994). More latterly the use of multiple and independent research methods 
is regarded as a way to maximise the amount of data collected to generate comprehensive and 
richer knowledge (Gable, 1994). Surveys and case studies are complementary methods of 
research that can be integrated to yield “rich” meaningful data (Gable, 1994).  
 
Data that results from surveys usually require refinement to identify new possibilities because the 
work usually takes the form of general opinion surveys, lacking reference to specific subjects 
(Malhotra and Grover, 1998). Punch (2003) supports this view, regarding surveys as being 
provocative and a step on the way to explanation, leading to questions such as “how did this come 
about? Why are these issues related in this way?” Such questions arising from surveys can be 
further investigated by the use of a case study (Yin, 2003b). 
 
In this research study, the case study will be used as an explanatory tool to provide a further, in-
depth qualitative explanation of data gathered from the opinion survey. The direct experiences of 
participants, told in the form of stories through extended interviews, should yield more 
meaningful information than that obtained from survey questionnaires. 
 
To summarise, several methods have been considered to collect the relevant research data. 
Relevant literature will be gathered from different sources of journal articles to identify the gaps 
in knowledge regarding the responses to HIV/AIDS in a workplace context. An opinion survey of 
construction professionals will be conducted to explore the perceptions of HIV/AIDS as a threat 
to the construction industry and the nature of HIV/AIDS programmes available. An in-depth 
analysis of case studies will be carried out in order to clear any misconceptions and substantiate 



















3.5 Survey Instrument Design 
 
An online questionnaire survey was chosen as the survey research instrument. The questionnaires 
were administered through Surveymonkey which is an online survey site that facilitates the design 
of surveys, the collection of responses, and the analysis of the data. The basis for selecting this 
research instrument was on the simplicity of administration at low cost. The location aspect of the 
research to be conducted in the Cape Town area was selected based on the researcher’s access to 
construction companies operating within this area, other than a particular theoretical justification. 
Moreover, the basis for selecting the Western Cape region was not based on HIV prevalence 
because the region presents the lowest HIV prevalence among the South African provinces. 
However, the region’s construction sector employs a significant number of employees. The Western 
Cape region emerges as the third largest employer in the construction industry, across all provinces.   
 
3.5.1 Questionnaire design 
 
A sectioned questionnaire was designed utilizing a mixture of closed, dichotomous, declarative and 
multiple-choice questions. Rating type questions used five-point Likert scales for indicators of 
importance. Using a seven-part structure, the survey questionnaire sought demographic information 
from respondents (e.g. category and size of firm, and number of permanent employees); explored 
company perceptions regarding HIV/AIDS as a long-term threat and the presence of an HIV/AIDS 
policy within the company; determined the existence and nature of HIV/AIDS awareness, 
prevention and treatment programmes; explored the relationship between HIV/AIDS and 
employees (e.g. disclosure of status and participation on treatment programmes); and company 
involvement in addressing the HIV/AIDS issue within the organization (e.g. support provided to 
HIV-positive employees, presence of medical aid benefits, perceptions of what constitutes the 
success of a treatment programme and perceptions regarding the financial viability of HIV/AIDS 
treatment programmes). The range of issues canvassed by the survey instrument was drawn from 
the background literature (see SABCOHA, 2004, 2005; Ellis, 2006; George and Quinlan, 2009). A 


















In this chapter, several weaknesses of survey research methods have been highlighted to give a 
clear justification for a combined survey and case-based methodology. It is apparent that surveys 
are best suited for problem identification purposes and offering recommendations for solutions 
that can be explored by the use of other research methods such as case studies. This chapter has 
highlighted how the survey method and case study method can complement each other to provide 
more comprehensive data. The survey instrument design has been described. The following 





































CHAPTER 4: Survey Administration, Data Presentation,  




The purpose of this chapter is to report and discuss the results of the web-based questionnaire 
survey. The survey was employed to answer the following research question: 
 
a) What are the perceptions of HIV/AIDS as a threat to the construction industry? 
b) What are the responses of construction companies to HIV/AIDS in the Western Cape 
construction industry? 
 
This chapter is structured in three sections. The first section outlines the method of data 
collection, describing the sampling method, selection and size of the sample. The next section 
focuses on the limitations that were experienced in the survey. In the last section, data collected 
through the survey instrument are analysed and discussed.  
 
4.2 Method of Data Collection 
 
Purposive sampling was used to identify the participants in the survey. This method was 
considered appropriate for this type of study because the purpose of the survey is to identify and 
explore issues rather than show the extent of applicability of the results (Babbie, 2010).  
 
The Construction Industry Development Board’s (CIDB Western Cape) electronic database and the 
Western Cape Master Builders’ Association (WCMBA) membership lists were used to identify 
potential respondents. The reason for selecting from these professional bodies was because 
companies that are members of such professional associations express professionalism by abiding 
by their duties and obligations. For example, it is required that members of the WCMBA possess 
the necessary technical qualifications, knowledge and practical experience according to the 
WCMBA membership 2009 directory. Likewise, CIDB members are required to recognise the 
dangerous nature of the industry and to give priority to the occupational health and safety of 












The aim of the sampling process was thus to identify formal sector professional construction 
companies who are likely to hold the value that the health and well-being of their workforce is part 
of their responsibility. 
 
Sample selection and size 
 
Contractors registered in Grades 5 to 9 inclusive on the CIDB electronic database, were considered 
for selection in the survey. These Grades are determined by the financial capability relating to the 
turnover history, value of completed contracts and available capital. Contractors registered in the 
Grade 5 category can tender for public sector contracts of a value not exceeding R6,5 million, 
Grade 6 not exceeding R13 million, Grade 7 not exceeding R40 million, Grade 8 not exceeding 
R130 million and Grade 9 has no limit (www.cidb.org.za) . 
 
Selected contractors were telephoned at random and asked to participate in the survey. Seventy-one 
construction participants agreed, 7 at Grade 5 level, 25 at Grade 6 level, 24 at Grade 7 level, 9 at 
Grade 8 level, and 6 at Grade 9 level. Similarly, members of the WCMBA were telephoned at 
random and invited to participate. Seventy-one contractors agreed to participate in the study. 
Various reasons were cited for those not taking part, with the majority citing a lack of time to 
undertake the survey due to busy schedules. Other individuals cited a lack of relevance of the study 
to the company. 
 
Once contact with the construction participant was established, a formal invitation to participate 
was emailed to the potential respondent. The email included a URL link where the questionnaire 
could be accessed online. Upon emailing the URL link, a follow-up phone call was made to ensure 
that the e-mail had been received by the appropriate respondent. Constant reminders and follow-up 
phone calls were made upon receiving agreement from the potential participant. 
 
The response rates were as follows: 
 
Administered  Received Response (%) 
CIDB    71   25  35% 
WCMBA   71   17  24% 













The purposive sample of 142 respondents represents approximately 11% of the total population of 
relevant contractors in the Western Cape region. It is conceded that the survey respondents 
constitute a self-selecting sample that may hold strong views (one way or the other) about 
HIV/AIDS in the workplace. The sample size and issues of representativity of the sample are not 
thought sufficient enough to invalidate the survey data, because further qualitative research, using a 
case study-based approach, is intended to enhance validity.  
 
4.3 Limitations of Survey 
 
The process of attaining data commenced in May 2009 and ended in April 2010 The process proved 
extremely difficult given the sensitivity of the HIV/AIDS issue being explored. A relationship of 
trust needed to be developed with the participants. Confidentiality and keeping company names and 
respondents’ names anonymous was stressed to the respondents upon initial contact as well as 
through the formal invitation. Securing company and respondents’ names was intended for follow-
up purposes only. 
 
Considering that 30% of the companies approached actually responded, a selection bias may have 
occurred in the sample if the companies that participated were significantly different from the 
companies that declined to participate. In order to reduce bias, respondents who returned 
uncompleted questionnaires were urged to complete the questionnaire. Only completed 
questionnaires were considered in the analysis. 
 
The use of questions that elicited peoples’ perceptions has been another limitation of the survey. 
Such questions are prone to elicit answers that are more indicative than actual because respondents 
may provide acceptable and ‘appropriate’ responses in order to protect their company’s credibility. 
The justification for including such questions was based on the subjectivity of the views of the 


















4.4 Analysis of the Data and Discussion of the Results 
 
The survey data was analysed using the Statistical Package for the Social Sciences (SPSS V17.0 for 
Mac) software application. Results were not weighted and therefore percentages stated relate to the 
responses to individual questions, unless otherwise stated. Where appropriate, cross-tabulation has 
been used to establish degrees of association between categorical variables; using the Pearson’s 
Chi-Square test (or the Fisher’s Exact Test where appropriate) at the 5% (p=0.050) level of 
significance. P values greater than 0.050 indicate no relationship between variables while p values 
smaller than 0.050 indicate a relationship between variables. 
 
The questions and responses were divided into six categories, namely: demographic profile of 
company respondents; perceptions of HIV/AIDS as a long-term problem; existence of HIV/AIDS 
policies, awareness, prevention and treatment programmes; HIV/AIDS and employees, company 
involvement and HIV/AIDS; and the financial viability of treatment programmes. 
4.4.1 Demographic profile of survey respondents 
 
Company representatives completing the survey were varied, including human resources 
managers, financial managers, health and safety managers, project managers, engineers, 
managing directors and administration personnel. Out of a total of 42 respondents, 67% (n=28) 
occupied senior management positions and 33% (n=16) were administration personnel. In 
instances where administration personnel completed questionnaires, they solicited information 
from senior personnel knowledgeable about HIV/AIDS within the company. 
 
In terms of the construction works category, the majority of construction companies surveyed are  
general building contractors involved in the construction of buildings (55%, n=23), followed by 
civil engineering contractors (26%, n=11). The least represented categories were specialist 
contractors, electrical and site preparation contractors, which were represented by only one 
















Respondents were asked to report on the size of the companies that they represented. Size of 
company was determined in terms of both the number of permanent employees and the gross 
annual turnover. Using gross annual turnover as a measure, the size groups were divided into four 
categories as stipulated in the Stats SA business register (Stats SA, 2008). Table 4.1 shows their 
distribution. 
 
Table 4.1 Size of company by annual turnover 
 
Annual Turnover  Size Percentage (%) 
Less than R6 million  Micro 24% 
R6 million to R13 million  Small 10% 
R13 million to R26 million  Medium 24% 
Exceeding R26 million  Large 43% 
 
The majority of construction companies covered in this study is large companies. Table 4.1 shows 
that 43% (n=18) of the companies reported a turnover exceeding R26 million per annum. Micro and 
medium sized companies were represented by 24% (n=10) of the respondents, and small companies 
were represented by 10% (n=4).  
 
The number of permanent employees was also used as a measure of company size because 
HIV/AIDS affects companies through the workforce. It is therefore arguably more appropriate to 
look at the relationship between the number of employees and HIV-related factors. Almost half 
(48%, n=20) of the companies employ less than 50 permanent employees and 24% (n=10) 
employed permanent staff exceeding 250. Companies employing staff in the intervening ranges (51-
100; 101-150; 151-200; 201-250) were each represented by 5% - 10% of the sample size.  
 
In view of the seriousness of the implications of HIV/AIDS on company profits and growth, the 
following section presents and discusses survey questions and responses pertaining to the 
perceptions of HIV/AIDS and responses employed. 
 













Respondents were asked to rate the perceived threat of HIV/AIDS as a long-term problem in the 
construction industry using the 5-point Likert scale question (1=not a problem; 5=a significant 
problem). A slight majority (55%: n=23) of the respondents perceived HIV/AIDS as a long-term 
problem in the construction industry. This finding is encouraging given the high prevalence of 
HIV in the South African construction industry (CIDB, 2003).  
However, 10% of the company representatives were unaware that a problem exists even when it 
may already be having a negative impact on their company’s profits and growth. Twenty-one 
percent of respondents were indifferent about whether HIV/AIDS is a long-term problem or not. 
Relating the size of firm (by either measure) and perceptions of HIV/AIDS as a long-term threat 
to the industry did not show any association between the two factors (p>0.050) meaning that 
company size and number of employees does not influence perceptions of HIV/AIDS.  
 
4.4.3 Implementation of HIV/AIDS policies 
 
The literature highlights the importance of developing a formal HIV/AIDS policy when 
implementing a comprehensive response. In this study, 67% (n=28) of the respondents had 
developed an HIV/AIDS company policy of some sort or another. This finding contradicts the 
findings from the SABCOHA study which reported the implementation of an HIV/AIDS policy 
by less than a third of construction companies (SABCOHA, 2005). Interestingly, three out of the 
nine respondents who professed indifference about the threat of HIV/AIDS claim the presence of 
an HIV/AIDS policy. 
 
As depicted in the literature, a comprehensive policy provides a framework for a company’s 
response and should entail all aspects of HIV/AIDS which includes awareness, prevention and 
treatment. In this study, inconsistency in adopting a comprehensive workplace policy was 
reported, with few companies reporting the inclusion of prevention and treatment components in 
their policies. Table 4.2 presents results on the presence of an HIV/AIDS policy and its 

















HIV/AIDS Policy Overall 
Policy  
Perceptions of 
HIV/AIDS as a 
threat  





Overall policy (n=28) 
Awareness policy (n=28) 
Prevention policy (n=17) 

















Note: Pearson’s chi-square test p-test value was used for cross tabulation analysis 
* denotes Fisher’s exact test being the most appropriate test. 
 
With reference to Table 4.2, all of the respondents with an HIV/AIDS policy (n=28) reported that 
their policy entailed awareness. Sixty-one percent (n=17) of the policies entailed prevention and 
46% (n=13) entailed treatment. It emerged that there is an association (p<0.050) between 
perceptions of HIV/AIDS as a threat and the implementation of an overall HIV/AIDS policy 
including all the components of a policy: awareness, prevention and treatment. This means that 
the perceived threat of HIV/AIDS to companies has most likely influenced the adoption of 
HIV/AIDS workplace policies. Company representatives that do not generally perceive 
HIV/AIDS as a long-term threat have not implemented an HIV/AIDS workplace policy. The 
results of this study support the findings of other studies which report on company responses 
being influenced by a representative’s view of HIV/AIDS as a company problem (see Rosen et 
al., 2004b; Dickinson, 2004a). 
 
The results show a highly significant relationship between the presence of an overall HIV/AIDS 
policy and an awareness and prevention policy. The relationship between the adoption of an 
overall policy and a treatment policy is also significant at p=0.002. With respect to the degree of 
association between company size and the implementation of HIV/AIDS policies, there is no 
association between the two variables (p>0.050). This contradicts findings from previous studies 
(see SABCOHA, 2004; Dickinson and Innes, 2004) that showed a positive relationship between 
company size and the implementation of policies. Evidence from previous studies has indicated 
that large companies are more likely to implement company HIV policies than small companies 













4.4.4 Implementation of awareness, prevention and treatment programmes 
 
An HIV/AIDS workplace policy provides a good basis for programme implementation. Their 
successful implementation and continued communication to employees is a major driver of 
workplace programmes (SABCOHA, 2005). However, the implementation of a workplace 
HIV/AIDS policy does not always guarantee the adoption of HIV/AIDS awareness, prevention 
and treatment programmes.  
 
Respondents were asked to report on the company’s involvement in the implementation of 
HIV/AIDS programmes. The questions posed aimed to establish if the company had implemented 
awareness, prevention and treatment programmes, what the programmes entailed, or their reasons 
for non-implementation.  
 
Table 4.3 shows the existence of these programmes in respondents’ companies, and their 
relationships with other factors.  
 

















Awareness (n=22) 52% p=0.103 p=0.458 p=0.068 p=0.008* 
Prevention (n=14) 33% p=0.200 p=0.261 p=0.315 p=0.015* 
Treatment (n=8) 19% p=0.222 p=0.784 p=0.103 p=0.037* 
Note: Pearson’s chi-square test p-test value was used for cross tabulation analysis. 
* denotes Fisher’s exact test being the most appropriate test. 
 
Interestingly, the results show no relationship between the perception of HIV/AIDS as a threat 
and the implementation of HIV/AIDS programmes. However, a significant relationship exists 
between the presence of an overall policy and the implementation of all three HIV/AIDS 
programmes (p<0.050), indicating that the adoption of HIV/AIDS programmes has been 












Among the three forms of interventions investigated in this study, the most prevalent were 
awareness campaigns. Fifty-two percent (n=22) of the companies surveyed report their presence, 
followed by prevention campaigns that had been implemented by 33% (n=14) of the companies. 
Treatment programmes were the least prevalent, with only 8 companies (19%) reporting their 
presence. 
 
With regard to HIV/AIDS policies, there seems to be little association between company size (of 
either measure) and the implementation of HIV/AIDS programmes. This contradicts findings 
from the SABCOHA studies, which shows a strong link between company size and the 
implementation of HIV/AIDS programmes. 
 
The section below briefly describes the findings of in relation to each of the three intervention 
programmes, reasons for non-implementation and their relationships with other variables. 




Various awareness campaigns exist in the various companies, which include: a one day course in 
safe sex and HIV/AIDS awareness for all employees and those on new contracts; annual 
workshops by CareWorks for all employees; confidential testing and counselling; monthly tool 
box talks, awareness posters displayed every second month and counselling and testing every 2-3 
years; placards, pamphlets and condoms on site; once off campaigns by request from the principal 
agent; flyers and red ribbons handed out each year; and monthly sessions by health and safety 
officers as well as on-site training courses run by a local clinic. These awareness campaigns are 
similar to the ones identified by Smallwood et al. (2001). 
  
With regards to the period when these campaigns were implemented, a reported 45% (n=10) were 
implemented after 2005 and 23% (n=6) were implemented in the period 2001-2005. This could 
have been spurred by the drive towards HIV/AIDS action in South Africa in the early 2000s. 
Twenty-seven percent (n=6) of the respondents were not aware of when the awareness campaigns 
were implemented. For companies that were not running any form of awareness campaigns, the 
most prominent reasons for not doing so were the absence of reported cases of HIV positive 













The absence of reported HIV/AIDS cases can be attributed to the invisibility of HIV/AIDS and 
fears of stigmatisation. Invisibility makes it difficult for employers to be certain that an employee 
is in fact suffering from the disease and fear of stigmatisation makes it difficult for employees to 
disclose their HIV status in fear of victimisation. Size of the companies in terms of number of 
permanent employees was considered a hindrance to the implementation of awareness campaigns. 





There was a general belief shared by the respondents that their employees are well informed 
about HIV/AIDS and likely to prevent themselves from contracting the disease. This reflected on 
the provision of prevention campaigns that was reported by 33% (n=14) of the companies. 
Various open responses were given regarding the nature of prevention campaigns, which 
included: the availability of male and female condoms on all sites; education on safe sexual 
practices; confidential counselling and testing; training on condom use, post exposure, 
prophylaxis and the effects of alcohol abuse and smoking. The majority of these campaigns (5 out 
of 11) were implemented after 2005.  
 
Besides the similar reasons that were cited for not implementing awareness campaigns, the 
following reasons were given for not implementing a prevention campaign: a belief that it is not 
necessary; lack of initiation; the sensitivity of the subject in the African culture; the presence of a 
link between the awareness campaign and prevention campaign; and lack of cooperation from 
employees when an HIV/AIDS survey was conducted. One respondent reported lack of 
cooperation by stating that ‘you can lead a horse to water but you cannot make it drink.’ Some 
respondents simply highlighted their intentions of being pro-active in this regard in the near 
future.  
 
Treatment programmes  
 
The implementation of treatment programmes was reported by 19% (n=8) of the companies. This 
confirms the literature that highlights the construction industry’s slow response in implementing 
treatment programmes. The SABCOHA (2005) study reported ART provision by 3% of the 












South African companies reported no ART provision by all 3 construction companies surveyed. 
In contrast, the SABCOHA (2010) study of the Western Cape business sector reported ART 
provision by 63% (n=9) of the construction companies surveyed. 
 
Respondents’ treatment programmes entailed the following: payment of AZT drugs 
(Azidothymidine – a type of antiretroviral drug); counselling and monitoring of HIV positive 
employees; a supply of antiretroviral drugs for 3 months to infected employees and thereafter a 
referral to enrol in the state programme and contracting out to CareWorks which is an external 
HIV/AIDS service provider. 
 
According to results presented in Table 4.3, there is no association (p>0.100) between company 
size in terms of both the turnover and number of employees and the implementation of treatment 
programmes, nor to the perceptions of HIV/AIDS as a long-term threat (see Table 4.3). Table 4.4 
shows the relationships between treatment programmes and the implementation of policies and 
other programmes. 
 
Table 4.4 Relationship between presence of a treatment programme and policy 
implementation and other HIV/AIDS programmes 
 
 Treatment Programme (n=22) 
Awareness Policy p=0.037* 
Prevention Policy p=0.004* 
Treatment Policy P<0.001* 
Awareness Campaign p=0.004* 
Prevention Campaign p=0.010* 
Note: * denotes Fisher’s exact test being the most appropriate test. 
 
As shown in Table 4.4, a relationship exists between the presence of a treatment programme and 
all components of an HIV/AIDS policy (p<0.050), with treatment policy presenting the strongest 
link (p<0.001). This finding reinforces the need for a policy to govern responses. Likewise, the 














Different models of offering treatment services have been described in the literature, that include: 
the employer provider model, medical aid scheme model, independent disease management 
model; and the clinic provider model. Three percent of the respondents with treatment 
programmes reported managing the treatment programmes in-house. In this study, the in-house 
treatment programme is similar to the employer provider model. 
 
The prominent reasons given for providing an in-house treatment programme was to keep the 
HIV positive employees healthy and productive for as long as possible and to retain the skills of 
the workforce. Other reasons include, creating a culture of goodwill to loyal employees, assisting 
with monitoring abuse of sick leave, creating a sense of social responsibility and reducing 
potential financial implications of HIV/AIDS on companies. 
 
Various open ended responses for not having treatment programmes included: time constraints; 
lack of need; lack of employees coming forward; cost implications and lack of resources; small 
company; a change in management and therefore a change in thought process around HIV/AIDS; 
fear of stigmatisation of HIV positive people and lack of knowledge. One respondent from a 
small company reported an open door policy that provided referrals for treatment and advice on 
lifestyle choices. Another reported that they would be happy if someone introduced a programme. 
A health and safety officer reported having difficulties in getting management’s involvement as 
their focus was on production. Contrary to management’s lack of interest, one respondent 
reported that their efforts to offer assistance received little cooperation from employees. 
 
4.4.5 HIV/AIDS and employees 
 
Management’s involvement and commitment is important in encouraging employees to engage 
with HIV/AIDS programmes and empowering them to know their HIV status (Rajak, 2010). In 
this study, only 33% of the respondents encouraged employees to know their HIV status.  
Questions were posed on the percentage of employees that respondents suspect of being HIV 
















Table 4.5 Respondents’ assumption of HIV positive employees 
 





1 – 5% 26% 
6 – 10% 10% 
11 – 15% 10% 
16 – 20% 2% 
21 – 25% 0% 
26 – 30% 0% 
31 – 35% 0% 
36 – 40% 2% 
41 – 45% 0% 
46 – 50% 0% 
>50% 0% 
Don’t know 26% 
 
As depicted in Table 4.5, the majority (26%) of the respondents suspected between 1-5% of their 
employees as being HIV positive and the other 26% of respondents claimed they had no idea. 
Only 4% of the respondents suspected more than 15% to be HIV positive. The reasons for their 
suspicions have been influenced by previous HIV tests that were carried out in the workplace and 
to some extent on the disclosure of HIV positive employees. One respondent commented “I 
suspect 10% but I’m sure that there is more. We have seen an increase in deaths over the past 
two years due to natural causes. Prior to the deaths of these employees, their immediate 
supervisor and/or co-workers have witnessed weight losses.” 
4.4.6 Disclosure of HIV status 
 
Disclosure of HIV status is an important aspect in the prevention, care, treatment and support for 
people living with HIV/AIDS (PLWHAs) (Ncama, 2007). It facilitates access to treatment and 
support services, but due to fears of discrimination and stigmatisation in the workplace, HIV 












This is evident in this study which reports on a low level of disclosure by employees 
confidentially or publicly. Regarding confidential disclosure, 10 respondents (24%) reported that 
such disclosure has taken place, 31 respondents (74%) reported that none of their employees have 
disclosed their status, even confidentially, and 1 respondent claimed not knowing whether it 
happens or not. Out of 10 respondents that claimed disclosure, 6 reported disclosure by less than 
5% of the employees and 2 reported disclosure by more than 50% of employees. 
 
With regards to public disclosure, five respondents (12%) reported public disclosure having taken 
place. Three respondents claimed disclosure by less than 5% of the employees and two 
respondents claimed disclosure to be between 6% and 10%. Thirty-three respondents (79%) 
reported that none of the employees had disclosed their HIV status publicly and four respondents 
(9%) did not know whether it happens or not. 
 
4.4.7 Participation of HIV positive staff on company treatment programmes 
 
Compared to other treatment models, the in-house (employer) disease management model has 
been reported to be the best treatment enrolment at large companies (Feeley et al., 2007). In-
house treatment and independent disease management models achieved high uptake by 
employees in a study of treatment services of South Africa’s largest employers (Connelly and 
Rosen, 2006). 
 
The majority of the respondents (81%) reported non-participation of employees in treatment 
programmes and 5% reported not knowing of anyone participating. Another 5% of the 
respondents claimed participation of employees in the following percentage ranges: 1–5% and 
exceeding 50%. Two percent of the respondents reported participation to be between 36–40% and 
46–50%, respectively. 
 
Respondents were asked to rate the level of participation of HIV positive staff, on a 5-point Likert 
scale with 1=very low and 5=very high. Seven out of eight respondents that reported the presence 
of a treatment programme answered this question. Three respondents (43%) reported a high level 
of participation of HIV positive staff on company treatment programmes. Each of the remaining 













Table 4.6 shows the relationship between disclosure and other factors such as the presence of 
awareness, prevention and treatment programmes and the participation of HIV positive staff on 
treatment programmes. 
 












p=0.102 p=0.202 p=0.001 P<0.001 
Public 
Disclosure 
p=0.083 p=0.065 p=0.017 P<0.001 
Note: Pearson’s chi-square test p-test value was used for cross tabulation analysis 
 
A significant relationship exists between confidential disclosure and the presence of a treatment 
programme. Likewise there is an association between public disclosure and the presence of a 
treatment programme. Highly significant relationships (p<0.001) are observed between disclosure 
and the participation of HIV positive staff on a treatment programme. These results validate 
literature that looks at disclosure as a way of accessing treatment and support. Employees are 
likely to disclose their status either confidentially or publicly when seeking treatment. On the 
other hand, there is no association between the presence of either awareness or prevention 
campaigns and disclosure of HIV status as shown by p>0.050. This means that awareness and 
prevention campaigns do not facilitate or encourage disclosure. 
 
4.4.8 HIV-positive staff remaining on treatment programmes 
 
Successful ART treatment requires long-term adherence to prescribed regimens (Page-Shipp et 
al., 2007). Contrary to other studies of ART uptake in the workplace that report on low levels of 
adherence (Dahab et al., 2008; Miller et al., 2010), this study reports a high level of adherence. 
Nineteen percent (n=8) of the respondents claim that more than 50% of HIV-positive employees 
remain on the treatment programme long term. Six percent claim adherence by 26-30% and 1-5% 
of HIV-positive employees, respectively. Fifty-six percent do not have staff remaining on the 












4.4.9 Company involvement and HIV/AIDS 
 
This section presents findings on the involvement of companies in HIV/AIDS interventions. The 
findings presented here outline the level of support that the companies offer to HIV-positive 
employees, the availability of medical scheme contribution policies, the allocation of 
responsibility of HIV/AIDS programmes, the level of commitment of a company towards the 
treatment programmes and the perceptions of the financial viability of running a treatment 
programme. 
 
Support for HIV positive employees 
 
Companies offer different support for HIV positive employees. These have been found in this 
study to include financial support, subsidised HIV treatment or therapy and nutrition or dietary 
supplements. The results shown in Table 4.7 indicate that the majority (14%) of the respondents 
offer financial support. 
 
Table 4.7 Support for HIV positive employees 
 
Form of Support Yes (%) No (%) 
Financial Support 14% 86% 
Subsidised HIV Treatment/Therapy 12% 88% 
Nutrition/dietary supplements 10% 90% 
 
Other forms of support include: promotion of a change in lifestyle, 50% subsidised medical aid 
with a treatment programme, providing time off to go for treatment, arranging for proper medical 
treatment and transportation to medical centres. One respondent made an interesting comment 
saying ‘This survey has made us realise how negatively we are approaching the problem and we 














4.4.10 Medical aid provision 
 
Medical aid schemes are capable of offering HIV/AIDS services. The various options they offer 
range from HIV counselling; testing, education and information; treatment, screening and 
preventative therapy for HIV-related conditions; mother-to-child prevention therapy to post-
exposure prophylaxis (Reed, 2004). Twenty respondents (48%) reported the presence of a 
medical scheme contribution policy and a similar number of respondents reported not having one. 
Four percent were unsure and did not know of the existence of a medical scheme contribution 
policy within the company.  
 
Out of the 20 respondents that have a medical scheme contribution policy, 15 claim it to be 
mandatory and 5 claim it to be voluntary. Company representatives have no knowledge of 
employees receiving ART treatment through a medical aid scheme. This is because medical aid 
schemes are required by law to protect the rights of their members not to disclose employee’s 
HIV/AIDS status (Department of Labour, Unknown). Likewise in this study there is no 
knowledge, by any of the respondents, of a medical insurer reporting anonymously to 
management on the number of personnel on HIV treatment. 
 
4.4.11 Responsibility of HIV/AIDS programmes 
 
In this study, it was revealed that the major responsibility of HIV/AIDS programmes lies with the 
health and safety officer, followed by human resources directors, managing directors and chief 
executive officers - see Table 4.8.  
 
Table 4.8 Responsibility of HIV/AIDS programmes 
 
Responsibility of HIV/AIDS Programme Percentage (%) 
Chief Executive Officer 12% 
Managing Director 12% 
Human Resources Director 21% 













Apart from the above-mentioned personnel, other personnel were also given the responsibility of 
HIV/AIDS programmes which included the company secretary, the financial manager, managing 
member, HR manager and general manager. 
 
4.4.12 Commitment of company to HIV/AIDS treatment programme 
 
The question posed on the level of commitment of the companies to HIV/AIDS treatment 
programmes, was based on a 5-point Likert scale questionnaire (1=very low and 5=very high). 
None of the respondents reported a very low or low level of commitment and therefore results 
given are for the three levels that the respondents answered. A total of nine respondents answered 
this question. Out of the nine, 3 claimed their commitment to be average, 4 reported a high level 
of commitment and 2 respondents claimed it to be very high.  
 
4.4.13 Measure of success of treatment programmes 
 
Monitoring and evaluation are important aspects of an HIV treatment programme in order to 
assess if the programme is having the desired effects. Respondents in this study measured the 
success of treatment programmes through various methods by: monitoring the CD4 count, 
assessing feedback from VCT, observing the health of staff members, monitoring absenteeism, 
receiving monthly reports and assessing the wellness and productivity of HIV positive 
employees. One respondent reported measuring success by recording the number of new cases of 
HIV/AIDS every year. Based on reports from the previous year, they had not had any new cases, 
indicating a measure of success. Another respondent reported on the positive impact of success 
stories and shared these at quarterly HIV facilitator meetings. 
 
4.4.14 Financial viability of treatment programmes 
 
Respondents were asked to give their opinions on the financial viability of their organisation to 












Twelve respondents (30%) perceived the provision of a treatment programme to be financially 
viable. However, 14 respondents (35%) did not consider it viable and another 14 were indifferent 
and did not know.  
 
The various reasons given regarding respondents’ opinions on financial viability are presented in 
Table 4.9 as quoted. 
 
Table 4.9 Reasons given for the financial viability of a treatment programme 
 
Reasons for financial viability Reasons against financial viability 
‘Because of value added by our workforce.’ ‘Because ARVs, vitamins, lab tests all cost 
money.’ 
‘It helps the company prevent skilled people from 
dying if treatment is taken adequately. The company 
can save money if they do not have to train new 
employees.’ 
‘At the moment considering our size (20 
employees), I am not convinced that it is a 
viable option until the economy improves 
leading to growth.’ 
‘Our company employ skilled labour. It takes a few 
years to develop such a person. If he should become 
ill, then the company loses that skill.’ 
‘It is of no value to the company. It depends on 
the size of the company and number of 
employees involved in the programme because 
if the numbers are very small it can be costly.’  
‘The less infections we have in our country, the fewer 
mortality we experience and the less we would have 
to spend on hiring and training replacement 
individuals.’ 
‘It would not be financially viable according to 
management as the company would then instead 
of making money they would be spending 
money.’ 
























The findings of this opinion-based survey research have revealed much of interest in the 
construction industry’s response to HIV/AIDS. Most of the findings are based on opinions and 
claims by participants in construction and have been valuable in providing data on the nature and 
availability of HIV/AIDS programmes. Differences have been observed between construction 
respondents’ perceptions of the HIV/AIDS threat and their responses in trying to manage the 
disease. What is apparent in this study is the focus of construction companies on HIV/AIDS 
awareness programmes. This serves as a confirmation of the literature with regards to the low 
availability of treatment programmes among construction companies. The data also revealed 
inconsistencies in construction respondents' perceptions of the financial viability of running a 
treatment programme. 
 
Generally, the findings indicate a lack of comprehensiveness and immaturity regarding the 
implementation of HIV/AIDS programmes. This shortcoming highlights several issues of concern 
as to why this is so. A case-based company-specific investigation is appropriate in order to examine 
issues such as: the nature of treatment programmes and how they are implemented and why some 
companies have not implemented them. The following chapter describes the protocol framework for 






























In this chapter, the purpose and relevance of adopting a case study approach is established and the 
development of case-based research design is explained. The research questions to be addressed 
by the case study are looked at in greater detail, as noted in Chapter 1; 
 
a) What are the barriers to the implementation of treatment programmes within construction 
companies? 
b) What are the benefits of implementing treatment programmes within construction 
companies?  
 
Impacting on the research questions are some of the issues identified through the discussion in 
Chapter 2 and the findings of the survey research reported in Chapter 4. This chapter first presents 
the main issues arising from the survey research that are to be further analysed by a case study, 
followed by a justification of adopting the case study as an appropriate technique. Concluding this 
chapter is the case study design that looks at the definition of the cases, selection of the 
construction companies, sources of data and the data interview requirements.   
 
5.2 The Survey Issues to be Explored 
 
The analysis of the survey data in Chapter 4 produced findings from which the following 
questions were identified for further exploration: 
 
a) What is the actual nature of available HIV/AIDS treatment programmes? 
b) How are treatment programmes being implemented by construction companies?  
c) Do the benefits of providing a treatment programme outweigh the costs?  
d) Why treatment programmes are the least implemented intervention?  
 
Each of the issues described above have been discussed in the literature review in Chapter 2.  The 
literature review identified the models available for implementing treatment programmes in the 
workplace in South Africa. It was established that the availability of treatment programmes was 












However, the survey was not sufficient enough to explore the actual nature of the treatment 
programmes implemented among construction companies and how the programmes were 
managed.  
 
With regards to reasons for non-implementation of treatment programmes, costs were regarded as 
the major barrier hindering the provision of ART in the workplace. However, evidence from the 
literature suggests that the long-term benefits of providing treatment to employees outweigh the 
costs. In this regard, the case study attempts to establish first hand practices and experiences of 
construction participants regarding the costs and potential benefits of providing these 
programmes. The potential barriers to implementing treatment programmes will also be 
established. 
 
5.3 Justification of a Case Study Approach 
 
Thus far, this research has explored a theoretical understanding of the rationale behind HIV/AIDS 
responses in the workplace, the nature that these responses can take and their general application 
to the construction industry (Chapter 2). This has been followed by the consideration of a 
combined survey and case study research approach to collect the relevant data in Chapter 3. The 
results of the opinion-based survey on the perceptions of HIV/AIDS as a threat and the nature of 
HIV/AIDS responses of construction firms have been presented (Chapter 4).  
 
Based on the issues arising from the earlier parts of the study, the literature review and the 
survey, the next step is to carry out a more company-specific investigation, in order to gain a 
more in depth of how available treatment programmes are being implemented and why they are 
the least implemented intervention. Looking at the insights gained from case studies by Schramm 
(1971), cited in Yin (2003a, p. 12), the essence of the case study is to illuminate a decision: why 
it was taken, how it was implemented and what the outcomes were.  
 
The justification for using a case study approach is based on three components identified by Yin 
(2003b); 
a. The form of research question posed. 
b. The control of the investigator on behavioural events.  













In terms of the form or research question, Yin (2003a:9) proposes that a case study technique is 
relevant when a ‘how’ or ‘why’ question is being asked about a contemporary set of events over 
which the investigator has little or no control. Compared to other research strategies such as 
experiments or surveys, case studies provide the opportunity to focus on contemporary events, 
particularly in terms of organisational and management studies in “real life” situations (Yin, 
2003b). Further, they do not require the researcher to have any control over behavioural 
situations, leaving the investigator free to act as an observer. The researcher therefore has a 
passive, rather than active role and is freed of the danger of imposing his or her influence on the 
case.  
 
A case-study approach can also be justified on the grounds of data validity and the reliability of 
the data collection procedures. Yin (2003b) proposes the use of logical tests that have commonly 
been used to establish the quality of empirical social research. These are namely construct 
validity, internal validity, external validity and reliability.  
 
Construct validity can be achieved by utilising multiple sources of data in order to establish 
correct operational measures for the concepts being studied (Yin, 2003a). Generally, case studies 
are perceived to be subjective because researchers can have close, personal contact with the 
research participants (Riege, 2003). Efforts therefore need to be made by the researcher to refrain 
from subjective judgements in order to enhance construct validity. This research study has made 
use of existing literature, survey instruments, cases study interviews and documents in order to 
facilitate construct validity throughout the process. 
 
Internal validity on the other hand aims to establish a causal relationship, where a certain 
condition is shown to lead to another condition (Yin, 2003a). However, this does not mean 
merely reporting on the patterns of similarities and differences between respondents’ experiences 
or beliefs. It requires exploring further to identify significant components for the examined 
patterns and the elements that produced them (Riege, 2003). This has been achieved through an 
inter-case analysis and pattern-matching of the findings. Internal validity was also assisted by 
ensuring that interview transcript summaries were subsequently checked for factual accuracy by 














According to Riege (2003:81), “external validity is concerned with the extrapolation of particular 
research findings beyond the immediate form of enquiry to the general.” The case study approach 
on the other hand does not form a good basis for generalisation and has been criticised on this 
(Tellis, 1997).  
 
In order to ensure external validity, this study will rely on the heterogeneity of construction 
companies within the various “size” levels. The relevance of this study will therefore be limited 
to other enterprises of similar size and structure in the construction industry (analytic 
generalisations). 
 
Reliability refers to the extent to which findings can be replicated by other researchers using 
similar techniques and procedures (Riege, 2003). This is often a problem with case study research 
due to the lack of a systematic procedure to follow. The reliability of this study documented in 
this thesis is sought from designing and making use of a case study protocol and the triangulation 
of the construct validity, internal validity and the external validity.    
 
5.4 Case Study Research Design 
 
This section describes a protocol design for the collection of data from the case studies. It 
discusses aspects of the case units, the case selection, the nature of the information sought and the 
preferred analytical strategy. 
 
5.4.1 Units of analysis  
 
Yin (1994) stresses the importance within case study research of deciding upon the unit(s) of 
analysis. In this study, the definition of the case is a case study of construction companies in Cape 
Town and the units of analysis are the construction companies and company representatives. 
Company representatives in management positions provide the context within which decision-
















5.4.2 Concerns of case selection 
 
Several points of concern have been addressed in the selection of cases. Among these are: 
• Heterogeneity versus homogeneity of cases; 
• Company location; 
• Participants spread; 
• Study approach; 
 
Heterogeneity versus homogeneity of cases 
 
The point of concern is whether the case study companies should be homogenous in nature, i.e., 
of similar type and size, or whether a heterogeneous approach should be adopted. The argument 
for homogeneity is the possibility of controlled comparisons i.e., small companies would be 
compared with similar companies of the same size and type. A counter argument for homogeneity 
would be whether the comparisons would be valid.  
Justifying a homogenous approach to this case study research would be more appropriate using a 
deductive argument with an appropriate hypothesis, as suggested by Edwards (2001). For 
example, the selection of a particular company might be based upon a hypothesis which 
postulates that “…small companies are not likely to implement treatment programmes because of 
the presence of x and y factors.” To test such a hypothesis, would require not only a 
representative sample of small construction companies, but a sample also representative in terms 
of similarities of other factors such as the scope of work, location, nature of employment, 
methods of operation, etc. The uniqueness of each company would be a confounding variable that 
might prove difficult to control.  
 
This research explores HIV/AIDS intervention programmes in a construction environment, and is 
not concerned with practices of particular types of companies. This part of the research seeks data 
"richness" in terms of the personal stories, experiences and practices of construction participants 
and will then attempt to draw meaning from them through inductive reasoning. To that end it is 















For these reasons, project heterogeneity is preferred. No attempt is made to limit the nature and 
scope of the case studies to any pre-determined characteristics of company size or scope of 
works. This allows a measure of randomness to occur in case selection, in that, individual 




While the randomness referred to above is desirable, it is constrained by the researcher's ease of 
access to the head offices of the construction participants. For practical and logistical reasons, the 
companies to be investigated will be limited to the greater Cape Town area.  
 
Participants spread 
To attempt to include every participant in each case study would be impractical from a research 
point of view. In any event it is not part of the objectives of this research, which focus on the 
HIV/AIDS intervention programmes of construction companies. The participants were identified 
in Chapter 4 as including management personnel responsible for addressing HIV/AIDS. The case 
study interviews are therefore generally targeted at these participants, and any exceptions are 
noted in the analysis. 
 
Study approach 
The anticipated study approach will be that of recording of construction participant's "HIV/AIDS 
stories" through personal interviews. A well-structured and flexible question framework will be 
used to elicit information and the researcher will try to be impartial. Structure ensures that 
participants’ perceptions are not overlooked while flexibility allows for sought-after data 
"richness". 
 
5.4.3 Case selection 
 
Little guidance exists regarding the number of cases required. Yin, (2003a) suggests that more 
than one is necessary, in order to provide adequate triangulation in terms of data validity. The 
most valuable advice offered was that the number should be sufficient not only to triangulate the 












In the research described in this thesis, the researcher sought to maintain a balance in selecting 
cases to accommodate both homogeneous and heterogeneous groups of companies. The initial 













Organisation size – based on gross annual turnover 
TP+ = Presence of a Treatment Programme 
TP- = No Treatment Programme 
 
Figure 5.1 Case study design concept 
 
The proposed selection of cases was designed to choose two construction companies from each of 
the four size categories (large, medium, small and micro), one with a treatment programme and 
the other without a treatment programme. Following the pilot survey conducted, selection was 
made on the basis of availability of participants and their willingness to be interviewed, which 
distorted the initial case study design. The final selection thus incorporated a degree of 
"accidental" randomness and as a result twelve case studies were selected. 
 
 































5.4.4 Case interview data requirements 
 
Much of the required data was collected through semi-structured face-to-face interviews with the 
key construction participants. The choice of selecting face-to-face interviews as the preferred 
method of data collection was because it offers flexibility in terms of question content and target 
population, and also generates higher response rates (Gubrium and Holstein, 2001). In the 
interview process, flexibility is likely to be a key factor in successfully capturing participants' 
HIV/AIDS stories. 
 
The case study protocol was designed to provide a guideline for the material to be discussed in 
the interview in order to prevent any deviation from the main purpose. The nature of the 
questions was largely generic and addressed to all participants as set out in the Table 5.1 (See 
Appendix B for the detailed case study protocol). Each question was rationalised in terms of the 
research questions and issues noted in earlier chapters.  
 
Table 5. 1 Case study interview design protocol 
 
Organisational Element Issues 
Demographics Size, gross annual  , interviewee status, 
organisational structure 
HIV/AIDS policies Formal and informal policies adopted 
HIV/AIDS campaigns (awareness, 
prevention and treatment) 
Nature, employee involvement, 
effectiveness and cost assessments 
Prevention/Treatment programme 
benefits 
Organisational benefits, programme 
responsibility 
Employee HIV status disclosure Level of disclosure, confidentiality 
measures 
HIV/AIDS stigmatization Nature, effects, consequences, responses 
Medical aid scheme data Management data provision 














5.5 Analytical Strategies 
 
According to Yin (1994), analytical strategies are methods employed to examine evidence 
collected in order to address the initial proposition of a study. These include: 
• Illustration 
• Agreement/difference 
• Domain analysis 
• Ideal types 
• Content analysis 
• Pattern matching 
• Explanation building 
• Time series analysis 
 
Three strategies have been identified to be appropriate for case study analysis. A simple content 
analysis of the answers to interview questions was done, followed by pattern matching of the data 
in order to facilitate comparisons on an intra- and inter- company basis. This leads to explanation 
building, which informed the conclusions to be drawn. The other strategies were considered 
inappropriate. Illustration and ideal types of analysis intend to typify cases against a given norm, 
while domain analysis is appropriate for homogeneous groups of cases. Time series analysis 
requires data to be temporally linked on an inter-company basis. Any documentation provided has 




This chapter critically looked at the case-based approach as an appropriate method to further 
clarify survey issues. Justification for using this methodology was undertaken along with the 
development of a case study-based research design. Furthermore, interviews were identified as 
the best method of data collection, using a structured, open-ended questionnaire. The main units 
of analysis were the appropriate construction participants identified through the survey. The 
strategy of case analysis comprised simple content analysis, pattern matching and explanation 
building, with inter-project comparisons. In the following chapter, the findings of the case studies 

















This chapter presents the analysis of the primary data collected through the case study companies, 
together with an interpretation of the data and a discussion of the findings. The case study 
interviews were digitally recorded and transcribed. As noted in Chapter 5, the individual 
companies and company representatives form the main units of analysis, in the context of their 
organisational environments. After careful consideration of all 12 case study interviews 
undertaken, it was considered that 6 case studies would be sufficient to “saturate” the issues to be 
explored. Three companies offering treatment programmes and three companies without 
treatment programmes were considered. The selection was based on the quality of information 
provided.  
 
The analytical strategies adopted include simple content analysis of the transcribed answers to 
interview questions. This involves analysing the case studies individually, commencing with a 
description of the company, followed by summaries of the interview responses of company 
representatives. The interview summaries follow the case study protocol, which looks at the 
presence of HIV/AIDS policies and provision or non-provision of HIV/AIDS awareness, 
prevention and treatment programmes. Other aspects of HIV/AIDS such as disclosure and stigma 
are presented, including challenges faced by companies and possible innovative approaches 
initiated. In some instances, company representatives provided useful information that did not 
follow the case study protocol. This information has been presented in the form of a “story”, 
explicitly highlighting their experiences.  
 
Pattern matching of the data follows, in order to facilitate comparisons on an intra- and inter- 



















6.2 CareWorks HIV Management Consultants 
 
CareWorks, as described in the literature review, was included as an exploratory case study that 
was conducted to obtain an understanding of how an external service provider approaches the 
HIV/AIDS epidemic. 
6.2.1 Company Description 
 
CareWorks can be classified as a large company as it averages a gross annual turnover exceeding 
R25 million and employs between 51-100 permanent employees. The company’s head office is 
based in Cape Town, with sub-regional offices in Johannesburg and Durban. The company has 
attracted a lot of international interest and owns an 80% share in subsidiary CareWorks Africa. 
The other 20% is held by EDFI, an organisation representing Development Finance Institutions of 
15 European Union countries, which has provided funding for establishment costs. CareWorks 
Africa provides similar programs in five African countries. 
 
CareWorks HIV Management is a South African healthcare company which was established in 
2004. Its primary focus is on managing HIV/AIDS in the workplace and treating HIV-positive 
people on behalf of employers and medical insurers. The company exists to combat the spread of 
HIV/AIDS effectively by ensuring that those who test HIV-negative remain negative; by keeping 
those who test HIV-positive healthy and productive for as long as possible; and by positively 
influencing attitudes to break down the stigma surrounding the disease. 
 
CareWorks operates as a “for profit organisation”, offering the following products: a workplace 
based educational programme including usage of their InterACTiveTM KAPtureTM Tool (which is 
an IT-based system developed to automate, regulate and record activities conducted in the field), 
a treatment programme and a long term prevention strategy built around on-going management of 
peer educators. The programmes include various training interventions, each directed at the 
different stakeholders within an organisation, such as the unions, supervisory staff and senior 
management; counselling and testing; policy formulation; knowledge, attitudes and practices 














The treatment programme is designed to provide excellent and accessible HIV positive patient 
management using state-of the-art technology and expertise. CareWorks treatment programme 
offers drug and therapy management, pathology monitoring, outreach counselling, extensive 
administrative support and reporting (see www.careworks.co.za). 
 
6.2.2 Interview Summary 
 
An interview was conducted on the 10th of February 2011 at the head office in Newlands, Cape 
Town with Dr Kim Teversham as the company representative. The interview lasted one and a half 
hours. Dr Teversham is a medical director of CareWorks. His responsibilities in the company 
include overseeing the treatment programme, managing the clinical process, monthly reporting to 
clients, floor management and data management. 
 
HIV/AIDS Awareness-to-Action Training, Counselling and Voluntary Testing (ACT) 
 
The company has for the last 10 years been running their Awareness-to-Action Training, 
Counselling and Voluntary Testing (ACT) programme. The objective of the ACT programme is 
to create an environment through a number of focused activities, so that a high percentage of the 
employees of a client company can volunteer to have an HIV test and thereafter, to assist all of 
those who are HIV infected to register on an ARV treatment programme.  
 
This programme provides essential HIV related training to all levels of staff within an 
organisation, ensures that appropriate policies are in place and provides all staff with an 
opportunity to have an HIV test. CareWorks realises the importance of management’s support 
and therefore it is compulsory for all personnel, including those in management positions, to 
attend. In the field, dates are booked and confirmed and each site or office is given advance 

















CareWorks deploys field teams which consist of a day manager, a medical sister and 3 
counsellors to conduct the awareness workshop. The awareness workshop is a four and a half 
hour long process which consists of a 2 hour session on HIV/AIDS education for all employees. 
One team can process a maximum of 25 people at a time for the four and half hour session, 
meaning that they can process 50 people per day, 25 in the morning and 25 in the afternoon. 
Depending on the number of employees, the process can take a number of days. 
 
Following the educational session is a one-on-one pre-test counselling session which enables 
participants to ask any unanswered or sensitive questions which could not be raised in a group 
context. This also helps in preparing for testing for those who choose to do so. After this, all 
participants are given an opportunity to go for testing. Participation in HIV testing is voluntary 
and confidential and as such CareWorks has adopted a bar-code system that has no direct links to 
any employee in order to ensure full anonymity of participants.  
 
Dr Teversham reported challenges in earlier years, during the process of screening HIV positive 
people to get their CD4 counts. Earlier, the probability of collecting blood for a CD4 test was 
limited because of the potential of compromising confidentially. This was because, after getting a 
finger prick HIV test, an HIV positive employee would have needed to have blood drawn from 
their arm for the CD4 count. The HIV positive employees could therefore have been easily 
identified because of a mark on their arm. In more recent years, an advance in technology allows 
for a CD4 count to be taken upfront, in conjunction with the HIV test, using a simple finger prick 
test.  
 
Dr Teversham reports on the high rate of success achieved by the ACT workshops. This has been 
reflected by the high rate of HIV testing which has been reported to be an average of 85% of all 
participants attending the workshop. To date approximately 100 000 people have been tested, out 
of the 118 000 that have attended these ACT workshops. 
 
After completing the ACT process, CareWorks provides a detailed report to the company 
managers on the number of participants and percentage of HIV positive workers per site and 
employment category, as well as suggested next steps for an HIV/AIDS Workplace Programme. 
The HIV status of employees is kept confidential on all reports to company managers. Only 
statistics are provided. Employees who test positive can provide counsellors during the post-












and support. CareWorks also assists workers in accessing treatment through whatever disease 
management option that might be available to them (i.e. medical aid, company sponsored 
treatment, state clinic, etc). The bridging process of moving people from testing to treatment is 
initiated in less than 48 hours.  
 
According to consolidated data from August 2007 to January 2011 provided by CareWorks, the 
skilled construction workers or technicians recorded the second highest HIV prevalence (16%) 
among the different job categories across all sectors. In the construction sector alone, the general 
workers presented the highest HIV prevalence at 21%, followed by the operators or drivers with a 
prevalence of 20% and the skilled construction workers with an HIV prevalence of 18%. The job 
categories presenting the lowest HIV prevalence were directors and senior management at 3%. 
These statistics present evidence of HIV levels in the construction workforce and especially 
among the relatively skilled workers. 
 
CareWorks, in some instances, provides the education and testing services free of charge, made 
possible by the (US) Presidential Plan for AIDS Relief (PEPFAR). CareWorks was allocated a 
sub-award in terms of the PEPFAR Programme for the provision of various HIV-related services 
to vulnerable populations in the Construction and Mining Industries, in South Africa. The funding 
covers the CareWorks ACT programme, but was said to be available until January 2011.  
 
HIV/AIDS Treatment Programme 
 
CareWorks also offers HIV/AIDS treatment services to corporate clients as well as workers who 
are on medical aid. The CD4 upfront approach has been reported to achieve a far higher yield, in 
some instances as high as 75% of the workers take up the treatment services offered when 
counselled on their CD4 results at the time of their HIV test. However it has been sadly reported 
that for most HIV infected people with ready access to ARV treatment through private health 
facilities or the state, they only get to register on a treatment programme when they start to feel 
sick, which is often too late.  
 
Dr Teversham pointed out that access to treatment services differs based on the financial 
capability of the company. Management personnel normally have a medical aid scheme and if 
treatment should be required, they are referred to their medical service providers. For permanent 












companies are not willing to pay, they are often referred to the state programme. Dr Teversham 
reports that employees on limited duration contracts are seldom put on a private programme, but 
are referred to the state programme. At the time of the interview, no limited duration contract 
employees were registered on the private programme. 
  
The average cost of providing treatment programmes was reported at R1 000 per employee per 
month for those receiving ARVs and R200 per month per employee for those not receiving ARV 
therapy. Using an example of a hypothetical company with 1000 employees, an estimated cost to 
a company can be calculated as follows;  
 
If 85% employees get tested and an estimated 10% have HIV, it is therefore presumed that 85 
people within the company will be confirmed as being HIV infected. If, for various reasons, 60% 
(n=51) of HIV positive employees are enrolled on the treatment programme and only 40% 
require immediate ARV treatment, the company ends up having 20 people receiving ARV 
treatment. The total cost such a company can expect to pay for running a treatment programme 
with 20 employees receiving ARV treatment and 31 receiving on-going monitoring (regular GP 
visits, pathology and counselling) can hypothetically be calculated at around R26 200 per month. 
 
Regarding administration of ARV drugs, CareWorks courier the drugs to the employees. In cases 
where employees have openly disclosed to company representatives, the drugs might be sent to 
their company. CareWorks emphasises the importance of adherence to medication. They are fully 
involved in taking measures to ensure that adherence is practised. CareWorks operates a call 
centre of trained consultants in different South African languages in order to accommodate 
differences in ethnicity. Continued support and follow-up is provided telephonically in the 
employee’s home language. Assistance such as sending transportation money through mobile 
phone banking and receiving it from the doctor is another way to ensure that drugs are collected. 
 
An HIV steering company committee consisting of peer educators and management personnel is 
formed in every company to offer continued support and education. The HIV steering committee 
provides direction to the corporate HIV program. A high adherence level of up to 80% has been 
reported with employees on the private programme, which stems from the provision of good 
education and on-going support to those people receiving ARV’s. However, no feedback is 













Dr Teversham reported on the observed success of HIV/AIDS treatment services through reduced 
deaths, high rates of uptake of treatment, disclosure to fellow employees, compliance in taking of 
drugs and viral load suppression. A major deterrent regarding uptake of treatment services that 
was highlighted in this interview was the fear of job losses especially for those on the state 
programme. For workers receiving treatment through the state programme, they have to take time 
off to collect drugs and because of the poor service delivery at the public health centres, it may 
take a full day to collect drugs thereby compromising their job security. Employees on the 
CareWorks programme are offered convenience as their medication is delivered directly to them. 
 
The CareWorks programme offers flexible services where an employee can request to get tested 
at any time. If the employee tests positive for HIV, CareWorks provides them with access to and 
support from a trained counsellor. CareWorks also facilitates sessions for HIV positive 
employees to receive counselling and advice along with their partners, to resolve issues such as 
fear of rejection from their partner. 
 
CareWorks suggests that companies can readily assess the effectiveness of their own HIV 
programmes by asking themselves the following six questions: 
 
a. How many employees have received HIV training? 
b. How many employees have taken an HIV test and know their status? 
c. Of the employees who have tested HIV positive, how many are on ARV treatment 
programmes? 
d. Of employees who are getting treatment, how many are adhering to the medication? 
e. How many employees within the company have disclosed their status? 
f. Over a period of time, is there a reduction in the number of new HIV infections? i.e. is there 
evidence that the companies prevention strategy is working? 
 
The answers provide a quick assessment of the adequacy of a corporate HIV programme.  
 
Challenges faced by CareWorks  
 
The construction sector faces a significant challenge when contemplating offering HIV/AIDS 
treatment services to their employees. Because it is a project-based industry, a high percentage of 












For this reason, Dr Teversham described the construction industry’s involvement to be more 
focused on prevention than treatment. He reported that some of the largest construction 
companies whilst very concerned about HIV/AIDS worry about the long term sustainability of 
the provision of ARVs. This reluctance for companies to offer treatment is mainly because of the 
anticipated high costs of treatment and the returns not being financially rewarding due to the 
factors noted above.  
 
On the other hand, for some companies, the major incentive for providing these services might 
have been corporate social responsibility. It has also been recognised that many companies in the 
construction industry have incurred significant expenses in providing HIV related training and 
testing to employees who are only working for the company for a month or two and in situations 
where the company has no immediate benefit other than through their contribution to fighting the 
national pandemic. However there are a number of construction companies that do fund the 
provision of a comprehensive HIV program, including ARVs, for their permanent staff.  
 
Another challenge that CareWorks currently faces is the loss of funding from PEPFAR. The 
national reduction in PEPFAR funding has had a negative impact on HIV management 
companies. By losing funding, it means CareWorks will have to offer the ACT workshop at a cost 
to companies. Since companies are reluctant to pay for HIV/AIDS services where up to ¾ of staff 
are employed on limited duration contracts, this could lead to a reduction of the provision of 
HIV/AIDS services within the construction industry.  
 
6.2.3 Conclusion of Supplementary Case Study: CareWorks 
 
The interview with CareWorks has provided information on the provision of HIV/AIDS services 
in the workplace. The company offers a comprehensive workplace programme from the 
discovery of HIV status to patient-management care and support. CareWorks emphasises the 
importance of HIV/AIDS education, and the importance of involvement of all employees at 
different levels within the company. Their observed high uptake of HIV testing has been 














Statistics on HIV infection rates, drawn from the ACT workshop, provide a good starting point 
for companies to consider offering treatment services. Since CareWorks operates as a profit-
making organisation, it allows them to provide good quality service and remain sustainable whilst 
still affording free ACT workshops. Information gathered from this interview provides a basis for 






































6.3 Case Study 1 
6.3.1 Case details 
 
Name: Company A 
Size: Large-scale construction company  
Programmes: Provides awareness campaigns and a treatment programme 
 
6.3.2 Company description 
 
Company A is a Cape Town based company with an average gross annual turnover exceeding 
ZAR26 million. The company trades as a civil engineering contractor, employing over 1 000 
employees. An estimated 60% (n=600) of these employees are contract employees.  
 
6.3.3 Interview summary 
Company representative 
 
The company representative (CRA1) was interviewed and digitally recorded on the 15th of 
February 2011. The interview lasted approximately fifty minutes. CRA1 is currently employed as 
a company director and oversees Human Resources and wellness of employees. On the human 
resources side, the job entails overseeing and facilitating training, recruitment, selection and 
placement of employees, as well as being responsible for bursaries. With regards to the wellness 























The company has a formal HIV/AIDS policy which has been in existence since the period 
1996/1997. The policy is reviewed annually. In terms of policy implementation, the company has 
a top-down, bottom-up approach. This means that top management draws up the policy with input 
from the employee representatives belonging to different forums (shop stewardship forum, 
employee representative forum and employment equity forum). The employees’ concerns and 
issues are taken into consideration in the policy development. 
 
The policy commences with a definition of HIV/AIDS and its implications on the workplace. It 
sets out its objectives which entail the following; 
 
Promotion of a non-discriminatory work environment – the policy speaks against employees or 
a job applicant being prejudiced against, victimised or discriminated against based on their 
HIV/AIDS status. It ensures that all workers receive training and understand the realities and 
misconceptions of working with an HIV/AIDS-positive co-worker. The policy also advocates 
against unfair discrimination of HIV-positive employees on termination of employment, 
retrenchment, demotion, transfer or allocation of employee benefits. 
 
Provision of HIV/AIDS awareness, counselling and testing – the policy sets out compulsory 
HIV/AIDS awareness training to be provided biannually to all employees by an accredited 
provider. Regarding HIV testing, an employee with HIV/AIDS is entitled to a legal right to 
privacy and is not required to disclose their HIV status to the company or other employees. 
However, if a person wishes to disclose his/her status to the company, this information may not 
be disclosed to others without the employee’s express consent. 
  
Provision of education and training – it is a requirement that education workshops be conducted 
to inform employees about HIV/AIDS and its transmission; company and employee rights; 
encouragement towards openness, acceptance and support for employees who voluntarily 
disclose their HIV status. The company ensures that management and first-aiders receive training 
on dealing with risks of occupational transmission of HIV and exposure to HIV. Company A 
encourages the use of employees who are openly living with HIV/AIDS in education, prevention 













Promotion of a safe working environment – the policy ensures that the company provides a safe 
working environment without risk to the health of its employees. However, compensation will be 
granted to an employee who becomes infected with HIV as a result of an occupational accident.  
 
Managing HIV/AIDS employees – the policy stresses the importance of treating HIV/AIDS like 
any other life threatening illness. Therefore, HIV-infected employees should continue to work 
under normal conditions for as long as they are medically fit to do so. 
 
Workplace HIV/AIDS programme 
 
The key elements of the HIV/AIDS Workplace Programme include the following: 
• An impact assessment of HIV/AIDS on the company; 
• HIV/AIDS awareness programmes;  
• Voluntary HIV testing and counselling programmes;  
• HIV/AIDS education and training;  
• Condom distribution;  
• Encouraging treatment for STI’s and TB;  
• Universal infection control procedures;  
• Creating an open accepting environment;  
• Wellness programmes for employees affected by HIV/AIDS;  
• The provision of antiretrovirals;  
• Education and awareness about antiretroviral and treatment literacy programmes;  
• Counselling and other forms of social support for infected employees; and  
• Monitoring, evaluation and review of the programme. 
HIV/AIDS awareness and prevention campaigns  
 
CareWorks initiated their ACT programme with the company in 2003. These have been 
conducted once every two years, to all employees, both permanent and temporary. Apart from 
CareWorks, the company conducts its own HIV/AIDS education campaigns on HIV/AIDS 
transmission, prevention of mother-to-child transmission (PMTCT), education on treatment and 
how the immune system works, opportunistic infections (OIs), disclosure and precautionary 
measures (they have Post Exposure Prophylaxis (PEP) kits which is an emergency medical 












CRA1 describes their approach to HIV/AIDS as proactive and fun, but at the same time 
highlighting the seriousness of the disease. They strongly emphasise the importance of looking 
after oneself and knowing one’s HIV/AIDS status. As a form of an awareness campaign, they 
display HIV/AIDS posters provided by CareWorks and by the company on site. Every month 
they have a talk which covers different themes related to HIV/AIDS, such as STIs and TB.  
 
Peer education is seen as an important part of HIV/AIDS education. As part of the CareWorks 
programme, the company has employees who were trained as peer educators. These are 
nominated and selected on the sites. CRA1 described them as the “go to guys” because they are 
well respected and trusted.  
 
Effectiveness of HIV/AIDS awareness and prevention is measured using the feedback reports 
from CareWorks on HIV infection rates. The uptake of VCT has increased since the start of the 
programme. In 2010, 134 infected employees were reported, out of 801 employees who 
volunteered for testing. Among these, the majority (n=95) were limited duration contract 
employees. CRA1 reported that the new rates of infections have been below 1% for the past 3 or 
4 years. In 2010, 3 new infections were reported. The company not only relies on CareWorks 
statistics, but also conducts their own in-house monitoring.  
 
HIV/AIDS treatment programme 
 
CareWorks is only involved until testing, after which the company takes over. The company has 
an independent supplier of ARVs and company doctors on each site. They approach a doctor, 
explain their programme and open an account with them. The benefits are explained to the 
employees in order to avoid them taking advantage of the system to get treatment for what they 
are not covered for. The company’s treatment programme covers the majority (80%) of 
employees that are not on medical aid. 
 
Having been diagnosed with HIV, employees who intend to receive treatment through the 
company’s programme approach the director or the HIV/AIDS facilitator and express their 
intention to register. They then get tested for their CD4 count and viral load and depending on the 
combination of CD4 count and viral load, a decision is made along with the medical doctor as to  
whether the employees should take ARVs or not. If a decision is made to go on treatment, 












Medication is delivered by hand to the sites, meaning that workers do not have to miss work 
while collecting medication at the clinics. This process takes about a month in order to deliver 
medication to all the sites, which is one of the reasons why they are provided with a 3 month 
supply of drugs. Each employee receives a box of tablets and a book for CD4 count recording and 
a doctor’s or a pathologist’s appointment. The company supplies Selenium which is an immune 
booster, and a gel for shingles and marks. A spread sheet of appointments is kept by the HIV 
management team, and when they deliver medication to the sites, they make follow-up 
appointments and take employees who are due for tests to the doctors. Employees are taken for 
check-ups every 3-4 months to check if they are complying with medication. The company 
receives scripts and records from the doctors to check on the progress of participants.  
 
The number of employees who were on the programme as at October 2010 was 66, which 
amounted to 14.8% of employees on the payroll. The majority (n=62) who tested HIV positive 
were permanent waged employees. At the time of the interview, 65 employees were on the 
treatment programme out of 450 permanent employees. Seventeen percent of employees on 
limited duration contracts (LDCs) who are HIV positive were offered counselling and assistance 
to get enrolled onto the national ARV programme.  
 
CRA1 reported on an upgrade of medication that was being administered, from 3 tablets to 1 
tablet per day. Liver tests and other tests were carried out in order to assess compliance to the 
new ARVs. Employees who failed to comply remained on the old regime of ARVs. Employees 
administering ARVs are strongly recommended to comply with medication. Non-compliance to 
treatment is usually picked up from the CD4 count and viral load monitoring and warning signs 
of alcohol abuse. Their incentive for compliance is to keep the employees on the payroll, 
although there have not been any cases where an employee was dismissed due to non-
compliance. Termination from the programme occurs when employees resign, die, retire or are 
dismissed. The programme offers flexible entry for new employees, who can request for testing to 
be arranged.   
 
Disclosure of HIV status 
 
Regarding disclosure of HIV status to fellow employees and management, this has been reported 
as one of their major accomplishments. When the programme started in 2003, out of 50 who 












stands at 100%. About 80% of the managers know the people who are HIV-positive by their own 
disclosure. CRA1 feels that it is important for employees to be aware of HIV-positive people in 
order to look out for them. For example, if they operate machinery and have started a new regime 
of medication that can affect their performance, someone will need to be aware of it.  
 
Benefits of providing HIV/AIDS services to employees 
 
CRA1 stresses the importance of keeping the employees healthy and productive for as long as 
they can. Besides the benefits of a healthy workforce, CRA1 highlighted that it also makes sense 
in terms of costs. They have a fixed budget of between R300 000 and R500 000 per year, 
calculated against real costs of the programme’s needs. It has been highlighted that offering an in-
house programme is convenient and prevents employees taking time off to visit the doctors and 
waiting in queues for medication. Also noted is the change in attitude of employees towards the 
company and management. The employees are more trusting and do not question the company’s 
intentions. 
 
The company offers full commitment which extends immediately after an employee leaves the 
company for whatever reasons. An employee is supplied with 3 months stock of medication and 
reference letters from doctors regarding their treatment, with the intention of continuing 
treatment. If problems are encountered in enrolling on another programme, the company 
personnel assist in getting employees onto a programme. The success of the HIV/AIDS 
programme has been reported to be largely driven by management. 
 
Innovative approaches to HIV/AIDS programmes 
 
The company aims to keep the programme alive and has been coming up with innovative 
approaches. Due to emerging problems of young, educated people being HIV-positive, the 
company has launched an HIV/AIDS awareness initiative with CareWorks at a local university 
for aspiring construction professionals to get tested. The aim is to have a compulsory course on 
HIV/AIDS and attain a certificate after completion of the course. This is a drive for institutions to 














The company has been involved with education on HIV/AIDS in schools, communities and 
farms. They have been approached by schools and communities expressing their interest of 
becoming part of the company’s programme but CRA1 highlights that there are problems when 
dealing with communities because of the large number of people involved. Management is 
involved in HIV/AIDS, attend HIV/AIDS seminars and are well informed on any developments 
in HIV/AIDS.  
 
6.3.4 Conclusion of case study on company A 
 
Based on the information drawn from the interview it can be concluded that Company A has a 
well-established HIV/AIDS workplace programme. The company has a comprehensive 
HIV/AIDS policy which facilitates the provision of awareness and prevention campaigns as well 
as treatment programmes. All aspects of the policy have been well translated into the HIV/AIDS 
intervention programme. Besides relying on an external service provider, company A also takes a 
proactive role in the education and training of employees. The company took a significant step of 
providing in-house treatment programme although these services are only provided to permanent 
employees.  
 
Disclosure has been reported as the biggest success of the programme as it creates a culture of 
non-discrimination and acceptance of HIV/AIDS among the workforce. The company strongly 
acknowledges the involvement of management as an important factor which drives the 
HIV/AIDS programme. The company shows commitment and intends to extend their programme 






















6.4 Case Study 2  
6.4.1 Case details 
  
Name: Company B 
Size: Large-scale construction company  
Programmes: Provides awareness campaigns and no treatment programme 
 
6.4.2 Company description 
 
Company B is a large company with the head office located in Johannesburg and regional offices 
operating in other provinces including Cape Town. The Cape Town office employs over 250 
permanent employees, with an estimated gross annual turnover exceeding ZAR26 million. Their 
work category is mainly general building construction.  
 
6.4.3 Interview summary 
Company representative 
 
The company representative (CRB1) was interviewed on the 23rd of February 2011. The 





The company has an employee wellness policy which covers dread disease, work performance, 
incapacity, education and prevention of HIV/AIDS and other dread diseases, confidentiality, 
grievance procedure, smoking policy and health and safety, among other things. On HIV/AIDS 
aspects, the policy acknowledges education as one of the most effective ways of reducing the 
spread of the disease. The company commits itself to providing on-going HIV/AIDS and dread 
disease awareness and prevention programme to all its employees, which involves distribution of 













Company B has a confidentiality clause in the policy, which provides persons with the right to 
privacy and confidentiality concerning their health and HIV/AIDS status. Furthermore, it states 
that employees with HIV/AIDS are under no obligation to disclose their HIV/AIDS status. 
However, if they choose to do so, precautions should be taken to ensure confidentiality and the 
employees’ right to disclosure. 
 
Policy development in this company takes a top down approach where executive directors 
develop the policy with no input from employees. Policy formulation is done by the head office 
in Johannesburg and adopted by the subsidiary offices in other provinces. The most recent 
revision of the policy was in 2010 after the merger of Company B with another company. The 
policy had last been revised in 2009. 
 
HIV/AIDS awareness and prevention campaigns  
 
As a response to the government’s requirement, the company got involved in HIV/AIDS 
interventions in 2007 when it was required on government projects to have monthly reports on 
HIV/AIDS training and awareness, employees’ attendance, cost budget and monthly cost reports. 
On a once-off basis, the company contracted an external service provider to conduct HIV/AIDS 
awareness and testing at the cost of about R55 000. Out of 360 employees who got tested, 8.9% 
(n=32) tested HIV positive. During that time, there was no budget allowance n an HIV/AIDS 
programmes but only on employee wellness. 
 
Since then, the company has been conducting HIV/AIDS awareness workshops every 2 years for 
all employees through CareWorks free of charge. For the gap year that the company goes without 
an HIV/AIDS workshop, they conduct TB awareness campaigns. Depending on the number of 
sites and number of employees, the company sets aside 1 or 2 weeks for CareWorks to conduct 
the workshops on all construction sites. CRB1 describes the uptake of testing to exceed 90%. In 
2010, out of 157 employees that attended, 150 received counselling and 135 volunteered to get 
tested.  
 
As a requirement by the company’s wellness policy, the company takes responsibility in issuing 
condoms on all sites, have posters displayed on the sites and brochures and pamphlets available in 
locker rooms. CRB1 expressed a problem they have been facing in outsourcing posters on 












the available posters have been for TB and STIs. The company had a site administrator who was a 
trained peer educator, whose job included going to the sites to encourage HIV positive people to 
come forward. He is no longer working for the company and they have no intention of replacing 
him. 
 
A lack of interest in discussing HIV/AIDS in toolbox talks has been highlighted. The talks 
generally cover construction regulations and risk assessment issues. At times they also cover 
topics on sexual harassment. CRB1 highlighted that the personnel conducting the toolbox talks 
are junior foreman or cadets who are not qualified to talk about HIV/AIDS and are not well 
equipped to answer certain questions regarding HIV/AIDS. With this in mind, the CareWorks 
peer education training programme has encouraged the company to consider training all health 
and safety officers to become peer educators. 
 
HIV/AIDS treatment programmes 
 
After the testing in 2007, management had a debate about offering ARVs to employees because 
of different contracts of employees. It was going to be difficult to determine to whom to give 
medication because salaried employees have medical insurance while artisans register with the 
Building Industry Bargaining Council which does not cover HIV/AIDS. Another possible 
difficulty that management identified was how they were going to manage the process. Based on 
these challenges, a decision was made not to offer ARVs. The company has also not taken on the 
option of CareWorks offering ARVs to employees. Instead, CareWorks made arrangements to 
deal with the HIV positive employees directly at the employees’ cost.  
 
In terms of disclosure, CRB1 has knowledge of two employees that have openly disclosed their 
HIV status. One of the two advocates for other employees to know their status. CRB1 identified a 
lack of trust and fear of discrimination as being the major barriers to disclosure. Employees’ not 
trusting management was identified as a hindrance by management because employees perceive 
that the company has a hidden agenda. The company’s new drive is to try and change this 
perception. 
 
No form of support is available for HIV-positive employees because of the confidentiality clause 
outlined in the policy. It would be difficult to keep the identity of the employee from other 












expenses. CRB1 described it as ‘opening a can of worms,’ which the company is not prepared to 
venture into. However, they are willing to offer assistance if someone comes forward. They 
advised CareWorks to inform them if any of their employees was having problems in paying for 
drugs or any other issues they can help with.  
  
CRB1 emphasised confidentiality as a big hurdle in the company trying to offer assistance. The 
initial service provider had proposed to deliver drugs to the sites but there was a risk of everyone 
knowing and identifying the employees on treatment. Another proposal was for the company to 
pick the employees up at a secret location and take them to collect the drugs. The proposal was 
not realised because the other employees would notice a pattern of certain employees coming to 
work late with no complaints from management. With the current employee on HIV treatment, 
she puts in sick leave because she is a salaried employee. CRB1 highlighted that if it was an 
hourly paid employee it would present problems because hourly paid employees are paid per 
hour. 
 
CRB1 suspects that a number of hourly-paid employees are missing work while collecting 
medication and seeking treatment. As indicated on the time sheets, they have been reported to be 
regularly taking time off work to seek medical attention from the clinics. However, HIV/AIDS 
cannot be ruled out as the cause as it could be other diseases such as TB or a chronic illness. A 
high rate of absenteeism has however been reported. Out of a total of 360 employees, 350 have 
been reported to have been absent from work throughout the year. They have been monitoring the 
level of absenteeism and if an employee is regularly absent, they call them in to further 
investigate the cause. If no valid reason is provided, they are taken for a disciplinary hearing. The 
company had an experience where one employee passed away after he got very ill. He had moved 
to the Eastern Cape. It was not confirmed that he had died of AIDS, but other employees merely 
suspected. 
 
CRB1 perceives that offering HIV treatment to contract employees would not be financially 
viable because they move when the contract ends. There is also a lot of credibility with the 
service provider because they do not disclose the names of people on the treatment programme 















Innovative approaches to HIV/AIDS programmes 
 
Going forward, the company intends to involve health and safety officers on HIV/AIDS training 
which will form part of an induction programme. The induction programme, which is currently a 
work in progress intended for all new employees would also involve HIV/AIDS. This will be to 
ensure that they get a start-up in respect of the HIV/AIDS awareness and prevention programme. 
 
6.4.4 Conclusion of case study on company B 
 
Company B acknowledges HIV/AIDS as a business problem as highlighted by the inclusion of 
HIV/AIDS aspects in their employee wellness programme. However, a comprehensive response 
is lacking because there is no commitment to provide management and care for HIV-positive 
employees. Currently the company offers HIV/AIDS awareness and prevention through 
CareWorks free of charge. Costs which the company incurs are on the provision of condoms and 
educational material. The main reasons for not providing treatment services were the difficulty in 
managing the process, ensuring complete confidentiality from other employees, and also the 
difficulty in selecting which employees to offer medication to.  
 
There is evidence of high absenteeism from weekly time sheets which the company uses for 
monitoring purposes. Employees who are regularly absent have also been noted, possibly 
suggesting that they could be missing work while collecting medication or for some other 
reasons. Offering treatment services is not considered viable by CRB1, due to the mobility nature 
of the workforce. This could also be another reason for the company not providing treatment 





















6.5 Case Study 3 
6.5.1 Case details 
 
Name: Company C 
Size: Large-scale construction company  
Programmes: Provides awareness campaigns and a treatment programme 
 
6.5.2 Company description 
 
Company C is a large company employing over 250 employees and earning a turnover exceeding 
ZAR26 million per annum. The company’s head office is located in Cape Town and it has 3 
subsidiary offices in Gauteng, KwaZulu-Natal and Port Elizabeth. The company has a department 
that is solely dedicated to the health and another to the safety of employees. They have an 
HIV/AIDS programme which has been integrated into the occupational health and safety 
initiative.  
  
6.5.3 Interview summary 
Company representative 
 
The company representative (CRC1) was interviewed on the 22nd of February 2011. The 
interview lasted approximately one and a half hours. CRC1 has been a senior manager since 
2006. The company representative expressed a great passion in including occupational health as 
part of the human resource responsibility and part of the CRC1’s job is to oversee the HIV/AIDS 
programme. 
 
CRC1 reported having gained experience from a previous employer where they were running a 
clinic. When CRC1 joined the company, they already had a service provider but it was not 
comprehensive. A proposal was put forward, which included a budget proposal to run a 













The proposal was presented as a business case with projected costs of providing treatment against 
the current losses on absenteeism. The company accepted the proposal and settled on a budget 
which currently sits at R70 000 per year. CRC1 describes the company as having an employee-





The company representative reported the presence of an HIV/AIDS policy. Formulation of the 
policy takes a top down, bottom-up approach, meaning that there is also input from employees in 
lower levels of employment. An employee unity forum which meets once every month provides a 
good communication platform between employees and management. A representative from each 
forum on each site brings forward issues and concerns from sites which are further analysed and 
discussed by management for consideration. 
 
HIV/AIDS awareness and prevention campaigns  
 
The company has combined HIV/AIDS education together with the annual medical examinations 
which are conducted every year for all construction employees. Medical examinations are 
conducted on an individual basis by a nurse, and therefore provide a platform for basic education 
on HIV. During the one-on-one examinations, the nurse can detect symptoms that could suggest 
that an employee is HIV-positive. In such cases, the nurse offers counselling and encourages 
employees to get tested or if they already know their HIV status, she encourages them to disclose 
their HIV status in order to receive assistance from the company. The nurse is qualified on life 
skills and safe sex education.  
 
CareWorks has been contracted to offer HIV/AIDS awareness and VCT services. These are 
conducted once every 2 years. CRC1 reported that the ACT workshop conducted by CareWorks 
two years back achieved a high uptake rate of HIV testing. All employees from top management 
to labourers took up HIV testing. Although the workshop was successful, it was considered as 
time consuming as 20 employees were attended to per day at the head office. This meant that 













The group training session was reported to have taken one and a half hours whilst testing was 
conducted individually. If an employee tested HIV-positive, they were informed about the 
CareWorks treatment programme and the extent of the company’s cover. CareWorks was 
prepared to test all employees’ spouses who were not in their employment. CRC1 reported that 
two girlfriends of their employees disclosed their HIV status and received assistance. 
 
HIV/AIDS treatment programmes 
 
CRC1 reported that the company currently pays for ARVs, which are posted directly by 
CareWorks to the employees. Monthly-paid employees who have comprehensive cover from their 
medical aid schemes are not included under the CareWorks treatment programme.  
 
Providing ARVs through CareWorks has been reported to offer convenience for employees. As 
the CR describes as quoted “there is no point for an employee to sit in a queue for 2 days for 
drugs that can be posted to him whilst sitting at home.” In terms of costs, CRC1 reported that the 
monthly costs for ARVs which is currently at R900 per person per month does not compare to the 
daily cost that the company ought to lose if not offering treatment. An example was provided 
where the company can lose R520 per day for a supervisor waiting in a queue for medication. 
This amount can pay for almost half the medication. Besides that, the quality of drugs from the 
state programme causes serious side effects which can cause the employee to stay at home and 
cost the company even more.  
 
CD4 count tests are conducted every 3 months and support provided through phone calls every 
month by CareWorks. The doctor’s visits are done once every two years, unless the CD4 count is 
less than 200 and not in sync with the viral load. CareWorks provides the company a detailed 
breakdown of the CD4 count and viral load which can be traced to see if employees are adhering 
to treatment or not. The CRC1 is responsible for checking the reports and contacting CareWorks 
to follow-up on an employee if there is no improvement on CD4 count and viral load.   
 
A nurse is responsible for lifestyle management of HIV-positive employees because constant 
monitoring is required. The company pays for her to conduct health check-ups on all employees 
on a monthly basis. These check-ups are necessary because of the high quality drugs which 
CareWorks administers, which have minimum side effects. CRC1 claims that when a person 












of weight gain and high cholesterol which will need to be managed. In one instance, an employee 
had to be asked to lose weight because he was getting overweight. Frequently they also need to be 
reminded of how their behaviour affects their lives when it comes to alcohol abuse and sexual 
behaviour. 
 
In cases of transfers, CareWorks either posts the medication or the company organises to receive 
the medication, depending on whether the employee has disclosed their HIV status or not. If 
undisclosed to the company, CareWorks deals with them directly. In cases of resignation, the 
company offers 3 months’ supply of medication until the employee can be placed on another 
programme. The company has an arrangement with CareWorks for employees that have disclosed 
their HIV-positive status to the company. If an employee is unavailable, CareWorks can ask the 
office to check on him. If an employee is uncontactable for 3 months, the employee will be taken 
off the programme and not receive treatment. 
 
For the other offices, CareWorks does not offer treatment but makes referrals to the state clinics. 
It has been reported that in regions such as the KZN where employees have difficulties enrolling 
on the state program, CareWorks facilitates employees to get enrolled.  
 
Disclosure of HIV status 
 
Cases have been reported where employees have disclosed their HIV status confidentially to the 
nurse, and in turn disclosed to the human resources officer for assistance to get onto the 
CareWorks HIV/AIDS programme. It is known to the human resources manager that only 4 
employees refused to disclose their HIV/AIDS status. Some HIV-positive employees have 
disclosed their HIV status to CareWorks and do not want the company to know. It is known that 
out of the 4 undisclosed employees, 1 is on treatment. CRC1 suspects that the reason for non-
disclosure of 2 of them could be that they are in complete denial and 1 could be as a result of 

















CRC1 was willing to share three different experiences which the company encountered. These 
have been reported below: 
 
CRC1 reported an incident where an employee disclosed his HIV positive status to a fellow 
employee who is a manager. The manager in turn disclosed to the personnel responsible for HIV 
management. The manager did not take it well and was having a difficult time trying to deal with 
the situation to the extent that he had to receive counselling from Careworks.  
 
Another reported incident was when an employee was in denial of his pregnant girlfriend’s HIV 
status. The girlfriend had tested HIV-positive at the site clinic and he had tested HIV negative. 
After consulting with CareWorks, a full blood test was done which presented similar results. The 
couple received two sessions of counselling in order to help them accept and deal with the 
situation. CRC1 commends the work that CareWorks has done. The relationship they have 
created is one such that if they suspect any trouble with the employee, they can contact 
CareWorks to do a follow-up. 
 
In the third incident, a site manager called CRC1 to have a word with an employee who was 
showing signs of illness. The employee had missed his medical examinations because of illness 
and therefore the company had not picked up any warning signs. CRC1 consulted with the 
employee, informed him about the programme and assured him that if he reveals his HIV status it 
shall be kept confidential. The employee was well known to CRC1 because he had been in their 
employment for a long time. He was informed about the importance of achieving a certain level 
of trust with the company. CRC1 described their approach as “upfront and straight-up”.  The 
employee took the decision to disclose his HIV-positive status and entered the programme. Upon 
testing his CD4 count, it was very low and he had to be placed on ARVs.  
 
Benefits of providing HIV/AIDS services to employees 
 
CRC1 feels that the HIV/AIDS programme is paying for itself because of the returns they are 
receiving. CRC1 states that if they had to replace some of the employees they would have to 
spend more than double the hourly rate than they are currently paying. The company has invested 













In terms of costs, the company pays a reported R900 per person per month including support for 
employees who are on ARVs, R200 per person per month for those not on ARVs for support 
only. Their biggest motivation has been purely business, to retain skills and keeping employees 
productive for as long as possible. Retaining skills is important due to the nature of the industry 
which does not attract the younger generation. As the interviewee puts it “they do not want to get 
their hands dirty.” 
 
CRC1 is of the opinion that the provision of an HIV/AIDS programme is dependent on the 
company size, but believes that even with a limited budget there is something that under-
resourced companies can do. They just need to explore their options.  
 
Challenges faced by company C 
 
The company is due to conduct their HIV/AIDS awareness workshop but with the recent news on 
the possibility of CareWorks losing funding for free voluntary counselling and testing, the 
company has planned to leave it until late this year to see if CareWorks can or will be able to get 
funding. CareWorks is looking to run an ACT at R450 per person and this is something the 
company had not budgeted for. A possible avenue would be to get the nurse to do the testing and 
get CareWorks to do the training process for employees. Another alternative would be to use the 
employees who were trained intensively by CareWorks to provide in-depth training for young 
upcoming employees and have refresher courses for existing employees.   
 
CRC1 highlights that it is always a challenge to find ways to deal with employees who are not 
compliant with their medication. There is usually an overlap between the nurse and CareWorks 
on monitoring and that is when it is discovered that employees are non-complaint. They have an 
employee who has been openly HIV-positive for about 6 or 7 years. CRC1 reports that he drinks 
alcohol and does not adhere to treatment. He sometimes takes his medication when he is feeling 
sick. The company has threatened take him off treatment but he has not stopped his behaviour.  
  
Another challenge is how to protect other employees from the potential risks of contracting HIV 
in the case of an accident, while maintaining confidentiality. CRC1 reported an incident where an 
HIV-positive employee got injured and had to be taken to the hospital by an ambulance. CRC1 
reported that they actually did not know how to handle the situation but the safety manager 












CRC1 feels that no matter how many times people are educated about HIV/AIDS, behavioural 
change is difficult to manage. Television was highlighted as a great source of influence of certain 
kinds of behaviours such as multiple sexual partners which conflicts with AIDS education. 
Despite these challenges, what motivates the company to keep offering treatment is the physical 
transformation that they see from an employee being very ill to regaining their strength after 
getting treatment. 
 
Innovative approaches to HIV/AIDS programmes 
 
The company has connected CareWorks with their business school in order to provide HIV/AIDS 
education as part of life skills. The interviewee feels that HIV should be treated like any other 
disease, but that society has shaped it to be a special disease. CRC1 advocates that the 
government gets more involved in getting people enrolled on the state programme.  
 
CRC1 organised for the researcher to have an interview with one of their employees who is 
currently on the treatment programme. This interview was done upon the employee’s consent and 
it was kept confidential from the other employees. This has been reported below. 
 
Report by an HIV positive employee (conducted through an interpreter) 
 
The interview commenced with employee’s general information, progressing to aspects of 
HIV/AIDS. It lasted for 15 minutes. 
 
The employee has been employed by the company for 6 years. When he started, he was a general 
worker, but is now working as a forklift operator. He went through training and holds a certificate 
which is renewed annually and is now classified as a skilled worker. He discovered that he was 
HIV-positive 4 years ago after he fell ill and went to one of the public hospitals where he was 
tested. When asked about his feelings after discovering his HIV status, he described that he did 
not know what was happening or how he was going to deal with it. He however was not angry or 
upset. He disclosed his HIV status to his family which accepted and took it well. His wife also 














Within the workplace, he disclosed his HIV status confidentially to senior management after the 
CareWorks testing and education workshop in 2009. In the same year, he joined the CareWorks 
treatment programme and has been receiving medication through the post at his house. He has 
regular check-ups with the nurse who provides advice on lifestyle changes, and reports that he has 
not changed his diet but has reduced his drinking habits. The employee feels that the company is 
being good and helping a lot because there has been improvement. Previously when he was 
receiving treatment through the state clinics, he had to wait for long to get medication. He hopes 
to continue with treatment even after he retires.  
6.5.5 Conclusion of case study on company C 
 
Company C provides a comprehensive HIV/AIDS workplace programme through CareWorks. 
Their services range from education, awareness and testing to patient management and care. 
HIV/AIDS forms part of the companies’ primary focus because they have dedicated people 
managing the programme in-house. The proposal to have an HIV/AIDS programme was 
presented as a purely business case highlighting the costs of providing treatment against their 
current losses on absenteeism. The company acknowledges the financial viability of the 
programme and confirms that after years of providing treatment, benefits of implementing a 
programme outweigh the costs.  
 
The way they administer ARVs is more on a needs basis because they are available to contract 
hourly-paid employees who generally do not have medical aid and cannot afford to pay for 
medication. Their main motivation for offering an HIV/AIDS programme was to keep employees 
productive for as long as possible. Another motivation was to offer the most convenience, while 





















6.6 Case Study 4 
6.6.1 Case details 
 
Name: Company D 
Size: Large-scale construction company  
Programmes: Provides awareness campaigns and no treatment programme 
 
6.6.2 Company description 
 
Company D is a large company employing permanent employees in the range 165-170 in the 
Western Cape region. The company is currently employing 110 contract hourly-paid employees, 
out of whom 35 are general workers and the remaining employees are artisans, team leaders or 
cadets. The company employs subcontractors for specialised work. Their average gross annual 
turnover exceeds ZAR26 million, making it a large company. The general structure of the 
company includes the managing director and 4 executive coordinators in senior management 
positions, operations managers (site-based personnel) and a support team which includes human 
resources, estimating and procurement, and health and safety departments. The company has 
other offices in other provinces of South Africa, with the head office in Johannesburg. 
 
6.6.3 Interview summary 
Company representative 
 
The company representative (CRD1) was interviewed on the 21st of February 2011. The interview 
lasted approximately forty minutes. The position held by CRD1 is that of a human resources 
manager which includes recruiting and retrenchment among general human resources 



















CRD1 reported the presence of an HIV/AIDS policy, but has no knowledge of what the policy 
entails. Policy development takes place at the Johannesburg head office. It takes a top down 
approach with no input from the employees. 
 
HIV/AIDS awareness and prevention campaigns 
 
CRD1, reported employing a once-off HIV/AIDS awareness campaigns on World AIDS Day. On 
this day, posters and banners are displayed on all construction sites. Currently they have TB 
posters on site and no AIDS posters. Free condoms are issued on the sites by the health and safety 
officer who is responsible for sourcing them out from an external service provider.  
 
The company once initiated an awareness workshop that was conducted about 4 or 5 years ago. 
The company had an AIDS week campaign which involved an industrial theatre showcase on 
HIV/AIDS on all the construction sites. Voluntary HIV testing was also conducted for 
employees, including subcontractors working on the site. The results were sent to Johannesburg 
and treated as confidential. No statistics were provided to offices in other regions. CRD1 
describes the motivation behind this workshop as a reaction to the general drive for companies to 
act against HIV/AIDS at the time. The company which conducted the workshop had approached 
them (the interviewee does not recall the name).      
 
CRD1 described their workforce as AIDS ‘naïve’ because they seem to be relatively healthy. The 
company is aware of their employees on site such that if anyone is missing work or drastically 
losing weight, they will be quick to notice it. CRD1 reports that they do not have employees 
dying or getting ill. CRD1 attributes this to the stable nature of their employees. It has been 
reported that they are not transient. They reside in Cape Town with their families because most of 
the work is concentrated in the great Cape Town area. Besides that, the interviewee highlights 
















In response to not having an HIV/AIDS programme, the interviewee highlighted that the 
company has a different focus and that no need has arisen yet. They currently have no future 
plans for retesting. The reason for their initial testing was because of the drive for companies to 
take action but that has since not been an issue.  
 
CRD1 reported never having any requests from an employee for any support regarding ARVs, 
counselling or financial support. However, employees receive support through ICAS, which is a 
provider of employee assistance, wellness and wellbeing, as well as behavioural risk management 
services and critical incident support (see www.icas.co.za). Their services for employees include 
psychological counselling for employees and their dependants; life management which offers 
telephone information and assistance on legal problems, financial concerns and family matters; 
eCare online services which provides employees access to health and wellbeing information.  
They offer free telephone counselling and emotional support and if a consultant feels that the 
employee needs to have a one-on-one consultation, a referral will be made. The first few sessions 
are free after which the employee would have to bear the costs.  
 
ICAS also offers a wide range of in-house programmes which include HIV/AIDS, training 
interventions and healthy living programme. Their HIV/AIDS services include policy 
development, VCT campaigns, assessment services, employee and managerial training as well as 
peer educator training. The company has not taken the option of making use of these services in 
order to provide an HIV/AIDS programme. Information received by the support staff is not 
reverted back to the offices, meaning that if an HIV-positive individual is receiving assistance, on 
ARV treatment or CD4 count tests, the company has no knowledge of this because it is strictly 
confidential.  
 
CRD1 believes that if they had HIV-positive employees who needed their assistance, they would 
support them. CRD1 has knowledge of 1 employee with TB who receives support from the 
company through getting time off to collect medication and not being penalised for it. The 
company has a contracted company clinic where all employees get their entry and exit medical 
check-ups as company policy. The company has a budget for the medical examinations, which is 
included in the work which they tender for. However, there is no inclusion of HIV/AIDS 













6.6.4 Conclusion of case study on company D 
 
Company D is a well-established large company operating in all provinces of South Africa. 
HIV/AIDS is not considered as a threat to the company as indicated by the reluctance to 
implement an HIV/AIDS workplace programme. The primary reasons for not providing 
HIV/AIDS services is the lack of visibility of the disease as no HIV/AIDS cases have been 
reported. The company’s response has been a reactive rather than a proactive approach, with a 
once-off awareness campaign. However, the company could be indirectly providing support for 





































6.7 Case Study 5 
6.7.1 Case details 
 
Name: Company E 
Size: Large-scale construction company  
Programmes: Provides awareness campaigns and a treatment programme 
 
6.7.2 Company description 
 
Company E employs over 250 employees in Cape Town, with an estimated 1 600 employees 
across South Africa. Of the 1 600 employees, 800 are permanent and the other 800 are contract 
workers. Among the permanent, 500 are monthly-paid skilled workers and 300 are hourly-paid 
semi-skilled labourers who move between sites. The majority of the contract workers are 
unskilled or semi-skilled workers who are employed from the local areas in the sites. The gross 
annual turnover exceeds ZAR26 million, making it a large-sized company. The head office is 
situated in Cape Town. The company embarks on both public and private projects nationally in 
other provinces, with the majority of the projects being civil structures. They are also involved in 
commercial as well as industrial building projects.  
 
6.7.3 Interview summary 
Company representative 
 
The company representative (CRE1) was interviewed on the 24th of February 2011. The interview 
lasted approximately 1 hour. CRE1 is employed as a director who is responsible for 




















CRE1 reported the presence of an HIV/AIDS policy which was implemented in 2002. The last 
revision was done in 2009. CRE1 was involved in the reviewing process of the policy. The nature 
of the policy formulation and development has been reported to take a top-down approach where 
top management develops the policy without input from the lower level employees.  
 
The policy acknowledges the seriousness of HIV/AIDS, highlighting the implications it has on 
individuals, families, business, managers as well as the co-workers of those affected. The policy 
was drawn up with the intention of providing positive strategies to address HIV/AIDS in the 
workplace. Company E commits itself to addressing HIV/AIDS in a positive, supportive and non-
discriminatory manner with the cooperation and participation of all members of the board of 
directors and employees.  
 
Objectives of the HIV/AIDS programmes are summarised as follows: 
• Education and prevention – basic knowledge of HIV/AIDS and prevention; 
• De-stigmatisation – eliminating discrimination against people with HIV/AIDS; 
• Empowerment – provision of information on rights of and services available to affected 
employees; and 
• Occupational education – protection of employees potentially exposed to HIV/AIDS. 
 
The HIV/AIDS policy sets out that all HIV/AIDS positive persons have the right to 
confidentiality and privacy concerning their health and HIV/AIDS status. Additionally, the policy 
states that an employee is not required to disclose his/her HIV/AIDS status to the company. 
However, if such an employee decides to disclose his/her HIV status to a colleague, supervisor or 
manager within the company, it is expected that the principle of confidentiality of such disclosure 
be adhered to. 
 
Concerning support and assistance, the company sets out to provide counselling, testing and 
treatment services to all employees with HIV/AIDS. Employees belonging to a medical aid 
scheme are required to utilize the medical aid services and for employees without medical aid, an 












The company is committed to fair, sound and non-discriminatory employment practices. The 
policy states that an employee’s HIV status should not justify termination of employment, 
retrenchment, demotion, transfer or discrimination in employment.   
 
The policy describes that the company will issue information on HIV/AIDS and the realities, 
misconceptions and circumstances of working with HIV positive co-workers. The company sets 
out to ensure ways to alleviate fears and concerns of co-workers who are likely to become 
reluctant, unwilling or resist working with an HIV-positive individual. The policy clearly states 
that employees who are HIV-positive will be subject to the same contractual obligations, 
practices and performance measurements as other employees. 
 
HIV/AIDS awareness and prevention programme  
 
CRE1 reported that the HIV/AIDS programme was initiated about 6 years ago with three issues 
in mind; knowledge of HIV status of employees, prevention of new HIV infections and for HIV 
positive employees to be provided with treatment. At the time considerable debate arose around 
the issue, in terms of not being able to manage and maintain the programme and the costs 
involved in paying for treatment. CRE1 reported that the company’s culture of caring for 
employees, and the increased awareness of HIV/AIDS at the time eventually prompted the 
company to provide HIV/AIDS services.  
 
The programme was initiated with CareWorks which provided testing, education and treatment 
services. When the company was approached by CareWorks, they already had a strategy because 
they were struggling with AIDS. AIDS was recognised as a real company problem and the 
programme received support from the top management right from the beginning. Another factor 
that prompted action was the need to alleviate some of the problems faced in society. The 
company felt it as the right thing to do.  
 
CareWorks has been their service provider since then and have been conducting awareness and 
prevention campaigns every 2 years. The programme has been reported to be flexible because it 
also caters for new sites that are established. The company can request for an ACT workshop to 













In terms of education, HIV/AIDS awareness posters are available in 4 different languages 
(English, Xhosa, Zulu and Afrikaans) in order to cater for all employees on the sites. The 
company receives basic posters which they customise to include their company logo. Peer 
educators trained by CareWorks are available on all sites to offer education on HIV/AIDS and 
encourage employees to engage in safe sex practices. Regarding prevention, the company issues 
free condoms on the sites which they outsource independent of CareWorks. On World AIDS Day, 
the company gets involved in the celebrations by providing red arm bands, water bottles and 
AIDS banners. CRE1 prepares a presentation for the site agents to read out to the employees.  
 
HIV treatment programme 
 
CareWorks has been contracted to provide treatment services to employees. The company pays 
for HIV treatment for permanent hourly paid employees who are not on medical aid. Monthly 
paid employees who are HIV-positive receive treatment through their medical aid schemes. 
Contract workers are assisted by CareWorks to receive treatment from public health centres.  
 
On a monthly basis, CRE1 receives reports from CareWorks on the number of people on the 
treatment programme. According to the latest report for January 2011, out of the 900 people who 
got tested, 8% (n=72) are HIV-positive. Out of the 72 HIV-positive employees, 58 have been 
enrolled onto the CareWorks treatment programme. The uptake gap of 14 people who are 
infected but are not enrolled can be assumed to be on medical aid or getting treatment from the 
state clinics or are still in fear of disclosure. Out of the 58 that are active on the programme, 60% 
(n=35) are on ARVs and the remaining 40% (n=23) are not yet receiving treatment. For HIV-
infected employees on ARVs, 30 are receiving medication from CareWorks, 3 are enrolled on the 
state programme and 2 are receiving from other programmes (occupational health or private).  
 
Since the beginning of the programme, a total of 86 employees have registered with CareWorks. 
This is according to CareWorks consolidated data provided by the CRE1 for January 2011. A 
reported 16 employees have resigned either from CareWorks or the company and 12 employees 
have died. The company reported not having taken anyone off the programme. After resignation, 
the company pays for treatment for 6 months, and afterwards CareWorks will assist to get them 













An adherence level of up to 75% has been reported by CareWorks, with 3 employees having been 
reported to be non-adherent based on their viral suppression. CRE1 suspects non-compliant with 
1 or 2 employees who take alcohol whilst on treatment. Employees who are not yet receiving 
treatment are provided with dietary supplements by the company. The company also offers other 
forms of assistance such as financial support. In cases where an employee is very sick and has to 
seek medical attention, the company can assist by paying an advance to cater for medical 
expenses. This advance will be paid when the employee returns to work. 
 
Running the day-to-day duties of the programme is a permanent HIV/AIDS facilitator who is 
employed by the company. Assisting the facilitator are temporary HIV/AIDS facilitators. Their 
responsibilities include taking HIV-positive employees to collect their medications, for routine 
tests and check-ups. The AIDS facilitator is also responsible for ordering supplements upon 
CareWorks’ recommendation and administering them. If at any time an employee is concerned 
about their HIV status, the facilitator can assist by taking the employee to CareWorks for testing. 
The facilitator receives training every 2nd or 3rd year. An HIV/AIDS facilitator committee meets 
with CRE1 on a quarterly basis to provide feedback. The facilitator initially started by collecting 
and distributing drugs but, with time, the system improved and was administered directly from 
CareWorks and some by the facilitator.  
 
Disclosure of HIV status 
 
The level of disclosure has been reported to be high. About 80% (n=46) of HIV-positive 
employees are known to the facilitator and 20% (n=12) have disclosed to CareWorks.  
 
Benefits of providing HIV/AIDS services to employees 
 
Currently, testing has been done for free and the company pays for patient management and care. 
CRE1 admitted that the programme is much cheaper than they had initially projected. The current 
budget is set at R600 000 per year, including salary and operational costs of the AIDS facilitator. 
The average cost of providing treatment and supplements is estimated at R620 per person per 
month. With 58 employees on the programme, the total cost is estimated at R35 960 per month. 
CRE1 reported paying CareWorks between R30 000 – R40 000 per month for patient 
management and care. The interviewee declares that the benefits of offering a programme 












therefore semi-skilled, they are considered a vital part of the operation on the sites which the 
company cannot afford to lose. Indirect benefits include trust and loyalty of employees towards 
the company. Physical change is also visible as most of the employees on treatment are very 
healthy. 
 
Concerning absenteeism, the company has managed to curb it by minimising downtime on 
machines. The CRE1 stated that they have a great arrangement with CareWorks which does not 
result in the employees missing work. Because the majority of employees are operators, the 
company cannot afford to have machines standing idle while employees go to collect drugs. Even 
though the company has reportedly lowered absenteeism of HIV-positive employees, CRE1 
reported absenteeism for HIV-positive employees to be lower than for HIV-negative employees.  
 
Challenges faced by company E 
 
CRE1 reported disclosure as a challenge because there is nothing the company can do if an 
individual does not want to disclose their HIV status. An instance was reported where an 
employee was suspected to have died from AIDS without disclosing. Disclosure is seen as a way 
of helping the company to be more proactive in helping employees. They have had some 
employees on the treatment programme volunteer to give testimonies on World AIDS Day.  
Looking back from when they started, the company has been successful in getting more and more 
employees on the programme. In 2004 there were only 8 people on the programme, but the trust 
has grown and the numbers have increased over the years to 58 in 2011.  
 
With regards to offering an HIV/AIDS programme, one of the major challenges reported is the 
mobility of the employees. Mobility creates a problem when an HIV positive employee receiving 
medication has to leave his/her place of residents to work on a project. Other arrangements will 
have to be made to deliver medication and it will be difficult to monitor adherence to medication.  
 
The possibility of CareWorks losing its funding for free ACT presents difficulties for the 
company. It means an increase in their current budgetary allowance. A proposition would be to 
get the company that is currently subcontracted for the medicals to do the testing at a fee and also 














Innovative approaches to HIV/AIDS programmes 
 
As a form of an incentive, the company offers AIDS awards every year to people who are 
actively involved in promoting the programme. Recognition is also given to the best AIDS 
facilitator. Employees who have gone through HIV/AIDS training are sent out into the 
communities to teach about HIV/AIDS and encourage people to know their HIV status. Another 
form of encouragement comes from testimonials of HIV-positive employees.  
 
CRE1 has conducted presentations to other companies, upon CareWorks request, in order to 
encourage them to respond to HIV/AIDS. CRE1 reported that it was well received by other 
companies but some showed a lack of interest.  With regards to this, CRE1’s opinion was that 
companies listed on the Johannesburg Stock Exchange (JSE) are unlikely to respond because they 
are shareholder driven whilst non-listed companies are dependent on their employees and 
therefore likely to respond. 
 
6.7.4 Conclusion of case study on company E 
 
The company has been offering an HIV/AIDS programme for a number of years and therefore 
has a great appreciation of the benefits it brings. They have a well-developed comprehensive 
HIV/AIDS policy which has been translated well into the programme. Aspects of awareness, 
























6.8 Case Study 6  
6.8.1 Case details 
 
Name: Company F 
Size: Medium-scale construction company  
Programmes: No awareness campaigns and no treatment programme 
 
6.8.2 Company description 
 
Company F has been in existence since the 1980’s. The company is a registered member of the 
Western Cape Masters Builders and Allied Trades Association and is the recipient of a 20 year 
continuous membership award. 
 
The average gross annual turnover falls between ZAR13 million and ZAR26 million, making it a 
medium-sized company. The company employs between 45-60 employees, with an estimated 57 
permanent employees at the time of the interview. Their permanent workforce consists of 12 
highly skilled workers, 5 trainee artisans or operators, 27 general workers and 4 general 
administrative office assistants. CRF1 briefly described most of their general workers to 
constitute long standing employees who have been with their company since their late teens (16-
20 years). He further pointed out that even though the workers are functionally illiterate they are 
highly productive and valuable employees. After years of training, they have acquired a number 
of skills and are regarded as artisans.  
 
The company relies on its own in-house labour for wet trades such as concrete work, brickwork, 
plastering, skimming, ceilings, roof construction and roof carpentry. Subcontractors are employed 
for specialist trades. The company trades as general contractors, undertaking a broad range of 
works in the residential, commercial and industrial markets.  They can take up to 5 or 6 building 
















6.8.3 Interview summary 
Company representative 
 
The company representative (CRF1) was interviewed on the 23rd of February 2011. The interview 
lasted approximately 1 hour 15 minutes. The representative is employed as the managing member 




CRF1 reported that they have not implemented an HIV/AIDS policy, but that they have in their 
possession one that has been instigated by the Master Builders South Africa (MBSA) which they 
will adopt and put into practice. The policy was still in the drafting stage at the time of the 
interview. The draft policy sets out the MBSA’s objectives, which have been highlighted to 
include clarity on MBSA’s views and commitment to HIV/AIDS and the management of HIV-
positive employees in the building industry. It is clearly stated that the MBSA recognises the 
seriousness and implications of HIV/AIDS for individual employees, co-workers and the impact 
on specialist skills in the construction industry. The policy acknowledges the implementation of 
proactive HIV/AIDS workplace programmes as a way of minimising the consequences of the 
disease to the industry. 
 
The MBSA commits itself to protect employees, create awareness, encourage behaviour changes 
and ensure that all employees are treated with dignity, fairness and equality. Aspects of 
HIV/AIDS which the policy outlines include: confidentiality, testing, non-discrimination and 
employees at risk. It also recognises the legal right of HIV-positive employees to confidentiality 
and privacy concerning their health and HIV status. The policy sets out that the MBSA will 
encourage member’s employees to undergo HIV testing, but asserts that no one is legally 
compelled to get tested. Regarding non-discrimination, it is stated that HIV/AIDS must be treated 
like any other illness and therefore HIV- positive employees should not be subjected to 
victimisation or discrimination. The policy identifies safety representatives and first-aiders as 
employees at risk of contracting the disease. In order to avoid this risk, the MBSA will promote 















HIV/AIDS awareness and prevention programme 
 
Company F has no HIV/AIDS workplace programme in place. CRF1 reported that no incidences 
of HIV/AIDS had been reported until 3 or 4 years ago. These have so far been dealt with on an 
individual basis. What follows is a report on 2 incidences of employees with HIV/AIDS which 
the CRF1 experienced and how they dealt with it.  
 
HIV/AIDS case 1 
 
This incident started 3 or 4 years ago with an employee who had been in their employment for 20 
years. CRF1 started noticing an extreme loss of weight, accompanied by a loss of energy. After 
sometime, the employee became noticeably ill and was progressively getting weaker. CRF1 
reported that other employees were covering up for him by letting him do the less physically 
challenging work. After consulting with the employee and discovering that he had not been to the 
doctor, CRF1 took him to his personal medical practitioner. An HIV test was conducted, which 
confirmed their suspicions that he could be HIV-positive.  
 
At the time of the test, the employee was at the threshold of having full blown AIDS because his 
immunity was very low. He was suffering from respiratory tract infections and other 
complications. The doctor advised that the employee was not fit to work on a construction site 
and needed to be put on HIV treatment. Because of lack of experience of dealing directly with an 
AIDS patient, CRF1 was under the impression that the government’s ARV rollout was easily 
accessible. The doctor’s comment to this regard was (as quoted) “the kind thing you can do for 
this guy is to take him and shoot him.” This comment was made with regard to the struggles that 
one has to go through in order to be enrolled on the state programme.  
 
CRF1 was informed that the state program requires that an individual be booked at a clinic or 
hospital near to their area of residence. The employee was living in one of the townships and 
therefore had to be booked at the local clinic in that area. Based on experience and knowledge, 
the doctor advised that they would not receive the assistance they needed from the clinic because 
they are under-resourced and only offer testing services and no treatment services. In order to 
avoid these obstacles, a decision was made in order to assist him quickly. The employee also 
worked as a watchman at the CRF1s house and therefore could be placed in that geographical 












The interviewee stated that it was the most disappointing and frustrating experience. They sent 
one of the company vehicles to fetch him from his house and took him to the hospital early in the 
morning. When they checked on him about 12 hours later, he had not been attended to. 
Eventually when he was attended to, he was sent off with a packet of pain killers. The interviewer 
was baffled by this because it is in contrast with what the media portrays regarding the national 
rollout of ARVs. After persistence, he was referred to a day hospital where he was given pain 
killers as well. Prior to this, the doctor had suggested that it would be difficult to receive ARVs 
because of the stage of his illness. 
 
CRF1 reported that the employee knew the nature of his illness. He described him as being 
anxious and not understanding the process. The employee and his spouse were counselled in the 
presence of CRF1. CRF1 recommended that the spouse get tested and the results came out 
negative. The employee was eventually admitted into hospital where he was receiving terminal 
treatment until he eventually passed away. During the final days, his family and friends distanced 
themselves and were not visiting him in the hospital.  
 
HIV/AIDS case 2 
 
Another case that the company experienced 6 months back from the time of the interview was 
with an employee in his 40s. He had been with the company since the age of 16. CRF1 described 
him as phenomenal in his ability to learn, exceptional, with an entrepreneurial mind.  
 
It started when the employee approached CRF1 explaining to him that he was not feeling well 
and did not have energy. The employee was taken to the doctor where he got an HIV test which 
came out positive. His CD4 count was relatively high, and in fear of losing this employee, the 
CRF1 asked the doctor to assist them. The employee moved from the townships to a better living 
area where he would receive better health services. The employee consulted the day hospital 
where he got his CD4 count tested and prescription of supplements due to him. CRF1 was 
frustrated that the employee was not receiving treatment. The reason was because of the national 
policy for ARV rollout which states that ARVs will not be administered until the CD4 count has 
dropped below 200. The employees’ CD4 count was 600. At the moment the employee has been 













CRF1 reports that the employee has been going for regular CD4 count check-ups, is in good 
health and has not fallen ill. The CRF1 stated that without the help from the medical practitioner 
the employee would be at the mercy of local hospitals who do not offer much help.  
 
Regarding general employee wellness, the company pays for workers insurance and makes use of 
the private medical practitioner if any employee needs medical attention. A number of the 
employees have been reported to be on TB treatment however it is not known how many are 
HIV-positive.  
 
CRF1 reports that the idea of having an HIV/AIDS awareness and prevention campaign has 
crossed their minds even before the HIV/AIDS cases. Currently the mobile caravan that goes on 
all the sites conducting medical examinations on all employees enquires if employees have been 
tested for HIV or are showing any symptoms for HIV/AIDS. In an informal way they discuss 
HIV/AIDS among themselves and the CRF1 encourages them to look after themselves. The talks 
around HIV/AIDS are not regular but are normally brought up after something has happened, for 
example, if someone has been diagnosed with TB. CRF1 stated that the talks help because at 
times employees suggest going for HIV testing.  
 
Challenges arise in getting the AIDS message across because the company employs 3 levels of 
generations, for example, from grandfather to father to son. When these discussions are held, the 
employers acknowledge the culture of the employees and the younger employees speak through 
the older employees. The older employees (>70 years) command more respect and therefore it 
becomes difficult for the younger employees to speak to them regarding engaging in safe sexual 
practices. CRF1 feels that the forum they use is not appropriate to put the AIDS precaution 
message across because of who they will be doing it through. In terms of teaching lifestyle 
changes, the interviewee feels that it is difficult to interfere in the personal lives of their 
employees. 
 
Disclosure of HIV status 
 
CRF1 reported that their workforce is stable and if anything happens to any one of them, 
everyone will be informed. There is also a high level of trust, which presented no problems of 
disclosure with these two employees. The interviewee strongly feels that his most success has 












ensuring that employees disclose. He attributes this disclosure to the culture of the company as 
top management have personal relationships with employees. He highlights that large companies 
have far more impersonal relationships. 
 
The interviewee reported that when the other employees saw their fellow worker deteriorating, 
they never ostracised him but instead covered up for him. CRF1 saw it as a social or culture 
response mainly because the employees might have been exposed to the disease through relatives 
and family. He affirms that they have a good understanding of the seriousness of the disease.  
 
Benefits of providing HIV/AIDS services to employees 
 
CRF1 acknowledged that he has been well informed about HIV/AIDS through these experiences. 
He feels that it is imperative to assist employees because they are an important asset to the 
company and are highly reliable. After working with a company for a while, employees build a 
certain level of trust with the company and integrity. He points out that in a small company, the 
impacts of HIV/AIDS are felt very strongly because in some instances, one person can be 
responsible for a certain job that is highly skilled. An economic consideration would therefore be 
required to keep the employees who are valuable to the company. 
 
6.8.4 Conclusion of case study on company F 
 
Company F holds strong values of employee wellbeing as evidenced by the two scenarios 
described above. The company does not have an HIV/AIDS policy and HIV/AIDS programme in 
place and had to deal with each situation as it occurred. A family culture and a culture of 
openness among the employees and management proved to be a good quality which the company 
holds. Because of these attributes, employees felt at ease to disclose their HIV status to 
management and fellow employees. The experiences incurred have been a learning curve for the 
company and highlight the importance of having an existing system in place. Since the general 
perception is that large companies are the most affected by HIV/AIDS, this illustrates the extent 















6.9 Conclusions Based on an Inter-Case Study Analysis of the Findings 
 
The case study findings have revealed different opinions concerning the provision of HIV/AIDS 
workplace programmes by large and medium sized construction companies. The findings provide 
a basis for an inter-case study to determine the reasons for provision of HIV/AIDS programmes 
and the non-provision by some companies. The findings of the HIV/AIDS factors under 
investigation have been summarised in Table 6.1, for each case study. These factors are, namely: 
HIV/AIDS policies, HIV/AIDS awareness and prevention campaigns, HIV/AIDS treatment 
programmes, disclosure, financial viability of treatment programmes, challenges encountered and 

















The following discussion is made with reference to Table 6.1. 
 
6.9.1 HIV/AIDS policy 
 
The findings have revealed HIV/AIDS policy implementation by five companies. Three of 
these policies are independent HIV/AIDS policies. They can be considered to be 
comprehensive as they cover all aspects of HIV/AIDS, clearly stipulating the approach and 
methods that these companies should follow in the provision of their HIV/AIDS-related 
programmes. Two of the policies follow a top-down, bottom-up approach and one follows a 
top-down approach in their implementation. All companies have, in turn, translated their 
policies well into their HIV/AIDS programmes as illustrated by their comprehensive 
HIV/AIDS workplace programmes, which range from awareness to patient management and 
care. These findings agree with the literature which suggests that the implementation of a 
good HIV/AIDS policy facilitates a comprehensive workplace HIV/AIDS programme.  
 
Out of the five companies that have HIV/AIDS policies, the remaining two do not constitute 
comprehensive policies. One company reported incorporating HIV/AIDS aspects into an 
existing policy and the other company had no knowledge of what the policy entails as it was 
formulated at the head office and not communicated to the other offices. The two companies 
in turn did not provide comprehensive HIV/AIDS programmes, but merely provide 
HIV/AIDS workshops through CareWorks. The only company which has not implemented an 
HIV/AIDS policy informed us of their intention to adopt the MBSA HIV/AIDS policy which 
was still at the formulation stage at the time of the interview. Following on the reports by 
company respondents, it can be noted that no relationship exists between policy reviewing 
and the presence of a treatment programme. Company A reported an annual review of their 
policy while the other two companies offering treatment programmes reported that their 
policies are not reviewed on a regular basis.  
 
6.9.2 HIV/AIDS awareness campaigns 
 
It was determined that four of the companies that reported the presence of awareness 
campaigns utilise CareWorks as their service provider. Of these four companies, three have 
been making use of these services since 2003, 2005 and 2007. CareWorks awareness 
workshops have been reported to be effective in getting workers educated and achieving high 













companies because of the size of the companies’ workforce. Their continued use of 
CareWorks as a service provider has been attributed to the comprehensiveness of their 
services and because they offer these services free of charge. The HIV/AIDS education 
session provided by CareWorks was commended by the representatives. It was the most 
preferred medium to get the HIV/AIDS message across to employees. Some companies have 
gone beyond the CareWorks HIV/AIDS awareness campaigns and provide in-house 
HIV/AIDS education on prevention, provision of condoms and posters on site. Despite the 
threat of CareWorks possibly losing funding and looking to offer these services at a fee, the 
companies highlighted an interest in continuing to utilise them. 
 
6.9.3 HIV/AIDS treatment programmes 
 
In this case study analysis, it was revealed that the implementation of an in-house treatment 
programme is less desirable than treatment provision through an external service provider. Of 
the three companies that reported the presence of a treatment programme, one company 
provides an in-house treatment programme. The other two companies provide treatment 
through CareWorks.  
 
The reason stated for providing an in-house treatment programme is that of convenience and 
reducing absenteeism from employees taking time off to wait in queues for medication. Other 
reasons for offering treatment were to retain skills and to keep employees healthy and 
productive for as long as possible. Interestingly, not all large companies share similar 
perspectives regarding the provision of treatment programmes. Company B’s decision not to 
provide treatment services rested upon the possible challenges of who to offer treatment to 
because of the different contracts that employees have and the difficulty in managing the 
process. Company D cited the non-visibility of HIV/AIDS among its workforce.   
 
The case study analysis revealed that administration of treatment by employees varied 
depending on level of disclosure and employees’ work category. Company A provides a 
comprehensive in-house treatment programme by providing workers with a three month’s 
supply of ARV drugs delivered to them personally on site or at the company’s head office. 
The company is able to undertake this because of the high level of disclosure within the 
company. A low level of disclosure does not allow the flexibility of delivering medication to 














In Company C, CareWorks is responsible for administering treatment directly to the 
employees. Company E has facilitated workers to receive medication through an HIV/AIDS 
facilitator, because of the high level of disclosure reported. Although Company F does not 
have an HIV/AIDS treatment programme, it reported utilising a private general practitioner 
(GP) in their HIV/AIDS consultations for the two cases they have experienced. Regarding 
employees’ work category, companies have revealed that they do not offer treatment services 
to all HIV-positive employees. Company A and C administer treatment to employees that are 
not on medical aid. Company E administers to permanent hourly-paid employees who are not 
on medical aid and assist contract workers to receive treatment from public health centres.  
 
6.9.4 Disclosure of HIV status 
 
As presented in the case study analysis, companies provided strict policies regarding 
disclosure of HIV/AIDS status to the companies. The policies make provision for the utmost 
confidentiality and protection of HIV-positive employees against discrimination and 
stigmatisation. In this regard, no companies reported HIV-positive employees being 
ostracised by other employees. Company F reported co-workers covering up for the sick 
employee. In the event that discrimination happens, the policies highlighted the specific 
action that the company would follow. Company policies have stringent measures in place to 
prevent employees being dismissed on the grounds of their HIV/AIDS status. From all the 
companies studied, it was reported that no employee had been dismissed as a result of their 
disclosing their HIV/AIDS status.  
 
Companies regard disclosure as a potential impediment to the effective provision of treatment 
to HIV-positive employees, due to fears of being stigmatised. In an effort to promote 
disclosure, one company allows for openly-disclosed HIV-positive employees to provide 
testimonials in order to encourage other employees to disclose their status in order to get 
access to treatment. For another company, a high level of trust was considered as a significant 
factor to encourage disclosure. 
 
In Company B, disclosure has been seen as a success of the programme and acceptance of 
HIV/AIDS-infected persons. This has been attributed to the culture of the company to treat 
HIV/AIDS like any other disease. Suspected reasons for non-disclosure of a few individuals 
was denial in accepting one’s HIV status and resistance to lifestyle changes. The case study 
analysis revealed a high level of confidential disclosure towards management, and reluctance 













challenge in bridging the gap between discovery of HIV status and uptake of treatment 
services. This transition from being tested to the worker actually receiving treatment depends 
on the ability of the company to uphold the anonymity of the employees. Over the years, 
companies providing treatment have devised ways of effectively managing the process and 
this has reflected on their reports on increased uptake of treatment services. Company E 
provided statistics which shows an increased uptake of HIV treatment over the years.  
 
6.9.5 Financial viability of HIV/AIDS treatment programmes 
 
All companies offering treatment programmes assert the financial viability of providing them. 
They reported that the benefits outweigh the costs. In this regard, Company A reported on 
spending within the budget; Company C feels that the costs are negligible and are absorbed 
by the returns, and Company E reported on spending within the budget and on the actual costs 
being cheaper than the anticipated costs. An important point to note is that the cost of offering 
a treatment programme depends on the number of employees receiving ARVs and the number 
of employees receiving supplements. Since it is more expensive to offer ARV’s than 
supplements, the more employees on ARVs, the more the company pays. 
 
Companies that do not provide treatment programmes had not conducted any financial 
analysis as to the costs of providing treatment to their workers and therefore are unaware of 
the true financial implications of providing a programme. However, Company B held a strong 
perception against the financial viability of a treatment programme. This claim was made 
specifically with regard to offering treatment to contract workers. This is because contract 
workers are employed for a certain period of time and therefore are likely to leave the 
company when the contract ends, meaning that they will either not stay on treatment for long 
or the company will not benefit from providing treatment. Companies offering treatment 
services have also justified this perception by not offering treatment services to contract 
workers. The companies merely facilitate contract workers to receive treatment from 


















6.9.6 Challenges in the provision of HIV/AIDS programmes 
 
Two companies reported facing challenges in the provision of HIV/AIDS programmes. A 
challenge facing Company C is the resistance of HIV-positive employees on treatment to 
change risky behaviour such as alcohol abuse. This was reported in terms of non-compliance 
to ARV treatment due to alcohol abuse. Another challenge identified is the difficulty in 
protecting employees at risk of contracting HIV/AIDS, without breaking the confidentiality of 
HIV-positive employees. Company E cited the mobility of employees from site to site as a 
major challenge which affects administration of medication and in turn adherence to 
treatment. 
 
6.9.7 Innovative approaches to HIV/AIDS programmes 
 
Two companies have reported extending their workplace programmes to include the wider 
communities and schools in HIV/AIDS education. This has been done with the aim of 
increasing awareness in the communities and amongst the younger generation. No 
consideration has been made to include treatment services because of the lack of resources 
and capacity for companies to manage large numbers of people. One company reported that a 
nearby community requested that the company open their HIV treatment services to the 
community.  
 
6.9.8 HIV/AIDS “stories” 
The recounting of HIV/AIDS experiences reported by the company representatives was one 
of the most satisfactory aspects of the case study investigation. The company representatives 
were forthcoming and provided rich data which was sought after in these case studies. They 
provided in great detail, their personal experiences and feelings regarding dealing with HIV-
positive employees.   
 
The assumption made by CRE1 regarding companies listed on the JSE not being proactive 
was investigated further by checking which case study companies were registered on the JSE 
website (see www.jse.co.za). On the face of it, the assumption was confirmed to be true for 
the case studies under investigation. Out of the 5 large companies investigated, 3 companies 
that were providing treatment services were not listed on the JSE and 2 companies not 















This chapter has documented the findings of each individual case study, followed by an inter-
case analysis. The study has established that a well-developed HIV/AIDS policy can be 
translated into a comprehensive HIV/AIDS workplace programme. It is evident in this study 
that education is a significant component of a comprehensive HIV/AIDS workplace 
programme as it can effect change in perceptions and behaviour. The most common form of 
HIV/AIDS workplace interventions are awareness campaigns, which have currently been 
offered free of charge by an external service provider. Despite the similarity in sizes of the 
large scale case study companies, the availability of treatment programmes differs because of 
differences in perceptions of costs and visibility of the disease. Reasons provided for offering 
treatment services range from retaining skills, keeping employees healthy for as long as they 
can be productive and offering convenience to employees. What has also emerged from this 
study is the tendency of some companies to deal with HIV/AIDS on a case-by-case basis. In 






































This study has explored HIV/AIDS in the construction industry, focusing on the way in which 
HIV/AIDS is perceived and how construction companies in the Western Cape region in South 
Africa have responded to the disease. The problem statement as presented in Chapter One was 
as follows: 
 
The construction industry’s response to HIV/AIDS lacks comprehensive intervention 
programmes, with the majority of the programmes focusing largely on awareness and 
prevention with little emphasis on treatment programmes. 
 
The research questions that were the focus of this study were stated as: 
a) What are the perceptions of HIV/AIDS as a threat to the construction industry? 
b) What are the responses of construction companies to HIV/AIDS in the Western Cape 
construction industry? 
c) What are the barriers to the implementation of treatment programmes within 
construction companies? 
d) What are the benefits of implementing treatment programmes within construction 
companies? 
 
The proposition tested by the research is as follows: 
The benefits of implementing treatment programmes outweigh those of non-
implementation, rendering the implementation of treatment programmes an effective 
response. 
 
The approach to this study was largely qualitative in nature, comprising a critical review of 
the pertinent literature on HIV/AIDS in the construction industry, a survey on perceptions of 
HIV/AIDS as a threat and responses to HIV/AIDS among construction companies, as well as 
a case-study based research examining the implementation of treatment programmes in the 
Western Cape construction industry. This chapter discusses the findings of the research 
questions posed, evaluates and validates the research proposition formulated for the research. 
Conclusions are drawn from the research findings, and recommendations made for future 
research and for practice. A discussion on the achievement of the research aims and 













7.2 Findings of the Research Questions 
 
The opinion survey instrument was designed (Chapter 3) and administered to explore the 
perceptions of HIV/AIDS as a potential threat to the construction industry and responses to 
HIV/AIDS. The survey aimed to substantiate issues identified in the literature review and 
expose any additional issues. 
 
What are the perceptions of HIV/AIDS as a threat to the construction industry? 
The findings of the survey indicate differences in the perceptions of HIV/AIDS as a threat by 
company representatives. A slight majority of the surveyed construction participants consider 
HIV/AIDS as a threat, followed by indifferences regarding these perceptions. The survey 
revealed that a few construction participants perceived HIV/AIDS as a slight problem or no 
problem at all. The perception of HIV/AIDS as a long term threat to the industry is not 
universally held. 
 
What are the responses of construction companies to HIV/AIDS in the Western Cape 
construction industry? 
The survey reveals differences in the implementation of HIV/AIDS policies and HIV 
intervention programmes. There is a lack of maturity and comprehensiveness in the response 
to HIV/AIDS. Much of the intervention programmes take the form of HIV/AIDS education, 
awareness and discovery of HIV status. There is a lack of provision of HIV/AIDS treatment 
programmes.  
 
What has other research in this field revealed? 
A review of the relevant literature (Chapter 2) revealed a comparative dearth of research in 
the field of HIV/AIDS in the construction industry. The available survey-based research 
conducted shows little practical applications of the theoretical aspects of the topic into the 
construction industry. Other researchers have revealed the need for the construction industry 
to take action against HIV/AIDS, but there has been no enforcement to ensure a universal 
adoption of HIV/AIDS programmes.   
 
Other issues revealed by the survey include the nature of treatment programmes employed 
and how they were implemented, management of HIV-positive employees and perceptions of 















Case studies were employed for more in-depth exploration of the research questions and 
issues. The case study protocol allowed for the collection of the primary data (Chapter 5). Six 
construction companies were investigated, out of which three were offering treatment and 
three were not offering treatment. The main findings from this investigation (Chapter 6) show 
that: 
 
• While construction respondents have slightly stronger perceptions of HIV/AIDS as a 
threat to companies, these are not related to the company’s responses in the provision of 
HIV/AIDS treatment programmes. If there is no uniform understanding of the potential 
threats of HIV/AIDS to company profits and productivity, then company representatives 
are likely to view the provision of HIV/AIDS treatment differently (as confirmed in the 
survey research discussed in Chapter 4). 
• The implementation of HIV/AIDS programmes in construction companies has largely 
been driven by CareWorks. Awareness campaigns and treatment programmes have been 
led by the service provider. 
  
In terms of current HIV/AIDS treatment programmes, the three relevant case studies showed 
that: 
• CareWorks is playing a major role in encouraging companies to offer treatment services 
• the formulation of an HIV/AIDS policy forms the basis of a treatment programme 
• the approach is proactive than reactive 
• top management involvement is essential to ensure employees involvement and 
participation 
• the provision of treatment is driven by productivity concerns 
• benefits outweigh costs of provision  
• treatment access is limited to permanent employees 
• disclosure concerns and fear of stigmatisation are impediments to the effectiveness of 
treatment programmes 
 
The organisational structures of the case study companies and their company representatives 
revealed that: 
• the involvement of top management in HIV/AIDS awareness workshops ensures 
participation and uptake of HIV testing services; 
• the relationships between top management and employees contribute towards ease of 













• The involvement of employees in HIV/AIDS policy implementation yields a positive 
response from employees.  
 
These findings validate the problem statement by indicating that the implementation of 
treatment programmes is still lacking among construction companies. Among the different 
HIV/AIDS intervention programmes available, the most adopted are HIV/AIDS awareness 
and prevention programmes which do not translate into an effective response considering the 
threat HIV/AIDS poses.  
 
7.3 Validation of the Research Proposition 
 
The research has tested the following proposition: 
The benefits of implementing treatment programmes outweigh those of non-
implementation, rendering the implementation of treatment programmes an effective 
response. 
 
The findings of Chapter 6 support the above proposition for the companies under review that 
have implemented an HIV/AIDS treatment programme. The company representatives report 
on treatment programmes giving returns of employee wellbeing that exceed beyond monetary 
value. The costs of providing treatment programmes have been regarded as negligible 
compared to the costs that the companies had initially envisaged. The offering of treatment 





The construction industry has been identified as being particularly vulnerable to the 
HIV/AIDS epidemic due to migratory nature of the workforce which promotes poor lifestyle 
choices, the tendency to employ semi-skilled labour which has a relatively high HIV 
prevalence, and the aging of the workforce. Furthermore, it has been established that the 
construction industry is labour intensive, making use of mass informal labour. These workers 

















The research has shown that the construction industry still has a considerable way to go in 
ensuring effective responses in the management and care of HIV/AIDS positive employees. 
CareWorks has been a major driver in implementing HIV/AIDS programmes among 
construction companies. They offer a comprehensive HIV/AIDS programme, with the facet 
most adopted being the HIV/AIDS awareness workshops. These were noted to be funded 
through PEPFAR from the US Global Health Initiative. Treatment programmes on the other 
hand have no supporting grants and therefore were a direct cost to construction companies 
and not always likely to be implemented.  
 
Despite the fact that CareWorks provides a comprehensive HIV/AIDS awareness workshop 
that yields a high uptake of HIV testing, the underlying threat of the industry lies in its failure 
to manage existing infections. The lack of a formal systematic approach to manage the disease 
works against adopting an effective approach. There is lack of promotion for construction 
companies to engage in HIV/AIDS treatment programmes and no standardised approach to 
assess HIV/AIDS risk within companies.  
 
For companies that have implemented treatment programmes, their main reason for offering 
treatment services has largely been a business case, to keep employees healthy and productive 
for as long as possible. What has emerged in this research to ensure survival of these 
programmes is continued support and commitment from top management in HIV/AIDS 
programmes and the participation of HIV/AIDS-positive employees. It has been established 
that non-disclosure of HIV/AIDS positive employees hinders efforts for companies willing to 
offer treatment services.  
 
Perceptions regarding the costs of providing treatment services have emerged as a major 
barrier to implementing treatment programmes. Companies are unaware as to the exact costs 
of these programmes and therefore unlikely to implement treatment programmes. However, 
testimonies from companies actually offering treatment reveal that paying for treatment is 
negligible compared to the returns that the company is receiving. While the consequences of a 
lack of a comprehensive response may not currently be felt by the companies, its absence is 





















In practice, professional associations for construction companies can play a proactive role in 
raising awareness through education and career development strategies and programmes. It 
has been recommended that they contribute towards an HIV/AIDS treatment campaign by 
providing guidelines based on examples of successful companies.  
 
Since the future of the construction industry lies with the younger generation, it is strongly 
recommended that HIV/AIDS education and training be included in the curriculum of tertiary 
institutions for construction disciplines. This will expose students more fully to the risks of 
HIV/AIDS towards themselves and the industry. 
 
Future research effort might be usefully directed towards developing a better theory of 
practice of HIV/AIDS management for construction companies and guidelines that can be 
adopted by companies of any size and category. These guidelines can be derived from well- 
developed HIV/AIDS management programmes from the mining industry, whose HIV/AIDS 
risk is relatively similar to that of the construction industry. 
 
Future research should also investigate ways in which comprehensive HIV/AIDS 
management practices can be applied more effectively. In particular, the research should 
focus on a detailed step-by-step preliminary assessment of HIV/AIDS risk, the 
implementation of HIV/AIDS awareness, prevention and treatment programmes, and 
measurement of their effectiveness. Another recommendation for future research would be to 
establish a cost-benefit analysis model based on the actual costs and benefits of providing a 
treatment programme.  
 
7.6 Achievement of the Research Aims and Objectives 
 
The objectives for this research were to: 
 
a. establish the perceptions of construction companies regarding the extent of the HIV/AIDS 
threat to the industry. 
b. establish the nature of existing HIV/AIDS programmes among construction companies. 
c. examine how construction companies have implemented treatment programmes. 














The first objective has been achieved through the opinion-based survey of construction 
companies undertaken in Chapter 4. The perceptions of HIV/AIDS as a long-term threat have 
been clearly stated, with the majority of the company representatives acknowledging it as a 
potential problem.  
 
The second objective has been achieved through the literature review, survey research 
findings, and case study analysis presented in Chapters 2, 4 and 6 respectively. Examination 
of the nature of existing HIV/AIDS programmes has been undertaken, highlighting the 
theoretical aspects of HIV programmes and their practical applicability.  
 
The third objective has been achieved through the findings drawn from the primary data 
collection from the case studies discussed in Chapter 6. The case studies have provided a 
detailed account of how HIV/AIDS treatment programmes are implemented and managed by 
the individual companies. An account of the administration of drugs has been provided, 
together with measure that the companies adopt to ensure confidentiality and to deal with the 
social effects of the disease on the employees.  
 
The fourth objective has been achieved through the literature review in Chapter 2 and 
findings drawn from the primary case study data collection as reported in Chapters 6. The 
benefits of providing treatment programmes have been clearly cited, including challenges that 
companies are facing. The prevailing hindrance to the implementation of treatment 
programmes was identified to be: the perceived negative financial impact that these treatment 
programmes have on certain companies. 
 
The aim of this research was to establish the response to the HIV/AIDS pandemic by selected 
Western Cape construction companies. This aim has been achieved by providing a more 
informed understanding of the experiences that companies are going through in dealing with 
HIV/AIDS. The research has contributed first hand experiences of construction companies to 
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Appendix B: Case Study Interview Questions 
 






















































Disclosure  Financial viability of 
treatment programmes 
Challenges Innovative approaches 





workshops and in-house 
HIV/AIDS education 
Provides an in-house 
managed treatment 
programme 
High level of 
disclosure, considered 
a driver for effective 
treatment provision 
Costs considered 
negligible as they fall 
within the expected 
budget 
None reported HIV/AIDS education in 
schools, communities 
and farms. Proposes to 
extend to academic 
institutions 
Company B Large HIV/AIDS aspects 






Does not provide any 
treatment programme, 
citing difficulties in 
managing the 
programme as a  major 
barrier 
Considered a barrier to 
the provision of a 
treatment programme 
Costs considered a 
possible barrier to the 
implementation of 
treatment programmes 
None reported Proposes to involve 
health and safety officers 
in HIV/AIDS training 





workshops and in-house 
HIV/AIDS education 
Provides a treatment 
programme through 
CareWorks 
Low level of 
disclosure, considered 
a barrier to effective 
provision of a 
treatment programme 
Costs considered 
negligible as returns 





employees at risk 
None reported 
Company D Large Implemented policy 
but centralised at 
the head office 
Provides once-off 
awareness campaigns on 
World AIDS Day 
Does not provide any 
treatment programme, 
citing no HIV/AIDS 
cases reported as the 
reason 
No disclosure Costs considered a 
possible barrier to the 
implementation of 
treatment programmes 
None reported None reported 




workshops and in-house 
HIV/AIDS awareness 
Provides a treatment 
programme through 
CareWorks 
High level of 
disclosure, considered 
a driver for effective 
treatment provision 
Costs considered 
negligible as they fall 
within the expected 
budget 
None reported Provides incentives such 
as AIDS awards. 
Involved in community 
outreach and stakeholder 
outreach 
Company F Medium No HIV/AIDS 
policy but intends 




HIV/AIDS, on an 
irregular basis 
Does not provide any 
treatment programme, 
citing cost implications 
as a  major barrier 
High level of 
disclosure, considered 
a driver for accessing 
treatment 
Costs considered a 
possible barrier to the 
implementation of 
treatment programmes 
Mobility of employees 












HIV/AIDS Interventions Survey - June 2009
Dear Construction Industry Colleague
As part of a UCT-based research project into the nature and effect of HIV/AIDS treatment programmes 
in the Construction Industry, we are undertaking a pilot study of randomly-selected construction firms. 
We would greatly value your contribution to the survey. 
Your responses are HIGHLY CONFIDENTIAL. While we ask for the name of your organization, this is 
merely to track who has responded rather than to link specific answers to specific companies. The 
results will be published in aggregate form only and responding organisations will remain anonymous. 
Should you have any questions or comments with respect to this survey, please feel free to contact the 
primary researchers at the University of Cape Town; details are given below. 
Professor Paul Bowen (paul.bowen@uct.ac.za)
Jonathan Marks (jonathan.marks@uct.ac.za)
NB: The starred (*) questions require to be answered before you can proceed.
1. Company Name
2. Position/Job Title












Construction of civil engineering structures
 
nmlkj
Construction of other structures
 
nmlkj
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4. How many permanent employees do you have?
























Less than R6 million per annum (Micro)
 
nmlkj
R6 million to R13 million per annum (Small)
 
nmlkj
R13 million to R26 million per annum (Medium)
 
nmlkj












HIV/AIDS Interventions Survey - June 2009
1. How does your company rate (perceive)the threat of HIV/AIDS as a long 
term problem in the Construction Industry?
2. Does your company have an HIV/AIDS policy?
3. If YES to Question 2; which of the following does the policy entail? (tick all 
applicable)
2. Company Perceptions and Policy
*
 Significant problem Problem Neutral Slight problem Not a problem



























HIV/AIDS Interventions Survey - June 2009
1. Does your company have an HIV/AIDS AWARENESS campaign?
2. If YES to Question 1; when was it implemented in your company and 
what does it involve?
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1. Does your company have an HIV/AIDS PREVENTION programme?
2. If YES to Question 1; when was it implemented and what does it involve?
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1. Does your company have an HIV/AIDS TREATMENT programme?
2. If YES to Question 1; when was it implemented and what does it involve?
3. If YES to Question 1; is the treatment programme managed in-house? 
4. What are the reasons for having a company-sponsored HIV/AIDS 
treatment programme? 
























HIV/AIDS Interventions Survey - June 2009
1. Do you encourage employees to know their HIV status?
2. In your opinion, what percentage of the permanent (site) staff are HIV 
positive and why do you think so?
3. What percentage of HIV positive permanent staff have disclosed their 
status?
4. What percentage of HIV positive permanent staff are known to be on a 
company treatment programme?
5. Rate the level of participation of your HIV positive permanent staff in the 
company HIV treatment programme 
6. Of those who embark on HIV treatment programmes in your 
organisation, approximately what percentage of participants remain on the 
programme long-term? 




a. Confidentially to the 
company or their 
manager
b. Publicly
 Very low Low Average High Very high
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1. Which of the following types of support does your company provide to 
HIV positive permanent employees? (tick all applicable)
2. Does your company have a medical scheme contribution policy?
3. If YES to Question 2; is the policy 
4. If voluntary, what percentage of the permanent employees belong to this 
medical scheme?
5. Does the company's medical insurer report to management on the 
number and prognosis (on an anonymous basis) of company personnel 
registered on the HIV treatment programme?






Subsidised HIV treatment/ Anti-Retroviral Therapy
 
gfedc
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6. Within the organisation, who holds responsibility for the HIV/AIDS 
programme? (tick all applicable)
7. Rate the level of commitment of your company to the HIV/AIDS 
treatment programme?
8. How is success measured with respect to your HIV/AIDS treatment 
programme?
9. In your opinion, is it financially viable for the organisation to run an 
HIV/AIDS treatment programme?
10. If YES to Question 9; why do you think it is financially viable?
 Very low Low Average High Very high
Commitment to HIV 
treatment
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Thank you for participating in this survey; your information will be highly valued in our on-going research 











ORGANISATION ELEMENT ISSUE QUESTION DATA SOUGHT 
A. DEMOGRAPHICS 1. Organisation Size 




e) 201-250  
f) >250 
Ordinal 
2. Gross Annual 
Turnover 
a) Micro <R6m  
b) Small >R6m  <R13m  
c) Medium >R13m  < R26m 
d) Large >R26m 
Ordinal 
3. Interviewee Status a) Director  
b) Senior Manager  
c) Manager 




1. Draft an organisational structure diagram Diagrammatic    
B. HIV / AIDS POLICIES 1. Policies 1. Describe any formal HIV/AIDS awareness, prevention 












2. Describe any informal policies known to employees? 
2. Supplementary 
questions 
1. Explain reasons if no policies adopted? 
2. Describe how policies were formulated? 
3. Explain any external influences to encourage policy 
development (e.g. Union / government pressure). 
4. Explain any internal influences on policy development 
(e.g. CSR, HR department). 
5. Show on the Org. Struct. Diagram where policy 
development responsibility is situated. 
6. Explain how policies are implemented and show 
responsibilities on the Org. Struct. Diagram. 
7. Are staff members at all levels involved in policy 
development and implementation? 
8. How frequently are policies reviewed? 
Descriptive 
C. HIV / AIDS 
CAMPAIGNS 
 
1. Awareness and /or 
prevention 
campaigns 
1. Describe any HIV/AIDS awareness and/or prevention 
campaigns run by your organisation: 
a) Presented by third party external organisation? 
b) Short internal course on safe sex and HIV/AIDS 
awareness. 
c) Short external course on safe sex and HIV/AIDS 
awareness. 
d) Awareness posters and leaflets. 










e) Information about voluntary counselling and testing 
(VCT). 
f) Information leaflets / counselling about abstinence, 
faithfulness, the use of condoms, and the importance of 
support groups. 
g) Information about availability of internal HIV/AIDS 
counsellors. 
h) Information about availability of external HIV/AIDS 
counsellors. Placement of condom dispensers. 
i) Free issue of male and female condoms on all sites and 
at all offices. 
j) HIV testing. 
k) Other campaign features (describe). 
2. Non-
implementation 
1. Explain any reasons for NOT implementing HIV/AIDS 
awareness and /or prevention campaigns. 
a) High start-up cost. 
b) High ongoing costs. 
c) Small firm size. 
d) Not urgent yet (HIV/AIDS prevalence perceived as not 
significant). 
e) Potential HIV/AIDS impacts cushioned by current staff 
numbers. 










f) Not sure how to do this. 
g) Issues too sensitive for organisation and employees. 
h)  Cannot guarantee confidentiality. 
i) Insufficient co-operation from employees. 
j) Responsibility delegated to external consultants / 
contractors. 
k) Other reasons? 
3. Peer involvement 1. Describe the nature and extent of any “peer education” 





1. Describe the nature and frequency of any measures used 
to assess the effectiveness of awareness and prevention 
campaigns. 
2. Feedback by external organisation (if involved)? 
Descriptive + Cardinal 
3. Cost 1. Describe any budgetary considerations and cost 
assessments for awareness and prevention campaigns. 
2. Approximately what % of gross annual turnover do 
awareness and prevention campaigns cost your 
organisation? 
Descriptive + Cardinal 
4. Campaign 
responsibility 
1. Show on the Org. Struct. Diagram; 












b) How campaigns are managed. 




1. Describe any HIV/AIDS treatment programmes run 
by your organisation: 
a) Part of package offered by external 
organisation? 
b) Financial support offered 
c) Treatment subsidy 
d) Company clinic 
e) Contracted clinic services 
f) Subsidised mandatory medical aid scheme (closed 
company scheme) 
g) Subsidised voluntary medical aid scheme 
h) Disease management programme (DMP) required 
by medical insurer 
i) Time off to attend treatment 
j) Transport to /from clinics 
k) ARV therapy 
l) Nutritional / dietary supplements 
m) Limited support for infected family members 
Other (explain) 












1. Explain any reasons for NOT implementing HIV/AIDS 
treatment programmes: 
a) High start-up cost. 
b) High ongoing costs 
c) Small firm size. 
d) Not urgent yet (HIV/AIDS prevalence perceived as 
not significant). 
e) Potential HIV/AIDS impacts cushioned by current 
staff numbers. 
f) Not sure how to do this. 
g) Issue too sensitive for organisation and employees. 
h) Cannot guarantee confidentiality. 
i) Insufficient co-operation from employees. 
j) Responsibility delegated to external consultants / 
contractors (e.g. NGO, CareWorks)  
k) Other reasons? 
Descriptive+ Frequency count 
 3. Programme entry / 
exit 
1. How can employees enter a treatment programme? 
2. How long do employees normally remain on 
treatment programmes? 











4. Why do employees leave treatment programmes? 
What are the impacts of late entry by employees 
into treatment programmes? 
4. Substitution 1. Describe any evidence to suggest that fellow employees 
might work harder to cover the gaps left by workmates 




1. Describe the nature and frequency of any measures 
used to assess treatment programme effectiveness. 
2. Feedback from external organisation (if involved)? 
Descriptive 
6. Programme costs 1. Describe any budgetary considerations and cost 
assessments for treatment programmes. 
2. Approximately what % of gross annual turnover do 
treatment programmes cost your organisation? 
Descriptive + Cardinal 
7. Programme 
responsibility 
1. Show on the Org. Struct. Diagram; 
a) How treatment programme development responsibility 
is assigned. 

















1. Treatment programme benefits 1. Identify any organisational benefits from the 
implementation of HIV / AIDS treatment 
programmes: 
a) Retention of skilled staff 
b) Motivation of staff 
c) Improved staff morale 
d) Visible sign of CSR 
e) Other? 
Descriptive + Frequency 
count 
F. EMPLOYEE HIV STATUS 
DISCOVERY / DISCLOSURE  
1. Encouragement and response 1. What steps are taken to encourage employees to 
discover their HIV status? 
2. What level of discovery occurs among 
employees? 
3. What steps are taken to encourage employees to 
disclose their HIV status? 












2. Data confidentiality 1. What measures are used to maintain employee 
confidentiality about HIV status? 





1. Presence 1. Describe any HIV/AIDS stigmatisation that 
occurs in your organisation. 
2. Describe any effects / consequences of 
stigmatisation. 
a) For the employee 
b) For the organisation 
 
Descriptive 
2. Mitigation response 1. Describe any measures used to mitigate 
stigmatisation. 
2. Describe a specific response to an employee 












I. MEDICAL AID SCHEME 
DATA 
1.Management data provision 1. Describe the nature and extent of any HIV / AIDS 





1. Alternative ideas/incentives 1. Describe any creative or innovative approaches (e.g.  
application of VM techniques) used in your 
organisation to address HIV / AIDS policy, campaign 
or programme issues. 
2. Describe any incentives (e.g. lucky draw prizes) 
used in your organisation to encourage employees to 




1. Additional information 1. Please provide any additional information or 
comment that you believe is relevant to the Issue of 
HIV / AIDS in your organisation or the construction 
industry generally. 
Descriptive 
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